Tissue-augmented scaffolds for use in soft tissue fixation repair - Patent Application 20070229633
Tissue augmentation structures address the inadequacies of current soft tissue repair devices by enlarging the suture footprint, reducing damage, and shortening procedure time, thereby enhancing healing and reducing costs.
Patent Information
- Application Number
- JP2020105206
- Authority / Receiving Office
- JP · JP
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2019-06-19
- Filing Date
- 2020-06-18
- Publication Date
- 2024-11-12
- Estimated Expiration
- 2040-06-18
AI Technical Summary
Current surgical devices for soft tissue repair, such as rotator cuff fixation, are inadequate for degenerated tissue, causing further damage and are cumbersome to deliver, leading to prolonged procedures and increased costs.
Tissue augmentation structures, including tapes, tubes, blocks, rings, and patches, are used to enlarge the suture footprint, distributing force over a larger surface area and promoting healing, with methods allowing easy on-demand application during surgery.
The solution reduces tissue damage, shortens procedure time, and enhances healing by distributing forces effectively, while being cost-effective and easy to deliver.
Smart Images

Figure 0007580948000001 
Figure 0007580948000002 
Figure 0007580948000003
Abstract
Description
[Technical field]
[0001] (CROSS REFERENCE TO RELATED APPLICATIONS) This application is a continuation of U.S. patent application Ser. No. 15 / 419,330, filed January 30, 2017, entitled "TISSUE AUGMENTATION CONSTRUCTS FOR USE WITH SOFT TISSUE FIXATION REPAIR SYSTEMS AND METHODS," which is a continuation of U.S. Provisional Patent Application Ser. No. 62 / 289,702, filed February 1, 2016, entitled "COMPRESSION STRIPS AND SCAFFOLDS FOR USE IN SOFT TISSUE FIXATION," U.S. Provisional Patent Application Ser. No. 62 / 348,548, filed June 10, 2016, entitled "COMPRESSION CONSTRUCTS AND RELATED METHODS FOR USE IN SOFT TISSUE FIXATION," and U.S. Provisional Patent Application Ser. No. 62 / 348,548, filed September 12, 2016, entitled "TISSUE AUGMENTATION CONSTRUCTS AND RELATED METHODS FOR USE IN SOFT TISSUE FIXATION," which is a continuation of U.S. patent application Ser. No. 15 / 419,330, filed January 30, 2017, entitled "TISSUE AUGMENTATION CONSTRUCTS FOR USE WITH SOFT TISSUE FIXATION REPAIR SYSTEMS AND METHODS," which is a continuation of U.S. patent application Ser. This application is a continuation-in-part of, and claims priority to, U.S. Provisional Patent Application No. 62 / 393,277, entitled "POLYMER FIBER GLASS FOR USE IN SOFT TISSUE FIXATION," all of which are incorporated herein by reference in their entireties.
[0002] FIELD OF THEINVENTION The present disclosure relates to systems, devices, and methods for fastening soft tissue to bone, and more particularly, to systems, devices, and methods that increase the range and / or area of compression between suture filaments and tissue during surgery such as rotator cuff repair. [Background technology]
[0003] A common injury, especially among athletes and the elderly, is the complete or partial detachment of tendons, ligaments, or other soft tissue from bone. Tissue detachment can occur during a fall, through overexertion, or for a variety of other reasons. Surgical intervention is often required, especially when tissue is completely detached from its associated bone. Currently available devices for tissue attachment include screws, staples, suture anchors, and tacks. Devices currently available for elderly patients can be particularly inadequate due to degenerated tissue, which can lead to inadequate fixation of sutures to anchors, resulting in further damage to the soft tissue.
[0004] Repair constructs made from one or more surgical filaments are typically used in soft tissue repair procedures, such as rotator cuff fixation, to fixate tissue in a desired position. The repair construct is typically placed through one or more portions of the tissue to be repaired, which can cause trauma to the tissue, and is often connected to anchors that are placed in the bone to which the tissue is approximated. Furthermore, in situations where the soft tissue has already begun to degenerate, the pressure applied by the sutures can cause further damage to the tissue, for example, by tissue avulsion or the occurrence of "cheese wiring," which refers to one or more threads that separate the tissue peel from the main tissue, such as the threads that separate the cheese peel from the cheese block when a wire cheese slicer is used to separate the cheese from the block. That is, because the surface area of the suture is small and a significant amount of force is applied to the soft tissue over a small surface area of the tissue, the suture has a tendency to penetrate into the already damaged tissue, which can cause further damage. Currently available solutions to this problem include the application of relatively large (typically about 3 cm by about 3 cm) allograft or xenograft formations to the soft tissue after the repair has been performed and before the soft tissue is sealed with sutures. However, formation application is often expensive, requires many sutures, and requires a high skill level to operate, and is therefore used only by a select few surgeons. Furthermore, the application of relatively large formations can add a significant amount of time to the surgical procedure, on the order of an additional 30 minutes to an hour per allograft or xenograft formation applied. Still further, with certain forms of repair structures, such as those that include a membrane that provides strength to the repair structure, it can be difficult for the surgeon to ensure that the preferred side of the repair structure is in contact with the host tissue.
[0005] In addition, repair constructs such as patches or scaffolds as provided herein can sometimes be cumbersome to deliver. Delivery occurs through a small opening or cannula, often deforming the construct before and / or during insertion into the surgical site. Existing repair surgeries involve delivering a tissue augmentation patch or scaffold to the surgical area through a small opening or cannula. Passing the tissue augmentation patch through a small opening can be very difficult, and often requires deformation of the tissue augmentation patch before or during insertion. Still further, methods using surgical repair constructs involve performing a surgical repair, such as a rotator cuff repair, first, and then inserting the surgical repair construct. The related art disrupts surgical workflow and lengthens the time to perform a procedure, among other drawbacks caused by decoupling these events. Summary of the Invention [Problem to be solved by the invention]
[0006] It is therefore desirable to provide systems, devices, and methods for use in soft tissue repair that are robust, strong, and promote healing, while minimizing the cost and time of procedures and providing easier delivery of the surgical repair constructs (e.g., tissue augmentation patches) provided herein to the surgical site. [Means for solving the problem]
[0007] Systems, devices, and methods are generally provided for performing suture surgery, such as rotator cuff repair, among other suture repair procedures. More specifically, the systems, devices, and methods are designed to allow a user to quickly add one or more tissue augmentation structures or matrices onto the sutures used to perform the tissue repair. Tissue augmentation structures in various configurations (including, but not limited to, tapes, tubes, blocks, rings, tacks, washers, and patches) can increase the footprint of the sutures with which they are associated. The increased footprint can help distribute the forces applied to the tissue by the sutures over a larger surface area, protect the appearance of the system and / or tissue, provide bulk to otherwise damaged or degenerated tissue and / or tendons, and promote tissue growth and repair at the surgical site.
[0008] The tissue augmentation structures may be associated with sutures in an on-demand manner allowing the surgeon to quickly and easily increase the footprint of the suture, or with materials of similar purpose, such as suture tape, that are used based on the needs presented during surgery. The structures may be associated with the sutures using a variety of techniques, including placing the structure over the suture and threading the suture through the structure, among other techniques. In some exemplary embodiments, the tissue augmentation structures are pre-placed in a threader that is operable to associate the sutures used in the soft tissue repair with the tissue augmentation structures. Surgical procedures utilizing the tissue augmentation structures provided in the present disclosure are also provided, along with various manufacturing techniques and methods for forming the tissue augmentation structures.
[0009] Exemplary methods of soft tissue repair including using a patch or scaffold, and exemplary methods of soft tissue repair including using a tissue augmentation block having a very wide configuration are disclosed. Additionally, exemplary configurations of tissue augmentation scaffolds, such as scaffolds with a foldable mechanism, and structures such as blocks having a very wide configuration are also provided herein. Still further, configurations in which the basement membrane is removed from the tissue repair structure are also provided herein.
[0010] One exemplary method of using the patch or scaffold includes passing a first and a second suture limb, respectively, through soft tissue and attaching a scaffold to the first and the second suture limb, respectively, resulting in a large area for engaging tissue associated with the first and the second suture limb, respectively. A first end of the scaffold is advanced to a position proximate to where the first and the second suture limbs pass through the soft tissue, and one or more suture tails are coupled to at least one suture anchor disposed in the bone to which the soft tissue is attached. In some embodiments, the one or more suture tails are part of the suture from which the first and the second limbs are formed, while in other embodiments, the one or more suture tails are separate sutures from the sutures from which the first and the second suture limbs are formed.
[0011] The tissue augmentation patch may have a number of different configurations. In one configuration, the tissue augmentation patch includes an opening extending through the first tissue augmentation patch. In this case, the first suture limb is positioned such that the first tissue augmentation block passes freely through the opening of the first tissue augmentation block along the length of the first suture limb in an unrestricted manner. In configurations in which the system includes first and second tissue augmentation patches, the first and second tissue augmentation patches may have the same or different configurations. Furthermore, in some embodiments, the first tissue augmentation patch may include at least one of fabric, plastic, synthetic polymer, natural polymer, collagen, collagen scaffold, reconstituted collagen, biological autograft, allograft, allogeneic, xenogeneic, or xenograft, connective tissue (including human dermal matrix, acellular porcine dermal matrix, acellular bovine dermal matrix, periosteal tissue, pericardial tissue, and / or fascia), and combinations thereof. In some embodiments, the first tissue augmentation block includes collagen. The patch may be woven, non-woven, knitted or manufactured using a variety of techniques known to those of skill in the art or others provided herein.
[0012] The patch can have a variety of configurations, shapes, and sizes and can be made from a variety of materials. In some embodiments, the patch can include at least one of fabric, plastic, synthetic polymer, natural polymer, collagen, collagen scaffold, reconstituted collagen, bioautograft, allograft, allogeneic, xenogeneic, or xenograft, connective tissue (including human dermal matrix, acellular porcine dermal matrix, acellular bovine dermal matrix, periosteal tissue, pericardial tissue, and / or fascia), and combinations thereof. In some embodiments, the patch includes collagen. The patch can be woven, nonwoven, knitted, or manufactured using a variety of techniques known to those skilled in the art or others provided herein. Still further, in some embodiments, the first layer of the patch can include a biodegradable polymer and the second layer of the patch can include an extracellular matrix. The thickness of the first layer can be greater than the thickness of the second layer. Additionally, in some embodiments, the patch can include one or more adjustable suture loops disposed on the edge of the patch. The adjustable suture loops are configured to prevent the patch from unintentionally sliding against the suture limbs which pass through each adjustable suture loop.
[0013] The patch may include a second layer of material disposed on the first layer of material, such that the second layer of material is disposed on the tissue-facing side of the scaffold, the second layer of material comprising the second surface of the scaffold. In such embodiments, the first suture limb and the second suture limb may be disposed between an outermost surface of the first layer of material opposite the tissue-facing side of the patch and a tissue-facing side of the second layer of material opposite the second surface of the patch.
[0014] One exemplary method of soft tissue repair includes passing a first suture from an inner suture anchor disposed in bone at a surgical repair site through soft tissue. The inner anchor is under the soft tissue. The passing of the first suture through the soft tissue is such that a first suture limb and a second suture limb of the first suture extend from the soft tissue. The method further includes passing a second suture from the inner suture anchor through the soft tissue such that a first suture limb and a second suture limb of the second suture extend from the soft tissue. An inner row stitch is placed on the second suture to secure the soft tissue to the bone. The first suture limb of the first suture is threaded through a channel in a tissue augmentation scaffold, and the tissue augmentation scaffold is delivered to the surgical repair site. The method further includes coupling the first suture limb of the first suture to a first outer suture anchor disposed in the bone. The coupling of the first suture limb of the first suture to the first outer suture anchor disposed in the bone occurs after the tissue-augmented scaffold is delivered to the surgical repair site. The second suture limb of the first suture passes over the top surface of the tissue-augmented scaffold after the tissue-augmented scaffold has already been delivered to the surgical repair site. The second suture limb of the first suture is coupled to the second outer suture anchor disposed in the bone at the surgical repair site.
[0015] In some embodiments, the method may include passing a first suture limb of a second suture through an inner opening extending through a thickness of the tissue-augmenting scaffold and tying the first and second suture limbs of the second suture together to secure the tissue-augmenting scaffold to the soft tissue. In some such embodiments, a third suture may be passed from the inner anchor to the soft tissue such that the first and second suture limbs of the third suture extend from the soft tissue. The first suture limb of the third suture may be passed through an inner opening extending through a thickness of the tissue-augmenting scaffold and the first and second suture limbs of the third suture may be tied together to secure the tissue-augmenting scaffold to the soft tissue.
[0016] The method may further include placing the inner suture anchor in the bone and / or placing the first outer suture anchor in the bone and / or placing the second outer suture anchor in the bone. Delivering the tissue-augmenting scaffold to the surgical repair site may include tightening the first and second suture limbs of the first suture to direct the tissue-augmenting scaffold towards the soft tissue. A channel in the tissue-augmenting scaffold may extend from a first edge of the tissue-augmenting scaffold to a second edge of the tissue-augmenting scaffold.
[0017] In some embodiments, the inner suture anchor may be a first inner suture anchor, and the method may further include passing a third suture from a second inner suture anchor disposed in the bone beneath the soft tissue to the soft tissue such that a first suture limb and a second suture limb of the third suture extend from the soft tissue. The method may include passing a fourth suture from the second inner suture anchor to the soft tissue to the soft tissue such that a first suture limb and a second suture limb of the second suture extend from the soft tissue. An inner row stitch may be placed on the third suture to secure the soft tissue to the bone. The first suture limb of the fourth suture may be threaded through a second channel in the tissue augmentation scaffold. Still further, the first suture limb of the fourth suture may be coupled to a second outer suture anchor disposed in the bone after the tissue augmentation scaffold is delivered to the surgical repair site. The second suture limb of the fourth suture may pass over the top surface of the tissue-augmenting scaffold. This may occur after the tissue-augmenting scaffold has already been delivered to the surgical site. Additionally, the second suture limb of the fourth suture may be coupled to the first outer suture anchor. In some such embodiments, delivering the tissue-augmenting scaffold to the surgical site may include tightening the first and second suture limbs of the first suture and the first and second suture limbs of the fourth suture to direct the tissue-augmenting scaffold towards the soft tissue. Alternatively or additionally, in some such embodiments, the method may include passing a first suture limb of a second suture through a first inner opening in the tissue-augmenting scaffold and tying the first and second suture limbs of the second suture together to secure the tissue-augmenting scaffold to the soft tissue, and passing a first suture limb of a third suture through a second inner opening in the tissue-augmenting scaffold and tying the first and second suture limbs of the third suture together to secure the tissue-augmenting scaffold to the soft tissue. In embodiments including first and fourth sutures, the second suture limbs of the first and fourth sutures may cross each other as they pass over a top surface of the tissue-augmenting scaffold.In some embodiments, coupling the first suture limb of the first suture and the second suture limb of the fourth suture to the first outer suture anchor may include installing a first outer row fixation, and coupling the second suture limb of the first suture and the first suture limb of the fourth suture to the second outer suture anchor may include installing a second outer row fixation.
[0018] In some embodiments where the medial suture anchor is a first medial suture anchor, the method may further include passing a third suture from the first medial suture anchor through the soft tissue such that a first and a second suture limb of the third suture extend from the soft tissue; passing a fourth suture from a second medial suture anchor disposed in the bone below the soft tissue through the soft tissue such that a first and a second suture limb of the fourth suture extend from the soft tissue; passing a fifth suture from the second medial suture anchor through the soft tissue such that a first and a second suture limb of the fifth suture extend from the soft tissue; and passing a sixth suture from the second medial suture anchor through the soft tissue such that a first and a second suture limb of the sixth suture extend from the soft tissue. In some such embodiments, an inner row stitch may be placed on the fourth suture to secure the soft tissue to the bone. A first suture limb of the third suture may be threaded through a first inner opening in the tissue-augmented scaffold, and the first and second suture limbs of the third suture may be tied together to secure the tissue-augmented scaffold to the soft tissue. Further, a first suture limb of the fifth suture may be threaded through a second inner opening in the tissue-augmented scaffold, and the first and second limbs of the fifth suture may be tied together to secure the tissue-augmented scaffold to the soft tissue. Still further, a first suture limb of the sixth suture may be threaded through a second channel in the tissue-augmented scaffold and may be coupled to a second outer suture anchor disposed in the bone. This may occur after the tissue-augmented scaffold is delivered to a surgical repair site. The second suture limb of the sixth suture may be passed over the top surface of the tissue-augmented scaffold, again after the tissue-augmented scaffold has already been delivered to the surgical repair site. The second suture limb of the sixth suture may be coupled to a first outer suture anchor that is positioned in bone at the surgical repair site.
[0019] In some embodiments where the medial suture anchor is a first medial suture anchor and the tissue augmentation scaffold is a first tissue augmentation scaffold, the method may include passing a third suture from a second medial suture anchor disposed in the bone beneath the soft tissue through the soft tissue such that a first suture limb and a second suture limb of the third suture extend from the soft tissue, and similarly passing a fourth suture from the medial suture anchor through the soft tissue such that a first suture limb and a second suture limb of the second suture extend from the soft tissue. Medial row stitches may be placed on the third suture to secure the soft tissue to the bone. The method may further include placing an inner row of stitches on the third suture to secure the soft tissue to the bone, coupling a first suture limb of a fourth suture to the second outer suture anchor, and coupling a second suture limb of the fourth suture to the first outer suture anchor.
[0020] The tissue-augmenting scaffold may comprise at least one of a fabric, a plastic, a synthetic polymer, a natural polymer, collagen, a collagen scaffold, a reconstituted collagen, a biological autograft connective tissue, a biological allograft connective tissue, a biological xenograft connective tissue, a human dermal matrix, a porcine dermal matrix, a bovine dermal matrix, a periosteal tissue, a pericardial tissue, and a fascia. In some such embodiments, the tissue-augmenting scaffold comprises collagen.
[0021] Another exemplary method of soft tissue repair includes passing a first suture from an inner suture anchor disposed in bone at a surgical repair site through soft tissue. The inner anchor is under the soft tissue. The passing of the first suture through the soft tissue is such that a first suture limb and a second suture limb of the first suture extend from the soft tissue. The method further includes passing a second suture from the inner suture anchor through the soft tissue such that a first suture limb and a second suture limb of the second suture extend from the soft tissue. The first suture limbs of the first suture and the second suture are threaded through channels in a tissue augmentation block, and the tissue augmentation block is delivered to the surgical repair site. The method further includes coupling the first suture limbs of the first and second sutures to a first outer suture anchor disposed in bone. The coupling of the first suture limb of the first suture to the first outer suture anchor disposed in the bone occurs after the tissue augmentation block is delivered to the surgical repair site. The second suture limbs of the first and second sutures are coupled to second outer suture anchors disposed in the bone at the surgical repair site. This occurs after the tissue augmentation block is delivered to the surgical repair site.
[0022] In some embodiments, the medial suture anchor can be a first medial suture anchor and the tissue augmentation block can be a first tissue augmentation block. A third suture can be threaded through the soft tissue from a second medial suture anchor disposed in the bone beneath the soft tissue such that a first suture limb and a second suture of the third suture extend from the soft tissue. Further, a fourth suture can be threaded through the soft tissue from the second medial suture anchor such that a first suture limb and a second suture limb of the fourth suture extend from the soft tissue. The first suture limbs of the third and fourth sutures can be threaded through a channel in the second tissue augmentation block and the second tissue augmentation block can be delivered to the surgical repair site. The first suture limbs of the third and fourth sutures can be coupled to a second outer suture anchor disposed in the bone after each of the first and second tissue augmentation blocks are delivered to the surgical repair site. Additionally, the second suture limbs of the third and fourth sutures may be coupled to a first outer suture anchor positioned in the bone after each of the first and second tissue augmentation blocks are delivered to the surgical repair site. In some such embodiments, the method may include placing inner row stitches on the first, second, third, and fourth sutures to secure the soft tissue to the bone.
[0023] A third tissue augmentation block (or more) may also be used. For example, the method may further include threading one or more of the second limb of the first suture and the second limb of the second suture through a channel in the third tissue augmentation block. The third tissue augmentation block may be delivered to form a variety of configurations, but in some embodiments, may be delivered to the surgical repair site such that one end of the third tissue augmentation block is adjacent to the first end of the first tissue augmentation block and a second opposing end of the third tissue augmentation block is adjacent to the second end of the second tissue augmentation block. The first end of the first tissue augmentation block may be adjacent to the first inner anchor and the second end of the second tissue augmentation block may be adjacent to the second outer anchor. The act of coupling the second suture limbs of the first and second sutures to the second outer suture anchor may occur after the third tissue augmentation block is delivered to the surgical repair site.
[0024] The tissue augmentation block may comprise at least one of a fabric, a plastic, a synthetic polymer, a natural polymer, collagen, a collagen scaffold, reconstituted collagen, a biological autograft connective tissue, a biological allograft connective tissue, a biological xenograft connective tissue, a human dermal matrix, a porcine dermal matrix, a bovine dermal matrix, a periosteal tissue, a pericardial tissue, and a fascia. In some such embodiments, the tissue augmentation block comprises collagen. In some embodiments, the tissue augmentation block is of a very wide configuration. For example, the width of the tissue augmentation block may be at least 6 millimeters. In some such embodiments, the length of the tissue augmentation block may be at least 15 millimeters.
[0025] An exemplary embodiment of a foldable soft tissue repair system includes a tissue-augmenting scaffold having a first layer of material, a tissue-facing surface, and a second surface opposite the tissue-facing surface. The first layer of material includes one or more intrusion features forming at least one fold axis that spans at least a portion of the length of the material (and in at least some cases the entire length of the material). The one or more intrusion features allow the tissue-augmenting scaffold to fold about the at least one fold axis to reduce an insertion profile of the tissue-augmenting scaffold relative to the at least one fold axis.
[0026] In some embodiments, the tissue-facing surface may define a first intrusion feature along a first folding axis, the first intrusion feature configured to bias the folding of the material in a first direction. The second surface may define a second intrusion feature along a second folding axis. The second intrusion feature may be configured to bias the folding of the material in a second direction opposite the first direction. Each of the one or more intrusion features may define a cut in the material from the inner edge to the outer edge along each folding axis. Alternatively or additionally, each of the one or more intrusion features may define a cut-out channel in the material from the inner edge to the side edge along each folding axis.
[0027] The scaffold may define an inner edge and opposing side edges. In such embodiments, the first layer of material may define one or more intrusion features forming at least one fold axis that spans at least a portion from the inner edge to the outer edge. Further, the one or more intrusion features allow the tissue-augmenting scaffold to fold about the at least one fold axis to reduce an insertion profile of the tissue-augmenting scaffold relative to the inner edge and the outer edge.
[0028] The one or more penetration features may define a plurality of openings through the material spaced apart along the folding axis. In some embodiments, the tissue-augmenting scaffold comprises a dermal scaffold. In some embodiments, the tissue-augmenting scaffold comprises a lyophilized scaffold. The tissue-augmenting scaffold may comprise at least one of a fabric, a plastic, a synthetic polymer, a natural polymer, collagen, a collagen scaffold, a reconstituted collagen, a biological autograft connective tissue, a biological allograft connective tissue, a biological xenograft connective tissue, a human dermal matrix, a porcine dermal matrix, a bovine dermal matrix, a periosteum tissue, a pericardial tissue, and a fascia. In some such embodiments, the tissue-augmenting block comprises collagen.
[0029] Unless otherwise specified, the steps of the methods provided in this disclosure may be performed in any order, such as in cases where advantages are described associated with delivering a tissue augmentation construct to a surgical repair site prior to performing the repair. [Brief description of the drawings]
[0030] [Figure 1A] FIG. 2 is a top view of an exemplary embodiment of a tissue augmentation structure. [Figure 1B] FIG. 1B is a side view of the tissue augmentation structure of FIG. 1A. [Figure 2A] FIG. 13 is a perspective side view of another exemplary embodiment of a tissue augmentation structure. [Figure 2B] FIG. 2B is a side view of the tissue augmentation structure of FIG. 2A having a threader disposed thereon. [Figure 2C] FIG. 2C is a perspective view of the tissue augmentation structure of FIG. 2B. [Figure 2D] FIG. 2B is a front view of the tissue augmentation structure of FIG. 2A. [Figure 2E] 13 is a perspective view of yet another exemplary embodiment of a tissue augmentation structure. [Figure 2F] 13 is a perspective view of yet another exemplary embodiment of a tissue augmentation structure. [Figure 2G] FIG. 13 is a side view of another exemplary embodiment of a tissue augmentation structure. [Figure 2H] FIG. 13 is a side view of yet another exemplary embodiment of a tissue augmentation structure. [Figure 2I] FIG. 13 is a side view of yet another exemplary embodiment of a tissue augmentation structure. [Diagram 3] FIG. 2B is a side view of an exemplary tissue augmentation structure attachment tool having associated therewith a tissue augmentation structure similar to that of FIG. 2A. [Figure 4] 1 is a perspective view of another exemplary embodiment of a tissue augmentation structure. [Diagram 5] 13 is a perspective view of yet another exemplary embodiment of a tissue augmentation structure. [Figure 6A] 1A-1D are schematic sequential views of an exemplary embodiment for attaching a tissue augmentation structure in a dual row fixation. [Figure 6B] 1A-1D are schematic sequential views of an exemplary embodiment for attaching a tissue augmentation structure in a dual row fixation. [Figure 6C] 1A-1D are schematic sequential views of an exemplary embodiment for attaching a tissue augmentation structure in a dual row fixation. [Figure 7A] 1A-1D are schematic sequential views of another exemplary embodiment for attaching a tissue augmentation structure in a dual row fixation. [Figure 7B] 1A-1D are schematic sequential views of another exemplary embodiment for attaching a tissue augmentation structure in a dual row fixation. [Figure 7C] 1A-1D are schematic sequential views of another exemplary embodiment for attaching a tissue augmentation structure in a dual row fixation. [Figure 7D] 1A-1D are schematic sequential views of another exemplary embodiment for attaching a tissue augmentation structure in a dual row fixation. [Figure 8A] 13A-13C are schematic diagrams of yet another exemplary embodiment for attaching tissue augmentation structures in a dual row fixation. [Figure 8B] 13A-13C are schematic diagrams of another exemplary embodiment for attaching tissue augmentation structures in a dual row fixation. [Figure 9] 13A-13C are schematic diagrams of yet another exemplary embodiment for attaching tissue augmentation structures in a dual row fixation. [Figure 10A] 2H is a schematic sequential view of an exemplary embodiment for attaching the tissue augmentation structure of FIG. 2G in a dual row fixation. [Figure 10B] 2H is a schematic sequential view of an exemplary embodiment for attaching the tissue augmentation structure of FIG. 2G in a dual row fixation. [Figure 10C] 2H is a schematic sequential view of an exemplary embodiment for attaching the tissue augmentation structure of FIG. 2G in a dual row fixation. [Figure 10D] 2H is a schematic sequential view of an exemplary embodiment for attaching the tissue augmentation structure of FIG. 2G in a dual row fixation. [Figure 10E] 2H is a schematic sequential view of an exemplary embodiment for attaching the tissue augmentation structure of FIG. 2G in a dual row fixation. [Figure 11A] 1A-1D are schematic sequential views of an exemplary embodiment for attaching a tissue augmentation structure in a single row fixation. [Figure 11B] 1A-1D are schematic sequential views of an exemplary embodiment for attaching a tissue augmentation structure in a single row fixation. [Figure 11C] 1A-1D are schematic sequential views of an exemplary embodiment for attaching a tissue augmentation structure in a single row fixation. [Figure 11D] 13A-13C are schematic diagrams of another exemplary embodiment for attaching tissue augmentation structures in a single row fixation. [Figure 11E] 13A-13C are schematic diagrams of yet another exemplary embodiment for attaching tissue augmentation structures in a single row fixation. [Figure 11F] 13A-13C are schematic diagrams of another exemplary embodiment for attaching tissue augmentation structures in a single row fixation. [Figure 12] 13A-13C are schematic diagrams of yet another exemplary embodiment for attaching tissue augmentation structures in a single row fixation. [Figure 13] 13A-13C are schematic diagrams of another exemplary embodiment for attaching tissue augmentation structures in a single row fixation. [Figure 14] 13A-13C are schematic diagrams of yet another exemplary embodiment for attaching tissue augmentation structures in a single row fixation. [Figure 15] 13A-13C are schematic diagrams of another exemplary embodiment for attaching tissue augmentation structures in a single row fixation. [Figure 16A] 13A-13C are schematic diagrams of yet another exemplary embodiment for attaching tissue augmentation structures in a single row fixation. [Figure 16B] 13A-13C are schematic diagrams of yet another exemplary embodiment for attaching tissue augmentation structures in a single row fixation. [Figure 16C] 13A-13C are schematic diagrams of yet another exemplary embodiment for attaching tissue augmentation structures in a single row fixation. [Figure 17A] 1A-1D are schematic sequential views of an exemplary embodiment for repairing soft tissue. [Figure 17B] 1A-1D are schematic sequential views of an exemplary embodiment for repairing soft tissue. [Figure 17C] 1A-1D are schematic sequential views of an exemplary embodiment for repairing soft tissue. [Figure 17D] 1A-1D are schematic sequential views of an exemplary embodiment for repairing soft tissue. [Figure 18A] 1A-1C are schematic sequential views of another exemplary embodiment for repairing soft tissue. [Figure 18B] 1A-1C are schematic sequential views of another exemplary embodiment for repairing soft tissue. [Figure 18C] 1A-1C are schematic sequential views of another exemplary embodiment for repairing soft tissue. [Figure 19] 13 is a schematic diagram of yet another exemplary embodiment for repairing soft tissue. [Figure 20A] 1A-1C are schematic sequential views of another exemplary embodiment for repairing soft tissue. [Figure 20B] 1A-1C are schematic sequential views of another exemplary embodiment for repairing soft tissue. [Figure 20C] 1A-1C are schematic sequential views of another exemplary embodiment for repairing soft tissue. [Figure 20D] 11A-11C are schematic sequential views of yet another exemplary embodiment for repairing soft tissue. [Figure 20E] 11A-11C are schematic sequential views of yet another exemplary embodiment for repairing soft tissue. [Figure 20F] 11A-11C are schematic sequential views of yet another exemplary embodiment for repairing soft tissue. [Figure 21A] 1 is a schematic diagram of an exemplary embodiment of a tissue augmentation structure. [Figure 21B] 21B is a schematic sequential view of an exemplary embodiment for attaching the tissue augmentation structure of FIG. 21A. [Figure 21C] 21B is a schematic sequential view of an exemplary embodiment for attaching the tissue augmentation structure of FIG. 21A. [Figure 21D] 21B is a schematic sequential view of an exemplary embodiment for attaching the tissue augmentation structure of FIG. 21A. [Figure 21E] 21B is a schematic sequential view of an exemplary embodiment for attaching the tissue augmentation structure of FIG. 21A. [Figure 21F] 21B is a schematic sequential view of an exemplary embodiment for attaching the tissue augmentation structure of FIG. 21A. [Figure 21G] FIG. 21B is a schematic diagram of another exemplary embodiment for attaching the tissue augmentation structure of FIG. 21A. [Fig. 21H] 21B is a schematic diagram of an alternative exemplary embodiment of the tissue augmentation structure of FIG. 21A. [Figure 21I] FIG. 21B is a schematic diagram of another alternative exemplary embodiment of the tissue augmentation structure of FIG. 21A. [Figure 22A] 2B is a schematic sequential view of an exemplary embodiment for manufacturing the tissue augmentation structure of FIG. 2A. [Figure 22B] 2B is a schematic sequential view of an exemplary embodiment for manufacturing the tissue augmentation structure of FIG. 2A. [Figure 22C] 2B is a schematic sequential view of an exemplary embodiment for manufacturing the tissue augmentation structure of FIG. 2A. [Figure 23A] 1A-1C are front views of multiple tissue augmentation structures in an exemplary embodiment for manufacturing a tissue augmentation structure. [Figure 23B] FIG. 23B is a top view of the multiple tissue augmentation structures of FIG. 23A. [Figure 23C] FIG. 23B is a front view of one of the tissue augmentation structures of FIG. 23A. [Figure 24A] 13A-13C are front views of multiple tissue augmentation structures in another exemplary embodiment for manufacturing tissue augmentation structures. [Figure 24B] FIG. 23B is a top view of the multiple tissue augmentation structures of FIG. 23A. [Figure 24C] FIG. 23B is a front view of one of the tissue augmentation structures of FIG. 23A. [Diagram 25] 2B is a side view of an exemplary embodiment of a distal end of a tool for manufacturing the tissue augmentation structure of FIG. 2A. [Figure 26A] 1A-1D are schematic sequential views of another exemplary embodiment for manufacturing a tissue augmentation structure. [Figure 26B] 1A-1D are schematic sequential views of another exemplary embodiment for manufacturing a tissue augmentation structure. [Figure 26C] 1A-1D are schematic sequential views of another exemplary embodiment for manufacturing a tissue augmentation structure. [Figure 26D] FIG. 26C is a side view of one tissue augmentation structure that may result from the manufacturing process illustrated in FIGS. 26A-26C. [Figure 26E] 26A-26C are side views of alternative tissue augmentation structures that may result from the manufacturing process illustrated in FIGS. 26A-26C. [Figure 26F] FIG. 26F is a top view of the tissue augmentation structure of FIG. 26E. [Figure 26G] 1A-1D are schematic sequential views of yet another exemplary embodiment for manufacturing a tissue augmentation structure. [Fig. 26H] 1A-1D are schematic sequential views of yet another exemplary embodiment for manufacturing a tissue augmentation structure. [Figure 26I] 1A-1D are schematic sequential views of yet another exemplary embodiment for manufacturing a tissue augmentation structure. [Figure 27A] FIG. 1 is a schematic side view of an exemplary embodiment of a tunneling station for use in manufacturing a tissue augmentation structure. [Figure 27B] FIG. 27B is a schematic side view of the support of the tunnel station of FIG. 27A. [Figure 27C] FIG. 27B is a schematic side view of the support of the tunnel station of FIG. 27A. [Figure 27D] 27B-27C are various exemplary embodiments of a distal end of a lumen formation tool that may be used in conjunction with the tunnel station of FIG. 27A. [Figure 27E] 27B-27C are various exemplary embodiments of a distal end of a lumen formation tool that may be used in conjunction with the tunnel station of FIG. 27A. [Figure 27F] 27B-27C are various exemplary embodiments of a distal end of a lumen formation tool that may be used in conjunction with the tunnel station of FIG. 27A. [Figure 27G] 27B-27C are various exemplary embodiments of a distal end of a lumen formation tool that may be used in conjunction with the tunnel station of FIG. 27A. [Fig. 27H] 27B-27C are various exemplary embodiments of a distal end of a lumen formation tool that may be used in conjunction with the tunnel station of FIG. 27A. [Figure 27I] 27B-27C are various exemplary embodiments of a distal end of a lumen formation tool that may be used in conjunction with the tunnel station of FIG. 27A. [Figure 27J] 27B is a schematic sequence diagram of an exemplary embodiment for manufacturing a tissue augmentation structure using the tunneling station of FIG. 27A. [Figure 27K] 27B is a schematic sequence diagram of an exemplary embodiment for manufacturing a tissue augmentation structure using the tunneling station of FIG. 27A. [Figure 27L] 27B is a schematic sequence diagram of an exemplary embodiment for manufacturing a tissue augmentation structure using the tunneling station of FIG. 27A. [Figure 27M]1 is a schematic side view of another exemplary embodiment of a tunneling station for use in manufacturing a tissue augmentation structure. FIG. [Figure 28] FIG. 2 is a side view of an exemplary embodiment of a tissue augmentation structure. [Figure 29A] 1 is a perspective view of another exemplary embodiment of a tissue augmentation structure. [Figure 29B] FIG. 29B is a perspective view of the tissue augmentation structure of FIG. 29A attached to a surgical site. [Figure 30A] FIG. 13 is a side view of another exemplary embodiment of a tissue augmentation structure. [Figure 30B] FIG. 30B is a top view of the tissue augmentation structure of FIG. 30A. [Figure 30C] 30B is a schematic sequential view of an exemplary embodiment for manufacturing the tissue augmentation structure of FIG. 30A. [Figure 30D] 30B is a schematic sequential view of an exemplary embodiment for manufacturing the tissue augmentation structure of FIG. 30A. [Figure 30E] 30B is a schematic sequential view of an exemplary embodiment for manufacturing the tissue augmentation structure of FIG. 30A. [Figure 30F] FIG. 30B is a schematic diagram of an exemplary embodiment for attaching the tissue augmentation structure of FIG. 30A. [Figure 30G] 30B is a schematic sequential view of an exemplary embodiment for attaching a tissue augmentation structure similar to that of FIG. 30A. [Figure 30H] 30B is a schematic sequence diagram of an exemplary embodiment for attaching a tissue augmentation structure similar to that of FIG. 30A. [Figure 30I] 30B is a schematic sequence diagram of an exemplary embodiment for attaching a tissue augmentation structure similar to that of FIG. 30A. [Figure 30J] FIG. 13 is a perspective view of yet another exemplary embodiment of a tissue augmentation structure having a retractable loop disposed thereon. [Figure 30K] FIG. 30J is a perspective view of the tissue augmentation structure of FIG. 30J having a suture limb passed through the retractable loop. [Figure 30L]FIG. 30C is a schematic diagram of an exemplary embodiment for attaching the tissue augmentation structure of FIG. 30J. [Figure 31A] 1A-1D are schematic sequential views of a further exemplary embodiment for manufacturing a tissue augmentation structure. [Figure 31B] 1A-1D are schematic sequential views of a further exemplary embodiment for manufacturing a tissue augmentation structure. [Figure 31C] 1A-1D are schematic sequential views of a further exemplary embodiment for manufacturing a tissue augmentation structure. [Figure 32A] FIG. 13 is a top view of yet another exemplary embodiment of a tissue augmentation structure. [Figure 32B] 32B is a schematic sequential view of an exemplary embodiment for attaching the tissue augmentation structure of FIG. 32A. [Figure 32C] 32B is a schematic sequential view of an exemplary embodiment for attaching the tissue augmentation structure of FIG. 32A. [Fig. 32D] 32B is a schematic sequential view of an exemplary embodiment for attaching the tissue augmentation structure of FIG. 32A. [Figure 32E] 32B is a schematic sequential view of an exemplary embodiment for attaching the tissue augmentation structure of FIG. 32A. [Fig. 32F] 32B is a schematic sequential diagram of an exemplary embodiment for attaching a tissue augmentation structure similar to that of FIG. 32A. [Fig. 32G] 32B is a schematic sequential diagram of an exemplary embodiment for attaching a tissue augmentation structure similar to that of FIG. 32A. [Fig. 32H] 32B is a schematic sequential diagram of an exemplary embodiment for attaching a tissue augmentation structure similar to that of FIG. 32A. [Fig. 32I] 32B is a schematic sequential diagram of an exemplary embodiment for manufacturing the tissue augmentation structure of FIG. 32A. [Fig. 32J] 32B is a schematic sequential diagram of an exemplary embodiment for manufacturing the tissue augmentation structure of FIG. 32A. [Figure 33A] 1A-1D are schematic top view illustrations of various exemplary embodiments of tissue augmentation structures and suturing configurations. [Figure 33B]1A-1D are schematic top view illustrations of various exemplary embodiments of tissue augmentation structures and suturing configurations. [Figure 33C] 1A-1D are schematic top view illustrations of various exemplary embodiments of tissue augmentation structures and suturing configurations. [Figure 33D] 1A-1D are schematic top view illustrations of various exemplary embodiments of tissue augmentation structures and suturing configurations. [Figure 33E] 1A-1D are schematic top view illustrations of various exemplary embodiments of tissue augmentation structures and suturing configurations. [Figure 34A] FIG. 13 is a top view of another exemplary embodiment of a tissue augmentation structure. [Figure 34B] FIG. 34B is a side view of the tissue augmentation structure of FIG. 34A. [Figure 34C] 34B is a schematic sequential view of an exemplary embodiment for attaching the tissue augmentation structure of FIG. 34A. [Fig. 34D] 34B is a schematic sequential view of an exemplary embodiment for attaching the tissue augmentation structure of FIG. 34A. [Figure 34E] 34B is a schematic sequential view of an exemplary embodiment for attaching the tissue augmentation structure of FIG. 34A. [Fig. 34F] 34B is a schematic sequential view of an exemplary embodiment for attaching the tissue augmentation structure of FIG. 34A. [Figure 34G] 34B is a schematic sequential view of an exemplary embodiment for attaching the tissue augmentation structure of FIG. 34A. [Fig. 34H] 34B is a schematic sequential view of an exemplary embodiment for attaching the tissue augmentation structure of FIG. 34A. [Fig. 34I] 34B is a schematic sequential view of an exemplary embodiment for attaching the tissue augmentation structure of FIG. 34A. [Fig. 34J] 34B is a schematic sequential view of an exemplary embodiment for attaching the tissue augmentation structure of FIG. 34A. [Figure 34K] FIG. 34B is a schematic diagram of another exemplary embodiment for attaching the tissue augmentation structure of FIG. 34A. [Figure 35A] FIG. 13 is a top view of yet another exemplary embodiment of a tissue augmentation structure. [Figure 35B]FIG. 35B is a side view of the tissue augmentation structure of FIG. 35A. [Figure 35C] 35B is a schematic sequential view of an exemplary embodiment for attaching the tissue augmentation structure of FIG. 35A. [Figure 35D] 35B is a schematic sequential view of an exemplary embodiment for attaching the tissue augmentation structure of FIG. 35A. [Figure 36A] FIG. 13 is a top view of another exemplary embodiment of a tissue augmentation structure. [Figure 36B] FIG. 36B is a side view of the tissue augmentation structure of FIG. 36A. [Figure 36C] 36B is a schematic sequential view of an exemplary embodiment for attaching the tissue augmentation structure of FIG. 36A. [Figure 36D] 36B is a schematic sequential view of an exemplary embodiment for attaching the tissue augmentation structure of FIG. 36A. [Figure 36E] 36B is a schematic sequential view of an exemplary embodiment for attaching the tissue augmentation structure of FIG. 36A. [Figure 36F] 36B is a schematic sequential view of an exemplary embodiment for attaching the tissue augmentation structure of FIG. 36A. [Figure 36G] 36B is a schematic sequential view of an exemplary embodiment for attaching the tissue augmentation structure of FIG. 36A. [Fig. 36H] 36B is a schematic sequential view of an exemplary embodiment for attaching the tissue augmentation structure of FIG. 36A. [Figure 36I] 36B is a schematic sequential view of an exemplary embodiment for attaching the tissue augmentation structure of FIG. 36A. [Figure 37] FIG. 13 is a top view of yet another exemplary embodiment of a tissue augmentation structure in an attached position. [Figure 38A] 38 is a schematic sequential view of an exemplary embodiment for attaching the tissue augmentation structure of FIG. 37. [Figure 38B] 38 is a schematic sequential view of an exemplary embodiment for attaching the tissue augmentation structure of FIG. 37. [Figure 38C] 38 is a schematic sequential view of an exemplary embodiment for attaching the tissue augmentation structure of FIG. 37. [Figure 38D]38 is a schematic sequential view of an exemplary embodiment for attaching the tissue augmentation structure of FIG. 37. [Figure 38E] 38 is a schematic sequential view of an exemplary embodiment for attaching the tissue augmentation structure of FIG. 37. [Figure 39A] 38 is a schematic sequential view of another exemplary embodiment for attaching the tissue augmentation structure of FIG. 37. [Figure 39B] 38 is a schematic sequential view of another exemplary embodiment for attaching the tissue augmentation structure of FIG. 37. [Figure 39C] 38 is a schematic sequential view of another exemplary embodiment for attaching the tissue augmentation structure of FIG. 37. [Figure 39D] 38 is a schematic sequential view of another exemplary embodiment for attaching the tissue augmentation structure of FIG. 37. [Figure 40A] 1A-1D are schematic sequential views of an exemplary embodiment for attaching a tissue augmentation structure. [Figure 40B] 1A-1D are schematic sequential views of an exemplary embodiment for attaching a tissue augmentation structure. [Figure 40C] 1A-1D are schematic sequential views of an exemplary embodiment for attaching a tissue augmentation structure. [Figure 40D] 1A-1D are schematic sequential views of an exemplary embodiment for attaching a tissue augmentation structure. [Figure 40E] 1A-1D are schematic sequential views of an exemplary embodiment for attaching a tissue augmentation structure. [Diagram 41] 1A-1C are schematic diagrams of another exemplary embodiment for attaching a tissue augmentation structure. [Figure 42A] FIG. 2 is a top view of an exemplary embodiment of a tissue augmentation structure having one or more folding axes. [Figure 42B] FIG. 42B is a side view of the tissue augmentation structure of FIG. 42A showing one exemplary embodiment of notches formed along one or more folding axes of the structure. [Figure 42C] FIG. 42B is a side view of the tissue augmentation structure of FIG. 42A, illustrating another exemplary embodiment of a notch formed along one or more folding axes of the structure. [Fig.42D] FIG. 42B is a side view of the tissue augmentation structure of FIG. 42A, illustrating yet another exemplary embodiment of a notch formed along one or more folding axes of the structure. [Figure 42E] FIG. 42E is a side view of the tissue augmentation structure of FIG. 42D after it has been folded. [Fig.42F] FIG. 2 is a top view of another exemplary embodiment of a tissue augmentation structure having one or more folding axes. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0031] Below, certain exemplary embodiments are described to provide a general understanding of the principles of the structure, function, manufacture, and use of the devices and methods disclosed herein. One or more examples of these embodiments are illustrated in the accompanying drawings. Those skilled in the art will appreciate that the devices and methods specifically described herein and illustrated in the accompanying drawings are non-limiting exemplary embodiments, and that the scope of the disclosure is defined solely by the claims. Features shown or described in connection with one exemplary embodiment may be combined with features of other embodiments. Such modifications and variations are intended to be included within the scope of the disclosure. Furthermore, in this disclosure, like-numbered components of the embodiments generally have similar characteristics. In addition, to the extent that linear or circular dimensions are used in the description of the disclosed systems, devices, and methods, such dimensions are not intended to limit the types of shapes that can be used in combination with such systems, devices, and methods. Those skilled in the art will recognize that the equivalent dimensions of such linear and circular dimensions for any geometric shape can be readily determined. The size and shape of the systems and devices, and their components, may depend at least on the anatomical structure of the subject within which the systems and devices are used, the size and shape of the components with which the systems and devices are used, and the method and procedure in which the systems and devices are used.
[0032] The drawings provided herein are not necessarily drawn to scale. Furthermore, to the extent that arrows are used to describe directions of movement, these arrows are exemplary and in no way limit the directions in which elements can or should move. Those skilled in the art will recognize other methods and directions for producing the desired results in light of this disclosure. In addition, various terms may be used interchangeably throughout the disclosure, as would be understood by those skilled in the art. As non-limiting examples, the terms suture, filament, and flexible member may be used interchangeably and include other similar purpose materials, such as suture tape. Furthermore, to the extent that the term "block" is used to describe some of the structures and matrices provided herein, the structures and matrices are not limited to square or rectangular shapes or any shape having flat surfaces for that purpose. Furthermore, to the extent that the terms "thread" and "thread" are used to describe the association of one component with another, the terms are not limited to mean the actual passing of a filament through another material. "Through" can also include passing through an aperture (e.g., an aperture formed in the body, as described below for at least some of the tissue augmentation blocks), and thus can more generally mean associating one component with another. To the extent that a "feature" or "step sequence" is described herein as a "first feature" or "first step" or a "second feature" or "second step," such order is generally arbitrary unless otherwise indicated, and thus such numbering may be interchangeable.
[0033] Systems, devices, and methods for soft tissue repair are generally provided, where such systems or devices include, but are not limited to, one or more surgical repair filaments and / or flexible members; one or more tissue augmentation structures or matrices (including strips, tubes, bars, tacks, washers, and / or patches, each of which is described in more detail below); and one or more suture implants, or devices of similar configuration or purpose. The terms "tissue augmentation structure" and "tissue augmentation matrix" may also be used interchangeably with the terms "suture augmentation structure" and "suture augmentation matrix," and more generally, the terms "augmentation structure" and "augmentation matrix," as well as the terms "structure" and "matrix." As described herein, the term "structure" refers to any implant that is associated with a suture rim and extends the footprint of the rim, the term "block" refers to a subset of structures including strips or tapes, tubes, bars, washers, and other cannulated bodies, and the terms "tack" or "button" and "patch" or "scaffold" are described in more detail below (as well as the terms strips, tapes, tubes, bars, and washers, among others). Surgical repair filaments or flexible members can take a variety of configurations, including typical suture configurations and tape shapes, and can be used in conjunction with various types of suture implants, such as filament anchors, suture anchors, or bone anchors (including hard and soft anchors) to attach or reattach soft tissue to bone. The repair filament can be passed through the soft tissue so that it can be positioned in a desired location. The repair filament is secured to the anchor, which is secured to the bone. Tissue augmentation structures may be associated with surgical repair filaments to provide increased coverage and bulk to injured or degenerated soft tissue, increasing the surface area over which compression is applied between the suture repair filament and the tissue being repaired, helping to promote tissue growth and repair.Although the repair filaments, tissue augmentation structures, and suture implants are each described as being part of this system and device, any one component may be provided separately for use with other components or other implants and devices used in surgical procedures.
[0034] While many different repair procedures may be improved by the present disclosure, in some exemplary embodiments, the soft tissue repair devices and systems provided herein may be used in rotator cuff fixation surgery. In a rotator cuff fixation procedure, a surgeon may reattach the rotator cuff to bone by first threading the sutures through the soft tissue so that two suture limbs extend from the tissue. The surgeon may thread each suture limb through a respective tissue augmentation structure, and then secure the suture limbs to one or more bone anchors adjacent the tissue. The tissue augmentation structure increases the surface area or footprint of the system in contact with the soft tissue. This increased footprint may distribute any forces applied on the soft tissue, such that the tensioned sutures will be less likely to scrape or otherwise damage the soft tissue, for example, by "cheese-wiring". Furthermore, the tissue augmentation structure may be easily and quickly threaded over or otherwise associated with the suture limbs during surgery. This is in contrast to existing systems that involve complex and time-consuming approaches to associate xenograft or allograft formations with suture rims. Thus, the resulting surgery allows for the addition of tissue augmentation structures on the suture rims in an on-demand manner. Furthermore, the tissue augmentation structures may be made from biocompatible materials (e.g., collagen), among other types of materials, which may result in new bands of tissue growth during healing, further improving the effectiveness of the rotator cuff fixation surgery. In other non-limiting exemplary embodiments disclosed herein, the soft tissue repair devices and systems may be used in other soft tissue repair procedures, such as anterior cruciate ligament (ACL) injuries, instability or joint surgery, meniscus repair, superior capsule reconstruction, and hip capsular plication, among others. Various methods of manufacturing the tissue augmentation structures and various methods of using attachment tools and / or threaders to associate the tissue augmentation structures with surgical sutures are also described.
[0035] Tissue Augmentation Structures - Tissue Augmentation Blocks with Strip or Tape Configuration One exemplary embodiment of a tissue augmentation structure is shown as a tissue augmentation block 10 and is provided in FIGS. 1A and 1B. In one exemplary embodiment, the tissue augmentation block 10 is a strip or tape configured to be threaded or otherwise associated with a suture rim 12a. More specifically, the tissue augmentation strip or tape 10 can have a substantially rectangular shape having a width W, a length L, and a thickness T, and includes substantially flat tissue engaging surfaces 10a and / or 10b. As shown, the tape 10 is longer than its width and wider than its thickness. Typically, the length L is substantially longer than the width W, and the width W is substantially wider than the thickness T. Additionally, the width W can be wider than the diameter of the filament or suture with which the tissue augmentation tape 10 is associated, e.g., the suture rim 12a, thereby allowing for a greater compression surface area for a system or device used in surgical repair.
[0036] Those skilled in the art will recognize that the dimensions of length L, width W, and thickness T of tissue augmentation strip 10 may depend on a variety of factors, including, but not limited to, the size of the associated filament, the patient's anatomy, and the type of surgery being performed. In some embodiments, the ratio of width W of strip 10 to the diameter of suture rim 12a may range from approximately 2:1 to approximately 20:1, and in particular, width W may in some instances be at least three times the diameter of the filament or suture with which tissue augmentation strip 10 is associated. In embodiments in which suture rim 12a is a suture tape, width W of tissue augmentation strip 10 may in some instances be at least two times the diameter of the suture tape with which the strip is associated. Those skilled in the art will recognize that the ratio of the width of the tissue augmentation strip to the diameter of the filament or associated structure with which the strip is used can be any suitable ratio, depending at least in part on the type of filament or associated structure used, the type of strip or other structure used, and the type of surgery being performed, and thus the ratio of width to diameter may be less than or greater than those provided herein. Further, in some embodiments, the ratio of the width L of the strip 10 to the width W of the strip 10 can be in the range of approximately 2:1 to approximately 20:1, particularly, the length L can be in some instances at least 3 times, in some other instances at least 5 times, and in some instances at least 10 times the width W, although other LW ratios are possible. Still further, the strip 10 can be substantially flat and generally uniform. In some embodiments, the ratio of the width W of strip 10 to the thickness T of strip 10 can be in the range of approximately 2:1 to approximately 20:1, and in particular, the width W can in some instances be at least 3 times, in some other instances at least 5 times, and in some instances at least 10 times the thickness T, although other WT ratios are possible.A variety of other sizes and shapes of tissue augmentation tape strips 10 may be utilized without departing from the spirit of the present disclosure, including the dimensional ratios of the tissue augmentation strips and associated components (eg, suture limbs 12a).
[0037] While ratios may be useful to help explain the relationship between the strip 10 and the filament limb 12a and the relationship between the dimensions of the strip 10, some exemplary, non-limiting dimensions for the tissue augmentation strip may also be helpful in understanding the present disclosure. As discussed above, these dimensions may depend on a variety of factors. In some embodiments, the length L may cover a substantial portion to almost the entire length of the tissue extending between the stitches formed in the tissue and the bone anchor used to help secure the tissue. In some embodiments, the length L may range from approximately 5 millimeters to approximately 1 centimeter, the width W may range from approximately 1 millimeter to approximately 5 millimeters, and the thickness T may range from approximately 0.5 millimeters to approximately 3 centimeters. Additionally, while the strip 10 is described in FIG. 1A as having a length, width, and thickness, and is shown as being substantially flat, FIG. 1B illustrates that the strip 10 may be relatively flexible, e.g., bunched, in part, by the suture limb 12 passing therethrough. Materials used to form the strip 10 are described in a later section of this disclosure.
[0038] A number of techniques may be used to associate the tissue augmentation strip 10 with the suture limb 12a. As shown in FIG. 1B, the suture limb 12a is threaded from the top side 10a of the tissue augmentation strip 10 to the bottom side 10b and back to the top side 10a. The process of threading the suture limb 12a through the tissue augmentation strip 10 may be repeated as many times as desired. In some embodiments, a suture threader may be threaded through the tissue augmentation strip 10 pre-operatively such that threading of surgical sutures through the tissue augmentation strip may be performed in vivo during surgery. Exemplary suture threaders are discussed below with respect to alternative tissue augmentation structures.
[0039] Although the tissue augmentation strip 10 in FIG. 1B is shown to have an exaggerated wave-like profile when engaged by the suture rim 12a, in principle the tissue augmentation strip 10 may conform to the shape of the soft tissue it contacts. By including the tissue augmentation strip 10 on the suture rim 12a, the suture rim 12a has a wider footprint and therefore covers a larger surface area of the tissue. Furthermore, the tissue augmentation strip 10 can distribute the force applied to the tissue by the suture rim 12a over a larger amount of surface area. The larger amount can be determined by the surface area of the tissue augmentation strip 10. Thus, in an embodiment where the width of the tissue augmentation strip 10 is at least three times the diameter of the suture rim 12a, the force of the suture rim 12a on the tissue can be distributed over at least three times the area than if the tissue augmentation strip 10 was not associated with the suture rim 12a. The increased tissue surface area coverage and distributed force of the tissue augmentation strip 10 can result in reduced pressure peaks on the soft tissue. During use, it is either surface 10a or surface 10b that engages the tissue and allows for increased dispersion. Where soft tissue has become degenerated due to injury or aging, reduced pressure may result in less chance of tissue abrasion. Additionally, greater tissue coverage may improve healing of tissue that has been injured in some way.
[0040] The suture limbs 12a used with the tissue augmentation strips 10 can be any type of suture (e.g., braided filament, cannulated filament, monofilament, suture tape, etc.) and can have a size between about a #5 filament (about 20 gauge to about 21 gauge) and about a #3-0 filament (about 29 gauge to about 32 gauge). One of ordinary skill in the art will also recognize various other filament types and sizes that can be used with the augmentation strips 10, for example, when suture tape is used.
[0041] Tissue Augmentation Structure - Tissue Augmentation Structure with Cannula-Like Portion Another exemplary embodiment of a tissue augmentation structure is shown as tissue augmentation block 110 and is provided in FIGS. 2A-2D. Alternatively, the tissue augmentation structure, e.g., block 110, may be generally referred to as a tissue augmentation structure having a cannulated body. The tissue augmentation structure having a cannulated body may include tube 110, bar 3010, 3010′, and washer 310, 410. In one exemplary embodiment of an augmentation block, the block may be a cannulated tube configured to be disposed on or associated in some manner with suture rim 112a. More specifically, augmentation tube 110 may have a substantially cylindrical or ovoid body having a hole or lumen 114 extending therethrough from a proximal-most end 110p to a distal-most end 110d. To the extent that block 110 is described as a tube, such description is not intended to limit the configuration of the tissue augmentation block to being a tube or having a tube structure. The tube-like configuration may be one of, or may be derived in some manner from, the various configurations of blocks provided herein. Other non-limiting embodiments of blocks include, but are not limited to, bars and washers, as described further below.
[0042] Returning to the cannulated nature of block 110, bore 114 may be used to receive, for example, a suture rim 112a so that block 110 and rim 112a may be associated with one another, as described in more detail below. As shown, block 110 has a length L' that is longer, and in many instances substantially longer, than diameter D. Additionally, diameter D may be larger than the diameter of the filament or suture with which tissue augmentation block 110 is associated, e.g., suture rim 112a, thereby allowing for a greater surface area of tissue augmentation in a system or device used in surgical repair.
[0043] Those skilled in the art will recognize that the dimensions of the length L' and diameter D of the tissue augmentation block 110 and the diameter d of the hole 114 may depend on a variety of factors, including, but not limited to, the size of the associated filament, the patient's anatomy, and the type of surgery being performed. In some embodiments, the ratio of the length L' to the diameter D may range from approximately 2:1 to approximately 20:1, and in particular, the length L' may be at least three times the diameter D in some instances. Further, in some embodiments, the ratio of the diameter D of the tube 110 to the diameter of the suture rim 112a may range from approximately 2:1 to approximately 20:1, and in particular, the diameter D may be at least three times the diameter of the filament or suture with which the tissue augmentation tube 110 is associated in some instances. Various other sizes and shapes of the tissue augmentation tube 110 may be utilized without departing from the spirit of the present disclosure, including the dimensional ratios of the tissue augmentation block and associated components (e.g., suture rim 112a).
[0044] While ratios may be useful to help explain the relationship between the tube 110 and the filament rim 112a and the relationship between the dimensions of the tube 110, some exemplary, non-limiting dimensions for the tissue augmentation tube may also be helpful in understanding the present disclosure. As discussed above, these dimensions may depend on a variety of factors. In some embodiments, the length L' may cover a significant portion to almost all of the length of tissue that extends between the stitches formed in the tissue and the bone anchor used to help secure the tissue. In some embodiments, the length L' may range from approximately 5 millimeters to approximately 2 centimeters, and the diameter D may range from approximately 1 millimeter to approximately 5 millimeters. The size of the diameter d of the hole 114 may also depend on a variety of factors, including but not limited to the size of the rim that passes through it. In some embodiments, the diameter d may range from approximately 0.75 millimeters to approximately 3 millimeters.
[0045] Alternative embodiments of tissue augmentation blocks 110 having cannulated portions are shown in Figures 2E, 2F, 2G, 2H, and 2I. While not all tissue augmentation blocks have cannulated portions, cannulated portions are a common feature of blocks 110, 3010, 3110, 2810a, 2810', 2810'' provided in Figures 2A-2I. Because other configurations of tissue augmentation blocks do not have cannulated portions or a cannulated portion through which a suture rim passes, other configurations may be associated with the rim using other techniques provided herein that are in any way known to those of skill in the art.
[0046] As discussed above and shown in Figures 2E and 2F, the tissue augmentation bars 3010, 3110 may have a rectangular and / or square cross-sectional shape. Other cross-sectional shapes are possible, including, for example, triangular, quadrilateral, pentagonal, hexagonal, octagonal, etc. As shown in Figure 2E, the cannulated bar 3010 is configured to be disposed on or in some manner associated with a suture rim, as described above with respect to the cannulated tube 110. More specifically, the bar 3010 may have a substantially rectangular body having a rectangular hole or lumen 3014 extending therethrough from a proximal-most end 3010p to a distal-most end 3010d. The hole 3014 may be used to receive a suture rim, for example, such that the bar 3010 and the suture rim may be associated with one another, as described in more detail below. It is contemplated that the holes 3014 may be made by the manufacturing techniques discussed below with respect to the augmentation block 110.
[0047] An alternative construction of the tissue augmentation bar 3010, the tissue augmentation bar 3110, is shown in FIG. 2F. As shown in FIG. 2F, the cannulated bar 3110 is configured to be disposed on or in some manner associated with a suture rim, as described above with respect to the cannulated blocks 110, 3110. More specifically, the bar 3110 may have a substantially rectangular body having a rectangular hole or lumen 3114 extending therethrough from a proximal-most end 3110p to a distal-most end 3110d. The hole 3114 may be used to receive a suture rim, for example, such that the bar 3110 and the suture rim may be associated with one another, as described in more detail below. As shown, the bar 3110 may be constructed from two portions 3110a, 3110b of material. The two materials 3110a, 3110b may be associated with one another by sutures 3124a, 3124b. The materials 3110a, 3110b may be attached to one another such that the lumen 3114 is formed using any of the manufacturing techniques discussed throughout this disclosure. Various other sizes and shapes of the bars 3010, 3110 may be utilized without departing from the spirit of this disclosure, including the dimensional ratios of the bars and associated components (e.g., suture limbs).
[0048] Further alternative configurations of tissue augmentation blocks 2810a, 2810', and 2810'' are illustrated in FIGS. 2G, 2H, and 2I, respectively. As shown, cannulated blocks 2810a, 2810', 2810'' may all be substantially similar to tissue augmentation block 110, as shown in FIGS. 2A-2D. Alternatively, cannulated blocks 2810a, 2810', 2810'' may have a configuration substantially similar to tissue augmentation bars 3010, 3110. Cannulated blocks 2810a, 2810', 2810'' may have a substantially longer length than tissue augmentation block 110. In one exemplary embodiment, block 2810a may have a length generally in the range of about 15.0 millimeters to about 25.0 millimeters. Advantageously, the blocks 2810a, 2810', 2810'' may have a length that may extend inward from the outer anchor over the soft tissue repair to provide additional protection for the repair and additional scaffolding to aid in healing.
[0049] A number of techniques may be used to associate the tissue augmentation block 110, 3010, 3110, 2810a, 2810', 2810'' with the suture limb 112a. For example, as shown in FIG. 2A, the suture limb 112a is threaded or passed from the proximal-most end 110p to the distal-most end 110d of the tissue augmentation tube 110 without passing through or spanning the body of the tube 110. That is, the suture limb 112a does not pass within a sidewall of the body that defines the lumen 114. The tube 110 is not coupled or attached to the suture limb 112a, but instead may pass freely, unimpeded or unrestricted, along the length of the limb 112a. In other embodiments, the rim 112a may pass through or span the body one or more times to further fix the position of the tube 110 relative to the rim 112a thereby connecting or attaching the tube 110 to the suture rim 112a. Those skilled in the art will recognize various other ways in which the tube 110 may be associated with or connected to the rim 112a without departing from the spirit of the present disclosure.
[0050] Threading of the suture limb 112a onto the tissue augmentation tube 110 may be performed manually, either at the surgical site or outside the body. Alternatively, as shown in FIGS. 2B and 2C, the tissue augmentation tube 110 may have a threader 206 inserted through the hole 114 prior to threading the suture limb 112a onto the tissue augmentation tube 110. The threader 206 may include a proximal handle portion 208, an intermediate elongated portion 210, and a distal suture receiving end 212. The proximal handle portion 208 may be configured to be easily grasped by a user, for example, by having a substantially rectangular shape as shown. Other shapes and mechanisms for grasping may be provided. The intermediate portion may be a filament portion 210 that may have a tissue augmentation structure, for example, a tissue augmentation tube 110 associated with the intermediate portion, thereby allowing the threader 206 to be flexible. The distal suture receiving end 212 may have a distal opening 212 through which a suture associated with the augmentation strip, e.g., suture limb 112a, may be placed. In the illustrated embodiment, the distal opening 212 is flexible and in some embodiments may be made from wire, fiber, thread, cord, and / or other flexible structures or other materials having similar characteristics. Because the distal opening 212 is flexible, its shape may change before, during, and after use, thus in the illustrated embodiment, the distal opening 212 has a diamond or kite shape, although other configurations are possible. Additionally, the flexible nature of the opening 212 may cause it to contract around a suture placed therein to pinch or otherwise hold the suture during use. In some embodiments, the intermediate portion 210 may also be made from wire, fiber, thread, cord, and / or other flexible structures. The term wire is not intended to imply that the suture is made of metal or has metallic characteristics, although the intermediate portion 210 and the distal suture receiving end 212 may be made of metal.
[0051] 2G-2I provide further configurations of suture limbs associated with tissue augmentation structures. As shown in FIG. 2G, the structure 2810a may include two threaders disposed therethrough to associate the structure 2810a with at least one suture limb. As shown in FIG. 2G, the first threader 2809a may be disposed through the block 2810a from the top surface 2811t to the bottom surface 2811a, with the handle 2808a proximate the top surface 2811t and the receiving end 2807b proximate the bottom surface 2811b. The first threader 2809a may be disposed through the block 2810a to intersect the central lumen 2870 of the block 2810a substantially perpendicular thereto. Alternatively, the threader 2809a may be disposed at any angle relative to the central lumen 2870. The first threader 2809a can be disposed at the proximal end 2811p or proximal half of the block 2810a. The second threader 2809b can be disposed through the distal portion 2811d of the block 2810a. For example, the second threader 2809b can extend from the distal end 2811d of the block 2810a, through the lumen 2870 to an inner location 2870m of the lumen, and out the bottom surface 2811b of the block 2810a. In one exemplary embodiment, the second threader 2809b can extend through the block 2810a such that the handle portion 2808b of the threader 2809b is adjacent the distal end 2811d of the block 2810a and the receiving end 2807b of the threader extends out the bottom surface 2811b of the block 2810a. Alternatively, other suture threader configurations are contemplated, as shown in Figures 2H and 2I, and discussed below.
[0052] In one alternative suture threader configuration, as shown in FIG. 2I, the block 2810′ may include a pre-threaded suture 2814′ at the proximal end 2811p′ of the block. In this case, a second threader is not necessary. The pre-threaded suture 2814′ may be threaded into the block 2810′ at a location substantially similar to the second threader 2809b of FIG. 2G. The pre-threaded suture 2014′, not shown, may be threaded into the block 2810′ either before or after the block is associated with the repair suture. In yet another alternative configuration, as shown in FIG. 2H, the block 2810″ may include two threaders 2809a″ and 2809b″. The threaders 2809a'', 2809b'' may be substantially similar to the threaders 2809a, 2809b discussed above. As shown, the second threader 2809b'' may be disposed through the central lumen 2870'', for example, from the proximal end 2811p'' to the distal end 2811d''. Alternatively, the second threader 2809b'' may extend through any length of the central lumen 2870''. The second threader 2809b'' may associate the suture limbs with the block 2810'', not shown, using techniques provided throughout this disclosure. The suture limbs may each exit the block 2810'' at the distal end 2811d'', along with the repair suture limbs, and then be anchored in the bone at a location offset outwardly from the soft tissue repair.
[0053] During use, a force P1 may be applied to the handle portion 208 to move the filament portion 210 and distal opening 212 relative to the augmentation tube 110 in the direction of force P1. This movement may pull the distal opening 212, and the suture limb 112a coupled thereto, into and through the augmentation tube 110, thereby disposing the augmentation tube 110 over the suture limb 112a. As the distal opening 212 is entered by the augmentation tube 110, the opening 212 may be reduced in size, e.g., compressed to a narrower width around the suture limb 112a, making it easier for the suture limb 112a to be pulled into the body of the augmentation tube 110 to tighten the limb 112a. Once the augmentation tube 110 is placed over or otherwise associated with the suture rim 112a, the suture rim 112a may be disassociated from the distal opening 212 and the threader 206, being no longer associated with either the augmentation tube 110 or the suture rim 112a, may be discarded or reused. The combination of the suture rim 112a and augmentation tube 110 may then be used in a variety of procedures, as will be described in further detail below. The process of placing the augmentation tube 110 over the suture rim 112a may be performed outside the body or inside the body, including near the surgical site.
[0054] Similar to the tissue augmentation strip 10, by including the tissue augmentation tube 110 on the suture rim 112a, the suture rim 112a has a wider footprint and therefore covers a larger surface area of the tissue. Additionally, the tube 110 can distribute the force applied to the tissue by the suture rim 112a over a larger amount of surface area. The larger amount can be determined by the surface area of the tissue augmentation tube 110. Thus, in an embodiment where the diameter of the tissue augmentation tube 110 is at least three times the diameter of the suture rim 112a, the force of the suture rim 112a on the tissue can be distributed over at least three times the area than if the tissue augmentation tube 110 was not associated with the suture rim 112a. The increased tissue surface area coverage and distributed force of the tissue augmentation tube 110 can result in reduced pressure peaks on the soft tissue. Where the soft tissue has become degenerated due to injury or aging, the increased tissue surface area coverage and reduced pressure can result in less likelihood of tissue denudation. Additionally, the greater tissue coverage may in some manner enhance healing of injured tissue and / or provide bulk to injured or degenerated tissue and / or tendons.
[0055] A threader, such as threader 206, may also be used with an attachment tool that aids in associating the augmentation structure with the suture. FIG. 3 provides a threader 206' that is similar to threader 206, except that the proximal handle portion 208' and the distal receiving end 212' have slightly different shapes. As shown, the proximal handle portion 208' is in the form of a gripping protrusion 208' that has a larger diameter than the diameter of the intermediate filament portion 210', allowing a user to easily grip the proximal handle portion 208'. Those skilled in the art will recognize that the proximal handle portion 208' may have most any shape. Similarly, the shape of the distal receiving end 212' may have most any shape. In the illustrated embodiment, the distal receiving end 212' is a distal opening 212', which is illustrated as being more rounded than the distal opening 212. However, as explained above, the distal opening 212' may be flexible, so that the illustrated embodiment may be further manipulated into other shapes.
[0056] The installation tool 200' may include a handle portion 202' and a cartridge portion 204'. The handle portion 202' may be of a length such that the installation tool 200' may be inserted through a cannula and into a surgical site within the body. Alternatively, the handle portion 202' may be of any suitable length. As shown in FIG. 3, the handle 202' includes a proximal portion 202p' and a distal portion 202d'. The distal portion 202d' of the handle 202' may be angularly offset from the proximal portion 202p' to allow the cartridge 204' to be oriented in a preferred direction for threading the augmentation tube 110' onto the rim 112a'. Alternatively, the proximal portion 202p' and the distal portion 202d' may be collinear with one another.
[0057] The distal portion 202d' may be attached to a cartridge 204' sized to receive the augmentation tube 110' threaded against the suture limb 112a'. The cartridge 204' may be cylindrical and have a generally cylindrical cross-section. Alternatively, the cartridge 204' may have a triangular, rectangular, or other shape and / or cross-section. The cartridge 204' may have a lumen 214' extending therethrough from a first opening 216' to a second opening 218'. The first opening 216' may be larger than the second opening 218'. Alternatively, the first opening 216' and the second opening 218' may be of any desired size. As shown in FIG. 3, the first opening 216' may have substantially the same diameter as the lumen 214' such that the augmentation tube 110' may enter therethrough. The second opening 218' may have a diameter sized to receive an associated portion of the threader 206' therethrough.
[0058] 3, the suture limb 112a' may be inserted through the opening 212' and the threader 206' may be manipulated in a manner similar to the threader 206 to place the augmentation tube 110' over the suture limb 112a'. For example, an operator may grasp the handle portion 208' of the threader 206' and apply a force F to the opening 212'. PApplication of the force of the threader 206' may pull the augmenting tube 110' through the cannula 114'. The handle 208' may be pulled until the entire threader 206' and a distal portion of the suture rim 112a' pass through the second opening 218'. Upon threading the suture rim 112a' through the augmenting tube 110', the threader 206' may be discarded or reused, and the attachment tool may release the augmenting tube 110' by actuation of a release mechanism (not shown). Alternatively, the augmenting tube 110' may be held in the cartridge 204' by an interference fit, such that no release mechanism is required. As noted above, reference is made to the augmenting tube 110' and suture rim 112a', but the attachment tool 200' may be used in the same manner with the augmenting strip 10 of FIGS. 1A-1B and other structures provided herein. Additionally, although the threader is discussed as being used in conjunction with the attachment tool, the threader itself may be considered an attachment tool since the embodiments provided herein allow the threader to be used to associate the suture and augmentation structure without the use of the attachment tool 200'.
[0059] Tissue Augmentation Structures - Tissue Augmentation Blocks with Washer, Disk, or Ring Configurations An exemplary embodiment of a tissue augmentation structure is shown as tissue augmentation block 310 and is provided in FIG. 4. Tissue augmentation block 310 has a configuration that may be described as a washer, disk, or ring, and in the illustrated embodiment is a square-shaped washer configured to be disposed on or otherwise associated with suture rim 312a. For example, washer 310 may have a substantially rectangular prism-shaped body having a hole or lumen 314 extending therethrough from a proximal-most end 310p to a distal-most end 310d. Hole 314 may be used to receive suture rim 312a, for example, such that washer 310 and rim 312a may be associated with one another, as described in more detail below. As shown, washer 310 has substantially equal lengths L B and width W B and length L B and width W BLower height T B Alternatively, the washer 310 has a width W B Longer length L B In a further alternative embodiment, the shape of the rectangular shape may be more elongated, with a length L B , width W B , and height T B is substantially equal, which allows the formation of a cubic body. B The diameter of the block may be larger than the diameter of the filament or suture with which the washer 310 is associated, e.g., the suture rim 312a. In other embodiments, the threading of the suture rim 312a may be performed through the washer 310 without a pre-formed lumen. When the block is associated with the suture rim 312a, the block may increase the surface area of the block, thereby increasing the compression surface area of the system or device used in surgical repair.
[0060] Those skilled in the art will recognize that the length L of the washer 310 B , width W B , thickness or height T B , and diameter d B It will be appreciated that the dimensions of the washer 310 may depend on a variety of factors, including, but not limited to, the size of the associated filament, the patient's anatomy, and the type of surgery being performed. In some embodiments, the washer 310 has a length L that is approximately in the range of about 3 millimeters to about 6 millimeters. B , a width W in the range of about 3 mm to about 6 mm B , and a thickness or height T in the range of approximately 1 millimeter to approximately 3 millimeters. B Alternatively, the length L B , width W B , and thickness or height T Bmay all be substantially equal and may have dimensions ranging from approximately 2 millimeters to approximately 5 millimeters. One benefit of the smaller size of the washers 310 is that a surgeon may place multiple washers 310 on one suture rim to precisely apply the washers on the area of injured tissue where they are needed, as described further below. For example, precise application of the washers may include moving the washers along the length of the suture rim in a more precise direction where the force from the suture rim will be distributed over a larger surface area. In view of the present disclosure, it is apparent that the thickness or height of the washers 310 may be substantially less than the length of the suture rim on which they are disposed. Any number of washers 310 may be disposed on a suture rim, including but not limited to a maximum of 30. In some exemplary embodiments, the number of washers 310 provided on one suture rim ranges from approximately 2 blocks to approximately 8 blocks.
[0061] An alternative embodiment of an augmentation structure configured to be effectively used with other similarly sized structures on the same suture rim is illustrated in FIG. 5. As shown, the tissue augmentation structure is a tissue augmentation block 410 having a configuration that may be described as a washer, disk, or ring. In the illustrated embodiment, it is a ring or circular washer. For example, the tissue augmentation washer 410 may have a hole or lumen 414 extending therethrough from a proximal-most surface 410p to a distal-most surface 410d. The hole 414 may be used to receive the suture rim 412a such that the washer 410 and rim 412a may be associated with each other, or alternatively, the rim 412a may be associated with the washer 410, for example, by threading through the body of the ring without any preformed holes or apertures.
[0062] Those skilled in the art will appreciate that the diameter D of washer 410 W , height H W , and the diameter of the hole d WIt will be appreciated that the dimensions of the diameter D may depend on a variety of factors, including, but not limited to, the size of the associated filament, the anatomy of the patient, and the type of surgery being performed. In some embodiments, the diameter D W can be in the range of approximately 3 mm to approximately 6 mm, and the height H W can be in the range of approximately 1 mm to approximately 3 mm, and the hole diameter d W can range from approximately 0.5 millimeters to approximately 2 millimeters. As with washer 310, in view of the present disclosure, the thickness or height of washer 310 can be substantially less than the length of the suture rim on which washer 410 is disposed. Any number of washers 410 can be disposed on a suture rim, including but not limited to a maximum of 30. In some exemplary embodiments, the number of washers 410 provided on a suture rim ranges from approximately 2 washers to approximately 8 washers.
[0063] One benefit of the washers 310, 410 is that the surgeon can pass both the anterior and posterior sutures through the washers 310, 410 at the suture insertion point to prevent cheese-wiring at the suture insertion point, as described further below. Additionally, the washers 310, 410 may be used with any of the disclosed tissue augmentation structures, including by placing one or more washers 310, 410 on the same suture limb where another tissue augmentation structure has already been placed or will be placed.
[0064] Numerous techniques known to those skilled in the art may be used to associate the washer 310, 410 with each suture limb 312a, 412a. The suture limb 312a, 412a is threaded or passed from the proximal-most end 310p, 410p to the distal-most end 310d, 410d of the washer 310 or 410 without passing through and / or through the body of the washer 310 or 410, i.e., the suture limb 312a, 412a may extend directly through the lumen 314, 414. Thus, the washer 310, 410 is not coupled to or attached to the suture limb 312a, 412a, and thus, similar to the tube 110, the washer 310, 410 may pass freely, unimpeded or unrestricted, along the length of the suture limb 312a, 412a. In other embodiments, the rim 312a, 412a may pass through the body one or more times to further secure the position of the washer 310, 410 relative to the rim 312a, 412a. Those skilled in the art will recognize various other ways in which the washer 310, 410 may be associated with the rim 312a, 412a without departing from the spirit of the present disclosure. For example, threading of the suture rim 312a, 412a onto the washer 310 or 410 may be performed manually, either at the surgical site or outside the body. Alternatively, one or more of the washers 310 or 410 may have a threader (not shown) inserted through each hole 314, 414 before the washer 310 or 410 is threaded onto the suture rim 312a, 412a. The threader can be the same as or similar to the threader 206, 206' described above and can be used to thread the suture limb 312a, 412a through the washer 310 or 410 at the surgical site.
[0065] Similar to augmentation blocks 10, 110, by including either or both of washers 310 or 410 on the suture limbs, the force applied to the tissue by the suture limbs is distributed over a greater amount of surface area, the greater amount being determined by the surface area of the augmentation washers 310 or 410 and the number of washers used.
[0066] Materials for forming the augmentation structure The structures discussed above, such as blocks 10, 110, 3010, 3110, 310, and 410, as well as those provided further below (including various patches or scaffolds), may be made from one or more biocompatible and biodegradable materials such that the strips gradually degrade or remodel over time after implantation in a patient to replace or repair connective tissue. The resorption profile of the structure may be long enough so that tissue structure is reinforced and given structure during the regeneration or healing process. Those skilled in the art will be able to determine the appropriate resorption profile depending, at least in part, on the desired use of the structure, and the resorption profile may be tailored by modifying the materials used to form the structure.
[0067] While many different materials can be used to form the tissue augmentation structure, in some instances, the material, either alone or in combination with other materials, is a biocompatible polymer. Exemplary embodiments of suitable biocompatible materials include synthetic polymers, natural polymers, and combinations of the two. As used herein, the term "synthetic polymer" refers to a polymer that is not found in nature, even if the polymer is made from a natural biomaterial. As used herein, the term "natural polymer" refers to a polymer that is derived from nature. In embodiments in which the tissue augmentation construct comprises at least one synthetic polymer, suitable biocompatible synthetic polymers may include polymers selected from the group including aliphatic polyesters, poly(amino acids), copoly(ether-esters), polyalkylene oxalates, polyamides, tyrosine-derived polycarbonates, poly(iminocarbonates), polyorthoesters, polyoxaesters, polyamide esters, polyoxaesters containing amine groups, poly(anhydrides), polyphosphazenes, polyurethanes, poly(ether urethanes), poly(ester urethanes), poly(propylene fumarates), poly(hydroxyalkanoates), polydioxanones, poly-hydroxybutyrate-co-hydroxyvalerate, polyaminocarbonates, polytrimethylenes, polyoxaamides, elastomeric copolymers, and combinations and blends thereof. Synthetic polymers suitable for use in tissue augmentation constructs can also include biosynthetic polymers based on sequences found in collagen, collagen scaffolds, ground collagen powder, elastin, thrombin, silk, keratin, fibronectin, starch, poly(amino acids), gelatin, alginate, pectin, fibrin, oxidized cellulose, chitin, chitosan, tropoelastin, hyaluronic acid, ribonucleic acid, deoxyribonucleic acid, polypeptides, proteins, polysaccharides, polynucleotides, and combinations or blends thereof.The types of materials that may be used to construct the tissue augmentation structure, either in whole or in part, include non-absorbable polymers selected from the group including, but not limited to, polyethylene, polypropylene, polyetheretherketone (PEEK), polytetrafluoroethylene, silicone, rubber, or other biocompatible non-absorbable polymers and combinations thereof. Natural polymers for use in the augmentation strip 10 may be selected from the group including, but not limited to, fibrin-based materials, collagen-based materials, hyaluronic acid-based materials, cellulose-based materials, silk-based materials, gelatin-based materials, glycoprotein-based materials, cellulose-based materials, polysaccharide-based materials, protein-based materials, fibronectin-based materials, chitin-based materials, pectin-based materials, elastin-based materials, alginate-based materials, dextran-based materials, albumin-based materials, natural poly(amino acid)-based materials, decellularized tissue, purified extracellular matrix (ECM), demineralized bone matrix, and combinations thereof.
[0068] Furthermore, practically any type of tissue can be used to form the tissue augmentation structure, including, but not limited to, autograft and allograft tissues and human allogeneic and xenogeneic tissues. Xenogeneic tissues include porcine, bovine, and equine, among others. The tissues used can be selected from biological connective tissues, including ligament tissue, tendon tissue, modeled tendon, skin tissue, muscle tissue, periosteum tissue, pericardial tissue, synovial tissue, epidermal tissue, acellular porcine dermal matrix, acellular bovine dermal matrix, fascia, small intestine tissue, embryonic tissue, amniotic tissue, placental tissue, periodontal tissue, peritoneal tissue, vascular tissue, blood, and combinations thereof. The materials used to form the tissue augmentation structure can be crosslinked or uncrosslinked, and any of the materials provided herein, whether synthetic, natural, or combinations thereof, can be used with other materials. Furthermore, the tissue-augmentation structures and / or materials used to form the tissue-augmentation structures may be treated with platelet-rich plasma (PRP), bone marrow, cells, and bone and / or tissue growth promoting materials.
[0069] The materials used to form the tissue augmentation structures may be fabricated and / or formed using a variety of techniques. These techniques include, but are not limited to, knitting them and weaving them. The overall construction of the materials may be described as woven, knit, nonwoven, and / or foamed, among other configurations resulting from techniques known to those skilled in the art. Furthermore, a combination of techniques may be used in one structure and / or portions thereof. For materials such as synthetic polymers and other materials and tissues provided above, forming techniques may be used.
[0070] In some embodiments, the tissue augmentation structure may be prepared without including a basement membrane. The basement membrane is a thin fibrous tissue that separates the epithelium from the underlying tissue located between the epidermis, connecting and functionally separating the epidermis and the dermis. Although the basement membrane can add strength to a tissue augmentation structure such as a dermal structure, the inclusion of such a membrane "orients" the membrane so that only one side, the epithelial side, is the side that is placed in contact with the tissue. Otherwise, the incorporation of the dermal patch into the host tissue will be at least significantly slower. It may be difficult for the surgeon to easily identify which side is the epithelial layer during the procedure.
[0071] As an improved alternative, the present disclosure contemplates taking steps to remove the basement membrane from the tissue augmentation structure. This can be done, for example, by severing or tearing the basement membrane from the remainder of the tissue augmentation structure. Alternatively or additionally, material contributing to the dermal patch incorporation can be associated with the side of the structure that includes (or previously included) the basement membrane.
[0072] Tissue Augmentation Kit The filaments and tissue augmentation structures provided herein may be included together as part of a soft tissue repair kit. Such a kit may also include components such as threaders, attachment tools, bone anchors, and / or bone drills. For example, an exemplary embodiment of a kit may include one or more tissue augmentation structures and one or more threaders. In some examples, the tissue augmentation structures may be pre-positioned on the threaders. The tissue augmentation structures may include any of the structures provided herein or others that can be derived from this disclosure, including, but not limited to, tissue augmentation blocks 10, 110, 3010, 3110, 310, 410, and tissue augmentation patches 2210, 2310, 2410, and 2510 described below. The threaders may include threaders 206, 206', and other threaders known to those skilled in the art or that can be otherwise derived from this disclosure. In instances where a tissue augmentation structure has been pre-placed on the threader, the structure may be placed on the intermediate portion 208, 208' of the threader 206, 206'.
[0073] The kit may also include other components for use with the tissue augmentation construct and threader, including, but not limited to, one or more sutures, e.g., suture 12a, 112a, one or more attachment tools, e.g., attachment tool 200', one or more implants, e.g., bone anchors, and one or more bone drills. In some exemplary embodiments, the kit may include connective tissue augmentation blocks 10, 110, 3010, 3110, 310, 410 for all suture limbs 12a, 112a, 312a, 412a that will be anchored onto soft tissue. The types and configurations of filaments, constructs, attachment tools (which may include threaders as the sole attachment tool), and bone anchors may be varied to provide the user with options for use in any surgical procedure. Thus, any combination of blocks having strip or tape configurations (e.g., strip 10), cannulated tube configurations (e.g., tube 110), cannulated bar configurations (e.g., bar 3010, bar 3110), and washer configurations (e.g., washer 310, washer 410) may be mixed and matched by the surgeon as needed, including by placing them on the same suture limb. The choice of structure used may depend, at least in part, on a variety of factors, including, but not limited to, the size of the filament involved, the patient's anatomy, and the type of surgery being performed.
[0074] The threader and / or attachment tool can be one device used to associate the tissue augmentation structure with the limbs multiple times, or multiple threaders and tools can be provided to allow for multiple strip-limb combinations to be formed, or different configurations preferred by different users. The threader and / or attachment tool can be specially adapted for use with a particular tissue augmentation structure, procedure, and / or surgeon preference without departing from the spirit of this disclosure.
[0075] To the extent that an implant, e.g., an anchor, is provided as part of a kit and used with any of the disclosures provided herein, the implant can be any type of implant known to one of skill in the art for use in various types of tissue repair procedures. For bone anchors, the anchors can be of a hard or soft configuration, and in some instances, they can be knotless anchors. A knotless anchor means that the filament associated with it does not need to have a knot tied by the surgeon during surgery to connect tissue to the filament and / or anchor. Some exemplary embodiments of stiff suture anchors for use in the kits, or more generally for the present disclosure, include the Heix Ti™ anchor (commercially available from DePuy Synthes), as well as the Heix Advance™ anchor, Heix Advance Knotless™ anchor, Heix BR™ anchor, Heix PEEK™ anchor, Heix Transtend™ anchor, Bioknotless® anchor, Gryphon® anchor, Fastin® anchor, Versalok® anchor, Microfix® anchor, Minilok™ anchor, Micro-Quickanchors® anchor, and Tacit® anchor, each of which are also commercially available from DePuy Mitek, Inc. Some exemplary embodiments of soft suture anchors for use in the kits, or more generally for the present disclosure, include those described in U.S. Pat. No. 9,345,567 (Sengun). The contents of this document are incorporated herein by reference in their entirety.
[0076] To the extent that the kit includes a bone drill, any type of bone drill known to those skilled in the art for forming holes in bone into which anchors can be placed may be provided.
[0077] How to Use - Rotator Cuff Repair Exemplary methods for using the types of systems, devices, and kits described herein will now be described in more detail. Although the methods described herein generally relate to attaching soft tissue to bone, this section of the disclosure will be primarily discussed with respect to rotator cuff repair, and one of ordinary skill in the art will recognize other types of surgery and repairs in which the structures and methods may be used. Furthermore, to the extent that a particular type of tissue augmentation structure is illustrated in the following embodiments, one of ordinary skill in the art will recognize how to utilize other tissue augmentation structures provided herein without departing from the spirit of the disclosure. Similarly, any suture or anchor provided herein or others known to one of ordinary skill in the art may be used, including knotless anchors. Still further, while in the illustrated embodiment the sutures and rims may be approximately equal in length, the lengths of the sutures and rims need not be equal, as any suture or rim may be of any desired length. Similarly, to the extent that the techniques described below contemplate having a particular number of suture limbs (e.g., one, two, three, etc.) extending from or otherwise associated with a suture anchor to perform a tissue repair, one of skill in the art will appreciate in light of this disclosure how different numbers of limbs may be used to perform the same or similar types of repairs. A benefit accrues from each of the methods described herein is that because the tissue augmentation structures may be associated in an on-demand manner with the sutures used in the repair, a surgeon may quickly and easily associate one or more tissue augmentation structures with the repair sutures to form a desired footprint for the repair.
[0078] Rotator Cuff Repair - Dual Row Application A first exemplary method of soft tissue repair using tissue augmentation blocks 110, illustrated as blocks 110a, 110b, in conjunction with a double row application or repair, is shown in Figures 6A-6C. This method involves fixing a piece of soft tissue 130, e.g., a rotator cuff, to a bone 150. If the tissue augmentation blocks 110a, 110b are dry, they may need to be rehydrated prior to surgery. An incision may be made to perform the surgery using one of a traditional open repair, an arthroscopic repair, or a mini-open repair. Once the surgeon has access to the surgical site and the tissue and bone are prepared according to common surgical techniques, the surgeon may attach the sutures 112 to the soft tissue 130 using an inner row stitch 140. Alternatively, any known stitch may be used. As shown in Figures 6A-6C, the inner row of stitches 140 results in two suture limbs 112a, 112b extending outwardly from the soft tissue.
[0079] As shown in FIG. 6B, the tissue augmentation blocks 110a, 110b are placed on the suture limbs 112a, 112b, respectively. The tissue augmentation blocks 110a, 110b may be threaded onto the suture limbs 112a, 112b manually with an attachment tool 200' (not shown) and / or a threader 206, 206'. As discussed above with reference to FIG. 3, if an attachment tool 200' is used, the suture limb 112a may be passed through an aperture or cinch loop 212, and then the handle portion 208 may be pulled to pull the threader 206 and the suture limb through the tissue augmentation block 110a. Similarly, if just the threader 206, 206' is used, a force may be applied to the threader to pull the suture limb 112a into and through the tissue augmentation block. Once the suture limbs 112a are threaded onto the tissue augmentation block 110a, the threader 206 can be removed and the tissue augmentation block 110a is released from the attachment tool 200', if one was used. The tissue augmentation blocks 110a, 110b may be threaded onto the suture limbs 112a, 112b at a surgical site inside the body. Alternatively, the tissue augmentation blocks 110a, 110b may be threaded outside the body.
[0080] Once the blocks 110a, 110b are threaded onto the suture limbs 112a, 112b, they may advance in a direction D1 along each of the suture limbs 112a, 112b. In the illustrated embodiment, the blocks 110a, 110b are positioned proximate the inner stitch 140 because the length of the blocks 110a, 110b is similar to the length of the distance extending between the inner stitch 140 and the end of the tissue 130. However, in embodiments in which the length of the blocks 110a, 110b is shorter than that distance, the blocks 110a, 110b may not need to be proximate the inner stitch 140, but may extend along some portion of the length of the limbs 112a, 112b that extends between the inner stitch 140 and the end of the tissue 130. After the blocks 110a, 110b are installed on the respective suture limbs 112a, 112b, the free ends of the suture limbs 112a, 112b can be secured within the body. For example, the free ends of the respective suture limbs 112a, 112b can be coupled to respective anchors 160a, 160b, as shown in FIG. 6C, which in some exemplary embodiments can be knotless anchors. The suture limbs 112a, 112b can then be tightened to secure the soft tissue 130 to the bone 150, after which the anchors 160a, 160b are fully secured to the bone 150, thereby completing the double row lateral fixation associated with the inner stitch 140.
[0081] This procedure can be repeated as many times as necessary to adequately secure the soft tissue 130 to the bone 150. The blocks 110a, 110b can provide a larger footprint for the rims 112a, 112b, providing a larger surface area to distribute the loading force of the suture rims 112a, 112b onto the soft tissue 130. While the patient is healing from surgery, new bands of tendon-like tissue can form near the suture rims 112a, 112b and in and around the blocks 110a, 110b, resulting in more robust tissue formation in and between the soft tissue and the bone. For example, blocks made from collagen scaffold or acellular dermal matrix material can remodel into tendon-like tissue and integrate with the native tissue while the patient is healing from surgery. Additional coverage of tendon-like tissue over the soft tissue can increase the strength of the tissue-to-bone bond and prevent further injury.
[0082] Another exemplary soft tissue repair method is provided in Figures 7A-7D. As shown, soft tissue 1030 is secured to bone 1050 using an alternative double row application. Once the surgeon has access to the surgical site and the tissue, bone, and blocks 1010a-1010c have been prepared according to common surgical techniques, including those provided herein, the surgeon may attach sutures 1012, 1016, respectively, to tissue 1030 using inner row stitches 1040, 1042. Blocks 1010a-1010c may be similar to blocks 110, 3010, 3110, or similar to other blocks and structures provided in this disclosure. Additionally, any known stitch may be used. An inner row of stitches 1040 provides two suture limbs 1012a, 1012b extending outwardly from the soft tissue, and a second inner row of stitches 1042 provides two suture limbs 1016a, 1016b extending outwardly from the soft tissue.
[0083] As shown in FIG. 7A, the blocks 1010a-1010c are threaded onto the suture limbs 1012a, 1012b, 1016b, respectively, using techniques provided throughout this disclosure. For example, as shown in FIG. 7A, the block 1010a is threaded onto the suture limb 1012a by the threader 206. Once the block 1010a is threaded onto the suture limb 1012a, as shown in FIG. 7B, the block 1010a may be advanced in a direction D1′ along the suture limb 1012a until the block 1010a is adjacent to the inner stitch 1040, since the length of the block 1010a is similar to the distance extending between the inner stitch 1040 and the end of the tissue 1030. Similarly, blocks 1010b, 1010c may be advanced along the suture limbs 1012b, 1016b until they are adjacent to the inner stitches 1040, 1042, respectively. Block 1010a may be advanced along the suture limb using an instrument such as a knot pusher 1080 or other instrument suitable for advancing a strip along a limb.
[0084] When the blocks 1010b, 1010c are mounted on the respective suture limbs 1012b, 1016b, as shown in FIG. 7C, the free ends of the respective suture limbs 1012b, 1016b may be secured within the body, for example, by attaching them to the anchors 1060b in an outer row fixation. Similarly, when the block 1010a is mounted on the suture limb 1012a, the free ends of the suture limbs 1012a, 1016a may be secured within the body, for example, by attaching them to the anchors 1060a in an outer row fixation. As shown in FIG. 7C, the suture limbs 1012b, 1016b are mounted within the anchors 1060b, and then the suture limbs 1012a, 1016a are mounted within the anchors 1060a such that the suture limbs 1016a rest on the block 1010b. Alternatively, the suture limb 1016a can be placed under the suture limb 1012b by changing the fixation sequence. As shown in FIG. 7D, the suture limbs 1012a, 1012b, 1016a, 1016b can be tightened to fixate the soft tissue 1030 to the bone 1050, after which the anchors 1060a, 1060b are fully fixed to the bone 1050.
[0085] An alternative exemplary method of soft tissue repair is illustrated in Figures 8A and 8B. In this method, the soft tissue 1030' is secured to the bone 1050' by an alternative double row application using washers 310, as shown, washers 310a, 310b, and 310c, instead of blocks 10, 110. The alternative double row application disclosed with respect to Figures 8A and 8B helps reduce additional bulk that may occur when two structures are stacked on top of each other when the suture limbs cross as part of the repair design. Additionally, the use of washers in such formations helps reduce the possibility of any convergence that may occur when using structures that are of the block configuration. Once the surgeon has access to the surgical site and the tissue, bone, and washers 310a-310c have been prepared according to common surgical techniques, including those provided herein, the surgeon may attach the sutures 1012', 1016' to the tissue 1030' using an initial mattress stitch. Alternatively, any known stitch may be used. An inner row of stitches 1040' in tissue 1030' results in two suture limbs 1012a', 1012b' extending outwardly from the tissue, and a second inner row of stitches 1042' results in two suture limbs 1016a', 1016b' extending outwardly from the tissue.
[0086] The following discussion will be limited to suture limb 1012a' for clarity, however suture limbs 1012b', 1016a', 1016b' may have washers 310 threaded thereon in substantially the same manner. Washers 310a-310c are threaded onto suture limb 1012a' as shown in FIG. 8A. Alternatively, any number of washers 310 may be used on any of suture limbs 1012a', 1012b', 1016a', 1016b'. Washers 310a-310c may be threaded onto suture limb 1012a' manually, with an attachment tool using techniques provided throughout this application, and / or with a threader. Once the washers 310a-c are threaded onto the suture limb 1012a', they may be advanced along the suture limb 1012a'. In the illustrated embodiment, the washers 310a-c are positioned such that they spread evenly along the length of the limb 1012a' over the tissue 1030'. After the washers 310 are attached onto each suture limb 1012a', 1012b', 1016a', 1016b' as shown in FIG. 8A, the free ends of the suture limbs 1012a', 1016a', and 1012b', 1016b' may be secured within the body, for example, by attaching them to anchors 1060a' and 1060b', respectively. In the illustrated embodiment, the suture limbs 1012b', 1016b' are coupled to the anchor 1060b', after which the suture limbs 1012a', 1016a' couple into the anchor 1060a' so that the suture limb 1016a' rides over the suture limb 1012b', although other configurations are possible without departing from the spirit of the disclosure. The suture limbs 1012a', 1012b', 1016a', 1016b' can be tightened to secure the soft tissue 1030' to the bone 1050', after which the anchors 1060a', 1060b' are fully secured to the bone 1050'.
[0087] A further exemplary dual row fixation technique is illustrated in FIG. 8B. The method for fixing soft tissue 1030'' to bone 1050'' is substantially the same as that illustrated in FIG. 8A, but further includes the use of circular washers 410, washers 410a and 410b as shown, at the location of the inner stitches (not visible). The placement of washers 410a, 410b as shown provides protection for the stitches located under washers 410a, 410b while also increasing the footprint of suture limbs 1012a'', 1012b'', 1016a'', 1016b'', allowing distribution of forces over the surface of washers 410a, 410b that would otherwise be applied directly to tissue 1030''. In use, the washers 410a, 410b can be threaded over each suture limb 1012a'', 1012b'', 1016a'', 1016b'', after which the washer 310' is threaded over the suture limbs 1012a'', 1012b'', 1016a'', 1016b''. The dual row fixation procedure can then be completed, for example, according to the process described above with respect to FIG. 8A. For both configurations illustrated in FIGS. 8A and 8B, the greater the angle formed by the anchors 1060a', 1060b' and the sutures extending from the washers 410a, 410b, the greater the stability of the repair.
[0088] A further alternative method for securing soft tissue 1030''' to bone 1050'''' using a dual row fixation technique is illustrated in FIG. 9. Once the surgeon has access to the surgical site and the tissue, bone, and blocks 1010a'''-d''' have been prepared according to common surgical techniques, including those provided herein, the surgeon may attach sutures 1012a'''-c''' and 1016a'''-c''', respectively, to tissue 1030''' using initial mattress stitches 1040'''', 1042''''. A first medial row anchor 1060a'''' can be inserted into bone 1050'''' with three suture limbs 1012a'''-c''' extending therefrom, which are threaded through tissue 1030''' by the first medial row stitch 1040'''. The second inner row anchor 1060b'' can be inserted into the bone 1050'' having three suture limbs 1016a''''-c'' extending therefrom, and the three suture limbs 1016a''''-c'''' are threaded through the tissue 1030'''' by the second inner row stitches 1042''''.
[0089] As shown, block 1010a''', which can be in the form of a strip, tube, or cannulated block, among other disclosed configurations, is threaded over one of suture limbs 1012a''', 1016a''', using techniques provided throughout this disclosure, and suture limbs 1012a'''' and 1016a'''' are tied together with a knot to secure tissue 1030'''' to bone 1050''''. Additionally, once the knot is formed, block 1010a''' can be moved over the knot to reduce the likelihood that tissue will be injured by the knot. Blocks 1010b''', 1010c''', can then be threaded over suture limbs 1012b''', 1012c''', respectively, using techniques provided throughout this disclosure, and advanced into position adjacent inner stitch 1040'''. Similarly, as blocks 1010d''', 1010e''' are threaded over suture limbs 1016b''', 1016c''', they may be advanced to a position adjacent to inner stitch 1042'''. After blocks 1010b''', 1010d''', and 1010c''', 1010e''' are attached over respective suture limbs 1012b''', 1016b''' and 1012c'''', 1016c''', the free ends of suture limbs 1012b''', 1016b''', and 1012c''', 1016c''' may be secured within the body. For example, the free ends of each of the suture limbs 1012b''', 1016c''', and 1012c''', 1016b''', may be coupled to a respective anchor 1062a''', and 1062b''',. The suture limbs 1012b''', 1012c''', 1016b''', 1016c''', can be tightened to secure the soft tissue 1030''' to the bone 1050''', after which the anchors 1062a''', 1062b''' are fully secured to the bone 1050'''.
[0090] A further alternative dual row fixation method of soft tissue repair is illustrated in Figures 10A-10E using the tissue augmentation structure 2810a of Figure 2G in conjunction with an identically configured tissue augmentation structure 2810b (shown in Figure 10E). The two structures may have similar configurations and / or other configurations provided herein or known to those of skill in the art, and the two structures need not be of identical configuration. This method may fix the soft tissue 2830 to the bone 2850 with an alternative extra long block application to provide additional coverage of the repair.
[0091] Once the surgeon has access to the surgical site and the tissue, bone, and tissue augmentation blocks have been prepared according to common surgical techniques, including those provided herein, the surgeon may insert a first anchor 2860a under the soft tissue 2830. The first anchor 2860a may have two suture limbs 2812a, 2812b extending therefrom. The two suture limbs 2812a, 2812b may pass through the soft tissue 2830 and begin to assist in securing the soft tissue 2830 to the bone 2850. A first mattress stitch 2840a may be formed in the soft tissue 2830 medial to the first anchor 2860a. The first mattress stitch 2840a may result in two suture limbs 2814a, 2814b extending out of the soft tissue 2830.
[0092] The block 2810a may be threaded over the suture rims 2812a, 2814a using techniques provided throughout this disclosure. For example, a first threader 2809a may be advanced in a first direction D1, as shown in FIG. 10B, to cause the suture rim 2814a to associate with the proximal end 2811p of the first block 2810a (threader 2809a is not shown, but in light of this disclosure, one of ordinary skill in the art would understand how threader 2809a may be manipulated to pass the suture rim 2814a through the proximal end 2811p of the first block 2810a). Further, the suture limb 2812a may be associated with the intermediate portion 2811i and the distal portion 2811d of the block 2810a, as shown by advancing the second threader 2809b in the second direction D2, as also shown in FIG. 10B. Although the respective threaders 2809a, 2809b for each suture limb 2814a, 2812a are not shown, one of ordinary skill in the art would understand in view of this disclosure how the threaders may be manipulated to pass each suture limb through a portion of the first block 2810a. The block 2810a may then be advanced inwardly such that the proximal end 2811p of the block 2810a is adjacent the first mattress stitch 2840a, as shown in FIG. 10C. This process may be repeated for the second block 2810b and its respective limbs 2816a, 2818b. For example, a second anchor 2862a may be attached under the soft tissue 2830, as shown in FIG. 10E. In this case, an anchor 2862b having two repair suture limbs 2816a, 2816b extends from the second anchor 2862a. The two repair limbs 2816a, 2816b may be passed through the soft tissue 2830 as well, and a second mattress stitch 2840b (shown in FIG. 10E) may be formed in the soft tissue 2830 medially to the second anchor 2862a. The second mattress stitch 2840b may result in two suture limbs 2818a, 2818b extending out of the soft tissue 2830. The resulting suture limbs 2816a, 2816b, 2818a, 2818b may be associated with the block 2810b to continue the tissue fixation repair.
[0093] After the blocks 2810a, 2810b are mounted on the respective suture limbs 2812a, 2814a, and 2816a, 2818a, the free ends of the suture limbs 2812a, 2812b, 2816a, 2816b may be secured within the body. For example, the free ends of the respective suture limbs 2812a, 2816b, and 2812b, 2816a may be coupled to respective anchors 2860b and 2862b, as shown in Figures 10C and 10E. In the illustrated embodiment, the suture limbs 2812b, 2816b may pass over the soft tissue 2830 to form an "X" configuration or shape such that the suture limb 2812b is secured to the same anchor 2862b as the suture limb 2816a and the suture limb 2816b is secured to the same anchor 2860b as the suture limb 2812a. The suture limbs 2812a, 2816a may be disposed through respective central lumens 2870a, 2870b of the blocks 2810a, 2810b to increase the footprint of the suture limbs 2812a, 2816a and subsequently reduce the likelihood of trauma to the soft tissue 2830, as discussed above. Because the blocks 2810a, 2810b have sufficient length, they can be attached to extend medially over the first and second repairs 2838a, 2838b, as shown in FIG 10E. The suture limbs 2812a, 2812b, 2816a, 2816b can then be tightened to secure the soft tissue 2830 to the bone 2850, after which the anchors 2860b, 2862b are fully secured to the bone 2850. As shown in FIG 10D and FIG 10E, the two limbs 2814a, 2814b can be tied together with a knot 2880a, and the limbs 2818a, 2818b can be tied together with a knot 2880b to secure the proximal end 2811p of each block 2810a, 2810b at a location medial to the repairs 2838a, 2838b. One of ordinary skill in the art will recognize, in light of this disclosure and the knowledge of one of ordinary skill in the art, the numerous repairs that may be represented by repairs 2838a, 2838b.
[0094] Rotator Cuff Repair - Single Row Application Another method of soft tissue repair is illustrated in Figures 11A-11C. With this method, the soft tissue 130' is secured to the bone 150' using a single row application. Once the surgeon has access to the surgical site and the tissue, bone, and blocks 110a', 110b' have been prepared according to common surgical techniques, including those provided herein, the surgeon may attach the sutures 112' to the soft tissue 130' using an initial mattress stitch. Alternatively, any known stitch may be used. The mattress stitch 140' results in two suture limbs 112a', 112b' extending outward from the soft tissue.
[0095] 11B, blocks 110a', 110b' are threaded onto suture limbs 112a', 112b', respectively, using techniques provided throughout this application. As blocks 110a', 110b' are threaded onto suture limbs 112a', 112b', they advance in direction D1' along their respective sutures until adjacent mattress stitch 140'. As discussed above, the position of the strip relative to stitch 140' may depend, at least in part, on the size of blocks 110a', 110b' and the distance between stitch 140' and the end of tissue 130'. After the blocks 110a', 110b' are attached onto each suture limb 112a', 112b', the free ends of the suture limbs 112a', 112b' may be secured within the body, for example, by attaching them to an anchor 160', as shown in FIGURE 11C. The suture limbs 112a', 112b' may be tightened to secure the soft tissue 130' to the bone 150', after which the anchor 160' is fully secured to the bone 150' to complete the single row fixation associated with the inner stitch 140'. In some exemplary embodiments, a second anchor having two suture limbs extending therefrom (each limb having at least one tissue augmentation structure disposed thereon) may be implanted in a similar manner to anchor 160', limbs 112a', 112b', and blocks 110a', 110b' into the same tissue 130' and bone 150' to provide a second fixation system for the tissue. As with all of the various configurations provided herein, any number and combination of implants, e.g., bone anchors, sutures, and tissue augmentation structures, may be used to secure soft tissue to bone.
[0096] Alternative single row applications are shown in Figures 11D-11F. In a first alternative single row application illustrated in Figure 11D, a standard single row repair may be completed using two anchors 160a'', 160b'', attached to bone 150'' below tissue 130''. Anchors 160a'', 160b'' may each have two suture limbs 112a'', 112b'' and 116a'', 116b'', respectively, extending therefrom. Suture limbs 112a'' and 116a'' may be threaded through soft tissue 130'' and used to bring soft tissue 130'' into contact with bone 150''. Suture limbs 112b'' and 116b'' may be similarly threaded through soft tissue 130''.
[0097] As shown in FIG. 11D, the tissue augmentation block 110'' may be threaded over one of the suture limbs 112b'', 116b'' using techniques provided throughout this disclosure and advanced to a desired location relative to the tissue 130''. After the augmentation block 110'' is attached over one of the suture limbs, the free ends of each suture limb 112b'', 116b'' may then be tied to one another using a knot, not shown. Furthermore, the block 110'' is moved into position such that the block 110'' covers the knot, thereby minimizing any possible tissue abrasion by the knot, and contacting the tissue 130''.
[0098] A second alternative single row application is illustrated in FIG. 11E. Similar to the approach of FIG. 11D, a standard single row repair can be completed using two anchors 160a''', 160b''', attached to the bone 150''' below the tissue 130'''. As shown, a first suture 111'' can be attached by a mattress stitch 140a''' on the inside of the repair with two suture limbs 111a''', 111b'''' extending out from the tissue 130'''', and a second suture 113''' can be attached by a second mattress stitch 140b''' on the inside of the repair with two suture limbs 113a'''', 113b'''' extending out from the tissue 130'''. In some examples, two mattress stitches 140a''', 140b''' may be attached to tissue 130''', and anchors 160a''', 160b''' may be attached to bone 150'''' below tissue 130''. Surgical sutures 112'''', 114'''' may be used to connect tissue 130''' to anchors 160a''', 160b''', respectively, attached to surgical sutures 112'''', 114'''', according to common surgical practice.
[0099] Tissue augmentation blocks 110a'''-d''' may be threaded over suture limbs 111a'''', 111b'''', 113a'''', 113b'''' using techniques provided throughout this disclosure and advanced along each suture to a desired location. The free ends of suture limbs 111a'''', 113a'''', and 111b'''', 113b'''' may be tied to and tightened around surgical sutures 112'''', 114'''', respectively.
[0100] 11F illustrates a further alternative single row application. A first suture 111'''' can be attached medially with two suture limbs 111a'''', 111b'''' extending from the tissue 130'''' by a mattress stitch 140a'''', and a second suture 113'''' can be attached with two suture limbs 113a'''', 113b'''' extending from the tissue 130'''' by a second mattress stitch 140b''''. After the first and second sutures 111'''', 113'''' are attached, first and second medial anchors 160a'''', 160b'''' are attached to the bone 150'''' below the tissue 130''''. Surgical sutures 112'''', 114'''' coupled to anchors 160a'''', 160b'''', respectively, may be used to effect the repair such that tissue 130'''' contacts bone 150'''', according to common surgical practice. Once tissue 130'''' has been repaired, blocks 110a''''-d'''' may be attached onto suture limbs 111a'''', 111b'''', 113a'''', 113b'''' using techniques provided throughout this disclosure. The free ends of suture limbs 111a'''', 113a'''', and 111b'''', 113b'''' may be secured within the body, for example, by attaching them to anchors 160c'''' and 160d'''', respectively. Suture limbs 111a'''', 111b'''', 113a'''', 113b'''' may be tightened to further secure blocks 110a''''-d'''' to soft tissue 130'''', such that the repair made by sutures 112'''', 114'''' is covered by the tissue augmentation block.
[0101] A further exemplary method of soft tissue repair is illustrated in Figure 12. According to this method, a piece of soft tissue 1130, e.g., a rotator cuff, is fixed to a bone 1150 using single row fixation. Once the surgeon has access to the surgical site and the tissue, bone, and tissue augmentation blocks have been prepared according to common surgical techniques, including those provided herein, the surgeon may attach sutures 1112, 1114 using mattress row stitches 1140 and sutures 1116, 1118 using mattress row stitches 1142 in the tissue 1130. Sutures 1112, 1114, and 1116, 1118 are attached to anchors 1160a, 1160b, respectively, in the bone 1150 below the tissue 1130. As shown in FIG. 12, mattress stitches 1140 and 1142 each result in four suture limbs 1112a, 1112b, 1114a, 1114b and suture limbs 1116a, 1116b, 1118a, 1118b extending outwardly from the soft tissue.
[0102] At least one block 310' may be threaded onto at least one suture limb of each suture 1112, 1114, 1116, 1118. Block 310' may be similar to block 310, with one difference between the two being that block 310' is thicker than block 310. Alternatively, block 310' may have any suitable dimensions as needed for a given procedure. In some embodiments, each of suture limbs 1112a, 1114a, 1116a, 1118a may have a block 310' threaded using techniques provided throughout this disclosure, and then the two suture limbs of each pair may be tied together. For example, block 310' may be threaded onto suture limbs 1112a, 1112b, and then suture limbs 1112a, 1112b may be tied together. After the suture limbs 1112a, 1112b are tied together, the block 310' may be moved over the knot to cushion or cover the knot. This process may be repeated for each of the suture limb pairs 1114a and 1114b, 1116a and 1116b, and 1118a and 1118b.
[0103] A still further exemplary method of soft tissue repair is illustrated in Figure 13. According to this method, a piece of soft tissue 1230, e.g., a rotator cuff, is secured to a bone 1250 using a single row of ripstop stitches. Once the surgeon has access to the surgical site and the tissue, bone, and tissue augmentation structures have been prepared according to common surgical techniques, including those provided herein, the surgeon may connect sutures 1212, 1214 to anchors 1260a using stitches 1240 and sutures 1216, 1218 to anchors 1260b using stitches 1242. Any known stitch may be used. As shown in FIG. 13, stitch 1240 results in four suture limbs 1212a, 1212b, 1214a, 1214b extending outwardly from the soft tissue, and stitch 1242 also results in four suture limbs 1216a, 1216b, 1218a, 1218b extending outwardly from the soft tissue.
[0104] The tissue augmentation block 1210 may be threaded onto one of the suture limbs associated with each mattress knot 1240, 1242 using techniques provided throughout this disclosure. The block 1210 in the illustrated embodiment is a structure similar to the bar 3010, 3110. In the illustrated embodiment, each of the suture limbs 1212a, 1216a has a block 1210 associated with it. Once each of the suture limbs 1212a, 1216a has a block 1210 threaded thereon, the suture limbs 1212a, 1216a may be tied to the complementary suture limbs 1212b, 1216b, respectively. Additionally, the block 1210 may slide over the knot to cushion or cover the knot, as shown. The suture limbs 1214a, 1214b may then be tied together at the top of the block 1210 to form a rip-stop stitch. Advantageously, when the suture limbs 1214a, 1214b are tied together, the block 1210 will act as a buffer to distribute the applied load, thereby preventing tearing of the soft tissue 1230. This process may be repeated for the second mattress stitch 1242.
[0105] 14 illustrates a further method of soft tissue repair. This method provides for securing a piece of soft tissue 1330, e.g., the rotator cuff, to a bone 1350 using an anterior-posterior mattress stitch that extends between the anchors. Once the surgeon has access to the surgical site and the tissue, bone, and tissue augmentation blocks have been prepared according to common surgical techniques, including those provided herein, the surgeon may thread the two limbs 1312a, 1312b of the suture 1312 connected to the anchor 1360a through the tissue 1330. Similarly, a second anchor 1360b may be embedded in the bone 1350 with the suture limbs 1314a, 1314b of the suture 1314 extending from the anchor 1360b through the tissue 1330. Any known stitch may be used.
[0106] A single block 1310 can be threaded over either of the suture limbs 1312a, 1314a of either of the anchors 1360a, 1360b using the techniques provided throughout this disclosure. The illustrated block 1310 has a length in the range of approximately 10 millimeters to approximately 20 millimeters, a width in the range of approximately 2 millimeters to approximately 5 millimeters, and a height in the range of approximately 1 millimeter to approximately 3 millimeters. After the suture limb 1312a has the block 1310 threaded thereon, the suture limb 1312a can be tied to the suture limb 1314a. Additionally, after the suture limbs 1312a, 1314a are tied together, the block 1310 can be slid over a knot (not shown) to cushion or cover the knot. The suture limbs 1312b, 1314b can then be tied together on the block 1310. Advantageously, when the suture limbs 1312b, 1314b are tied together, the block 1310 will act as a buffer between them to distribute the applied load, thus preventing the soft tissue 1330 from tearing.
[0107] An alternative single row fixation method of soft tissue repair is illustrated in FIG. 15. With this method, soft tissue 1430 is fixed to bone 1450 with an alternative very long, very wide block application. Once the surgeon has access to the surgical site and the tissue, bone, and tissue augmentation blocks have been prepared according to common surgical techniques, including those provided herein, the surgeon may fix the soft tissue 1430 to bone 1450 according to common surgical techniques to form repairs 1438a, 1438b, shown in hidden lines. Once repairs 1438a, 1438b are completed, a first mattress stitch 1440 is formed through the soft tissue 1430 medial to the soft tissue repair 1438a and a second mattress stitch 1442 is formed medial to the repair 1438b to attach sutures 1412 and 1414 into the soft tissue 1430. A first mattress stitch 1440 results in two suture limbs 1412a, 1412b extending outwardly from the soft tissue 1430, and a second mattress stitch 1442 results in two suture limbs 1414a, 1414b extending outwardly from the soft tissue. Alternatively, the stitches 1440, 1442 may be formed before the repairs 1438a, 1438b are made.
[0108] The blocks 1410a-1410c have configurations that may be considered to be larger versions of some of the other block configurations provided herein. As shown, the blocks 1410a-1410c have a substantially rectangular shape, like the cannulated block configurations 3010, 3110 of Figures 2E and 2F, but are thicker. Other configurations of the blocks 1410a-1410c are possible, particularly in light of the present disclosure, including, but not limited to, configurations more similar to one or more tape strips 10, tubes 110, and washers 310, 410, or combinations thereof. In one exemplary embodiment, the blocks 1410a-1410c may have a length approximately in the range of about 15 millimeters to about 25 millimeters, a width approximately in the range of about 4 millimeters to about 5 millimeters, and a thickness approximately in the range of about 1 millimeter to about 3 millimeters.
[0109] The blocks 1410a, 1410c may be threaded onto the suture limbs 1412a, 1414a using techniques provided throughout this disclosure. In the illustrated embodiment, the block 1410b has two suture limbs associated therewith, suture limbs 1412b and 1414b. This latter configuration may be accomplished using techniques provided throughout this disclosure, but in one exemplary method, one attachment tool may be used to simultaneously associate both suture limbs 1412b, 1414b with the block 1410b. For example, the threader 206 (not shown) may be placed into the block 1410b and may have both sutures passed through its distal opening 212 (not shown). The threader may then be manipulated to associate the limbs 1412b, 1414b with the block 1410b, as described above. Alternatively, block 1410b may have two threaders disposed therethrough for separately threading suture limbs 1412b, 1414b. In a further alternative, one threader may be threaded through block 1410b to pull suture limb 1412b through block 1410b, and then this threader or a different threader may be inserted into block 1410b to thread suture limb 1414b through block 1410b.
[0110] Once the blocks 1410a-1410c are threaded over the suture limbs 1412a, 1412b, 1414a, 1414b, they may be advanced along the suture limbs 1412a, 1412b, 1414a, 1414b, respectively, until they are adjacent the inner stitches 1040, 1042. One advantage of the blocks 1410a-1410c is that they may be sized to cover a significant portion of the surgical site, including the periphery defined by the anchors 1460a, 1460b and the mattress stitches 1440, 1442. Other advantages of the tissue augmentation structures provided herein may also be applicable. After the blocks 1410a-c are attached onto each suture limb, the free ends of the suture limbs 1412a, 1412b and 1414a, 1414b may be secured within the body, for example, by attaching them to anchors 1460a, 1460b, respectively. The suture limbs 1412a, 1412b, 1414a, 1414b may be tightened to secure the soft tissue 1430 to the bone 1450, after which the anchors 1460a, 1460b are fully secured to the bone 1450.
[0111] The various embodiments described above may be used in conjunction with any of the other embodiments described above such that some soft tissue is secured with a double row application and some with a single row application. Furthermore, any number of suture limbs and tissue augmentation blocks may be used during any particular procedure, including placing multiple strips on a limb and / or using only one limb or more than two limbs.
[0112] Rotator Cuff Repair - Partial Tear Repair An exemplary method of soft tissue repair of a partial tear is illustrated in Figures 16A-16C. With this method, a piece of soft tissue 1530, e.g., the rotator cuff, is secured to a bone 1550 in the presence of a partial tear. As shown in Figure 16A, the soft tissue 1530 is maintained in contact with the bone 1550 at 1530d. Length X indicates that a "healthy" footprint of contact should exist between the tissue 1530 and the bone 1550. This procedure may assist in reattachment of the soft tissue to the bone to form a "healthy" footprint. In conventional procedures, the necessary compression of the suture against the tissue may result in collapse at the attachment point, weakening the tissue and, more generally, the rotator cuff.
[0113] Once the surgeon has access to the surgical site and the tissue, bone, and tissue augmentation structures have been prepared according to common surgical techniques, including those provided herein, the surgeon may attach an anchor 1560 to the bone 1550. The anchor 1560 may pass through the soft tissue 1530 and may have a suture 1512 extending from the anchor 1560 and connecting thereto, the suture 1512 having two suture tails 1512a, 1512b. The block 1510 may be threaded over at least one of the suture tails 1512a, 1512b. The block 1510 may be of any of the configurations provided herein, including, but not limited to, blocks 10, 110, 3010, 3110, 310, and 410, as well as patches 2210, 2310, 2410, and 2510 described below. The construct 1510 may be threaded over the suture limbs 1512a and advanced along the suture 1512a until it is in proximity to the tissue 1530, for example, using techniques provided throughout this disclosure. After the construct 1510 is attached onto one of the suture limbs, the free ends of each suture limb 1512a, 1512b may then be tied together using a knot, not shown, to bring the injured tissue 1530 into contact with the bone 1550. The construct 1510 may then be moved into position such that it covers the knot and is in contact with the tissue 1530. Once the construct 1510 is attached, it may be constructed to add height to the collapse and restore height to the repaired tissue 1530, as shown in FIG.
[0114] How to Use - Non-Rotator Cuff Repair The present disclosure contemplates that the tissue augmentation structures provided herein have applications outside of the rotator cuff as tissue augmentation structures. Some non-limiting examples of those alternative procedures are provided below. These examples are not exhaustive. Furthermore, one skilled in the art will understand how some of the disclosures provided in this non-rotator cuff repair section can be adapted for use in rotator cuff repair procedures. Each of the embodiments described below is discussed with respect to the use of the tissue augmentation structures, including those discussed after non-rotator cuff repairs (i.e., labrum repair or augmentation, ACL repair, Achilles repair, AC joint repair, meniscus repair, and superior capsule reconstruction). Such structures include any of the blocks and patches disclosed herein or others that can be derived from the present disclosure. One skilled in the art will understand, in light of the present disclosure, how to adapt the various tissue augmentation structures for use in various procedures. Furthermore, in each of the exemplary embodiments of the methods described in this disclosure, for example, collagen can be used as part of the structure or to form the entire or nearly entire structure. This allows the structure to grow in the area of healed repair. Other materials can also be used to form the structure, including others that achieve similar results to collagen.
[0115] Non-rotator cuff repair - correction of labral defect One alternative procedure is illustrated in Figures 17A-17D. This method uses a tissue augmentation structure 1610 or structure to fill the gap where the soft tissue 1630 has been damaged and detached from the bone 1650. For example, as shown in Figure 17A, the labrum 1630 may have a cleft or defect 1635 exposing a portion of the bone 1650. Once the surgeon has access to the surgical site and the tissue, bone, and tissue augmentation structure have been prepared according to common surgical techniques, including those provided herein, the surgeon may attach a first anchor 1660a into the bone at a location 1635p proximal to the cleft 1635. The first anchor 1660a has a suture 1612 attached to it. The tissue augmentation structure 1610 may be threaded over the suture limb 1612 using techniques provided throughout this disclosure and advanced along the suture until the tissue augmentation structure 1610 is adjacent to the proximal end 1635p of the cleft. Any type of tool provided herein or known to one of skill in the art, including a knot push tool, may be used to advance the structure 1610 towards the anchor 1660a. The tissue augmentation structure 1610 may be approximately the same length as the implanted defect 1635 and may be pre-cut and / or cut to ensure a proper fit in real time at the surgical site.
[0116] After the tissue augmentation construct 1610 is mounted on the suture rim 1612, the free end of the suture rim 1612 can then be anchored to the bone with a second anchor 1660b, for example a knotless type fixation anchor. The tail of the suture 1612 can be tightened and then the anchor 1660b is fully inserted into the bone. By placing the anchors 1660a, 1660b and the construct 1610 in these locations, the construct 1610 terminates at the posterior edge of the joint rather than on the face of the glenoid, and the repair can be used to reconstruct the labrum rather than simply fixating the defect as has been more typical in previous labrum repair surgeries. In another alternative embodiment, a separate suture extending from each of the two anchors 1660a, 1660b can be threaded through the labrum on either side, and the tissue augmentation structure 1610 can be placed over one of the two sutures and the two sutures can be connected to each other, for example, using a knot. Additionally, the tissue augmentation structure 1610 can be placed over the location where the two sutures are tied together to protect the location where the sutures connect to each other.
[0117] Non-rotator cuff repair - ACL repair Another alternative procedure is illustrated in Figures 18A-18C. This method uses a tissue augmentation structure 1710 or structure to repair a torn ACL. For example, as shown in Figure 18A, a bundle of ACL 1702 is torn or otherwise injured. Once the surgeon has access to the surgical site and the tissue, bone, and tissue augmentation structure are prepared according to common surgical techniques, the surgeon may begin the partial ACL repair. First, a bone tunnel 1704 is drilled into the femur 1706 and the tibia 1707 adjacent to the native, intact ACL 1708. Next, the tissue augmentation structure 1710 shown in Figure 18B is fabricated in the same manner as described above with respect to the other embodiments, with suture limbs 1712a, 1712b extending from opposite ends. The structure 1710 may have a length generally ranging from about 5 millimeters to about 100 millimeters. 18C, the structure 1710 may be passed through the bone tunnel 1704 such that the structure 1710 contacts the intact ACL 1708. Suture limbs 1712a, 1712b may be used to secure the structure 1710 within the bone tunnel according to known surgical techniques.
[0118] Alternatively, the structure 1710 may be used to augment an autograft implant. In situations where the autograft or allograft implant is too short and / or too thin and not strong enough to complete the repair, the structure 1710 may be sutured or otherwise connected to the autograft implant to form an implant of the required size. In a further alternative, a structure having a lumen extending therethrough may be threaded over the autograft or allograft implant to further strengthen the autograft or allograft implant for ACL repair.
[0119] Non-rotator cuff repair - superior capsule reconstruction Yet another alternative procedure is illustrated in FIG. 19. In this method, at least one of the tissue augmentation structures 1810a, 1810b may be used to assist in anchoring the superior capsular reconstruction implant 1820 onto the humeral head 1802. Once the surgeon has access to the surgical site and the tissue, bone, tissue augmentation structures, and superior capsular reconstruction implant are prepared according to common surgical techniques, including those provided herein, the surgeon may secure one end of the implant 1820 to the glenoid rim 1804. The surgeon may secure one end of the implant 1820 to the glenoid rim 1804 by attaching a first medial anchor 1860a having a suture 1812a extending therefrom. The first tissue augmentation structure 1810a can be threaded over the suture 1812a using techniques provided throughout this disclosure, and the structure 1810a can be fastened to the implant 1820 using techniques provided herein or known to those of skill in the art, such as by tying the suture 1812a to the suture 1812b (both extending from the anchor 1860a), not shown. The pressure of the structure 1810a onto the implant 1820 can hold the implant 1820 in a desired position relative to the articular rim 1804. Opposite ends of the implant 1820 can be anchored proximate the humeral head 1802, and the position and / or size of the implant 1820 can be adjusted so that the articular rim 1804 contacts the humeral head 1802 according to techniques used for upper capsule reconstruction surgery.
[0120] While a number of different techniques may be used to proximally couple the other end of the implant 1820 to the humeral head 1802, in the illustrated embodiment, first and second lateral anchors 1862a, 1862b are used in conjunction with a second tissue augmentation structure 1810b to form the repair. More specifically, in one exemplary embodiment, at least one of the anchors 1862a, 1862b may have a suture 1812b associated therewith, and the second tissue augmentation structure 1810b may be placed over at least a portion of the suture 1812b using techniques provided herein. The suture 1812b can be stretched between the two anchors 1862a, 1862b using any of the techniques provided herein or known to one of skill in the art, and the structure 1810b can be tightened against the implant 1820 to help maintain the position of the implant 1820 relative to the humeral head 1802 while allowing the structure 1810b to better distribute any forces applied by the suture 1812b across the surface area of the structure 1810b. Any number of tissue augmentation structures can be used in the repair, and in alternative embodiments, tissue augmentation structures may only be used in conjunction with connecting the implant 1820 to only one of the glenoid rim 1804 and the humeral head 1802.
[0121] Soft tissue repair with gap closure - Rotator cuff and non-rotator cuff examples Two exemplary embodiments for closing a gap or space in tissue are illustrated in Figures 20A-20F. The first illustrated embodiment relates to rotator cuff edge convergence, as shown in Figures 20A-20C, and the second illustrated embodiment relates to hip capsular closure, as shown in Figures 20D-20F. However, one skilled in the art will recognize other types of procedures. These embodiments may be applied in practice without departing from the spirit of the present disclosure.
[0122] FIG. 20A shows rotator cuff tissue 1930 having a gap or void 1905. First and second sutures 1912a, 1912b can be associated with first and second structures 1910a, 1910b using techniques provided throughout this disclosure. As shown in FIG. 20B, a first free end of the first suture 1912b can be threaded into the rotator cuff tissue 1930 on a first side of the gap 1905 and can be threaded into the rotator cuff tissue 1930 on the opposite side of the gap 1905. The first free end can be tied to the second free end to bring the edges 1930a, 1930b of the gap 1905 together. As shown in FIG. 20C, this process can be repeated for the second suture 1912b to complete the repair. The tissue augmentation structures 1912a, 1912b can provide many of the benefits provided herein, including, but not limited to, a large surface area over which forces from the sutures 1912a, 1912b can be distributed, protection of the knots used to join the free ends of the sutures 1912a, 1912b, and providing a scaffold for new tissue growth to create a stronger repair between the edges 1930a, 1930b, where the scaffold essentially becomes a new layer of tissue on top of the existing rotator cuff tissue 1930.
[0123] FIG. 20D shows hip capsule tissue 1930' with a gap or void 1905'. First and second sutures 1912a', 1912b' can be associated with the first and second structures 1910a', 1910b' using techniques provided throughout this disclosure. As shown in FIG. 20E, a first free end of the first suture 1912a' can be threaded into the hip capsule tissue 1930' on a first side of the gap 1905' and threaded through the hip capsule tissue 1930' on the opposing side of the gap 1905'. The first free end can be tied to the second free end to bring the edges 1930a', 1930b' of the gap 1905' together. As shown in FIG. 20F, this process can be repeated for the second suture 1912b' to complete the repair. Like tissue augmentation structures 1912a, 1912b, tissue augmentation structures 1912a', 1912b' can provide many of the benefits provided herein, including the highlighted benefits provided with respect to structures 1912a, 1912b.
[0124] Tissue Augmentation Constructs - Collagen Tacks / Buttons Another exemplary embodiment of a tissue augmentation structure is illustrated in Figures 21A and 21B. The tissue augmentation structure, as shown, includes a tack or button 2010 having a generally cylindrical shape that is configured to be disposed over or otherwise associated with a suture 2012. More specifically, the tissue augmentation tack 2010 may have a substantially cylindrical body having a hole or lumen 2014 extending therethrough from a proximal-most end 2010p to a distal-most end 2010d. The hole 2014 may be used to receive the suture 2012, for example, by a stitch 2013, such that the tack 2010 and the suture 2012 may be associated with one another, as described in more detail below. In alternative embodiments, the suture 2012 can be passed through the tack 2010 without a predefined lumen formed in the body of the tack 2010, and / or the suture 2012 can be wrapped around or otherwise coupled to the tack 2010 without passing through it. As shown, the tack 2010 has a diameter D T Lower height HT Furthermore, the diameter D T The tack 2010 can be larger than the diameter of the associated filament or suture, e.g., suture 2012, thereby allowing for a larger footprint for the suture 2012 and a larger surface area for tissue augmentation in a system or device used in surgical repair.
[0125] The suture 2012 can be any type of suture provided herein or known to one of skill in the art. In the illustrated embodiment, the suture 2012 includes a self-locking feature 2015 associated with an intermediate portion 2012i of the suture 2012, a retractable loop 2040 extending from one side of the self-locking feature 2015, and a fixation tail 2012f and a tension tail 2012t extending from an opposite side of the self-locking feature 2015. The self-locking feature 2015 can take a variety of shapes, and in the illustrated embodiment, the self-locking feature 2015 has a finger-trap like configuration formed by having the first limb pass through a portion of the second limb of the suture 2012 and then exit the second limb resulting in a fixation tail 2012f and a tension tail 2012t. The fixation tail 2012f can be wrapped and / or connected around the tack 2010, and as shown, a stitch 2013 is used to help manage the fixation tail 2012 and attach it to the tack 2010. The tension tail 2012t can be used to help adjust the diameter of the retractable loop 2040.
[0126] The retractable loop 2040 can be coupled to an implant, for example, a bone anchor 2060, and the diameter of the loop 2040 can be adjusted by moving the self-locking mechanism 2015 proximally away from the anchor 2060 and distally toward the anchor 2060, for example, by applying a force to the tension tail 2012t proximally away from the anchor 2060, as shown in the illustrated embodiment. The anchor 2060 can be a low profile anchor such that the anchor 2060 can more easily pass through the tendon. One of ordinary skill in the art will recognize a variety of suitable low profile anchors that can be used in conjunction with the present disclosure, including several anchors as provided above, for example, the Gryphon® and Healix Transtend™ anchors.
[0127] Numerous other suture configurations are possible, including some disclosed further below and others known to those of skill in the art. Some suture configurations that may be incorporated into this design include, but are not limited to, those disclosed in U.S. Patent No. 8,821,544, entitled "Surgical Filament Snare Assemblies," and U.S. Patent No. 9,060,763, entitled "Systems, Devices, and Methods for Securing Tissue," the contents of each of which are incorporated herein by reference in their entirety.
[0128] Those skilled in the art will appreciate that the height H of the tissue augmentation tack 2010 T and diameter D T It will be appreciated that the dimensions of the diameter of the hole 2014 may depend on a variety of factors, including, but not limited to, the size of the filament associated with the tissue augmentation tack 2010, the anatomy of the patient, and the type of surgery being performed. In some embodiments, the diameter D of the tack 2010 may be determined by a variety of factors, including, but not limited to, the size of the filament associated with the tissue augmentation tack 2010, the anatomy of the patient, and the type of surgery being performed. T The ratio of the diameter of the suture rim 2012 to the diameter of the suture rim 2012 can be in the range of about 2:1 to about 100:1, and more particularly, the diameter DT can, in some instances, be at least three times the diameter of the filament or suture with which the tissue augmentation tack 2010 is associated. A variety of other sizes and shapes of tissue augmentation tack 2010 may be utilized without departing from the spirit of the present disclosure, including the dimensional ratios of the tack and associated components (e.g., suture 2012).
[0129] While ratios may be useful to help explain the relationship between the tack 2010 and the filament 2012 and the relationship between the dimensions of the tack 2010, some example, non-limiting dimensions for the tissue augmenting tacks may also be helpful in understanding the present disclosure. As noted above, these dimensions may depend on a variety of factors. In some embodiments, the height H T can range from approximately 1 millimeter to approximately 1 centimeter, and the diameter D T can range from approximately 1 millimeter to approximately 10 millimeters. The size of the diameter d of the hole 2014 can also depend on a variety of factors, including but not limited to the size of the rim that passes through the hole 2014. In some embodiments, the diameter d can range from approximately 0.5 millimeters to approximately 3 millimeters. Alternatively, the hole 2014 can be absent and the filament 2012 can pass through the tack 2010 without a hole. The tack 2010 can be made from any of the materials provided above with respect to other tissue augmentation structures, including but not limited to collagen.
[0130] 21B, an inserter tool 2070 can be used to attach the anchor 2060 to a pre-formed bone hole in the bone 2050 in a trans-tendon approach. The inserter tool 2070 can have a releasable mechanism (not shown) at a distal end 2070d that can releasably engage the anchor 2060 so that the inserter tool can be removed after the anchor is attached to the bone 2050. For example, the releasable mechanism can be a compression fit, threads for engaging the anchor 2060, a ball detent, or other releasable mechanism that can be associated with the inserter tool 2070 in view of this disclosure and what is known to one of ordinary skill in the art.
[0131] In use, as shown in FIG. 21C, the inserter tool 2070 may be used to insert the anchor 2060 into the tendon or other soft tissue 2030. The surgeon may then remove the inserter tool 2070 from the anchor 2060 after the anchor 2060 is secured into the bone 2050 below the tendon 2030, as shown in FIG. 21D. Once the anchor 2060 is secured to the bone 2050, tension may be applied to the tension tail in a direction T1, as shown in FIG. 21E. As the tension tail 2012t is pulled, the diameter of the suture loop 2040 decreases and the tack 2010 contacts the tendon 2030, compressing the tendon 2030 against the bone 2050. The self-locking mechanism 2015 maintains the position of the tension tail 2012t to keep the construct in a locked configuration. The tension tail may then be cut off.
[0132] The use of the tissue augmentation tack 2010 provides many advantages. As illustrated in FIG. 21E, the resulting configuration is one in which the tack 2010 is placed on top of the tissue 2030, with no exposed rigid components and / or knots. This reduces the chance of tissue abrasion, among other benefits. The same types of benefits provided for the other structures provided herein are equally applicable. For example, if the tissue augmentation tack 2010 is made from collagen or other types of tissue growth promoting materials, the repair may result in tissue remodeling with no components remaining other than the sutures. Furthermore, after the tack 2010 has been advanced towards the anchor 2060 and secured in the tissue 2030, management of the sutures is not actually necessary post-operatively.
[0133] Alternatively, as shown in FIG. 21F, if two tension tacks 2010a, 2010b are used, the tension tacks 2010a, 2010b may be attached in the same manner as described above with respect to FIG. 21A-21E. Instead of cutting off the tails 2012t_1, 2012t_2, the tension tails 2012t_1, 2012t_2 may be secured within the outer row anchors 2062 to provide additional compression of the tissue 2030 against the bone 2050. In a further alternative method, as shown in FIG. 21G, the two tension tails 2012t_1′ and 2012t_2′ may be tied together with a knot 2018. The knot 2018 may be covered by one or more additional tissue augmentation structures provided herein.
[0134] Other non-limiting alternative embodiments of the tack 2010 are illustrated in FIGS. 21H and 21I as tacks 2010' and 2010'', respectively, which focus on other types of self-locking mechanisms associated with each suture 2012', 2012". The configuration of the suture 2012' includes a self-locking sliding knot 2015' that is configured to selectively limit the movement of the tension tail 2012t' relative to the tack 2010'. One of ordinary skill in the art will recognize many different types of self-locking knots 2015' that may be used with the tack 2010'.
[0135] A further alternative tack 2010'' is shown in FIG. 21I. Tack 2010'' may have substantially the same dimensions as tack 2010 and be made from substantially the same materials. However, tissue augmentation tack 2010'' has two holes 2014a'', 2014b'' that extend from a proximal-most surface 2010p'' to a distal-most surface 2010d''. As shown in FIG. 21I, the two holes 2014a'', 2014b'' may be parallel to one another, although other alternative configurations are contemplated. In some embodiments, there may be no holes, and instead a suture may pass through or be otherwise associated with tack 2010'', as provided herein or known to one of skill in the art.
[0136] The suture 2012'' used with the tack 2010'' can be similar to the suture 2012, but as shown, the suture 2012'' is manipulated into a configuration having two self-locking features 2015a'' and 2015b'' and two loops 2040a'' and 2040b''. The self-locking features 2015a'' and 2015b'' can be formed as described above or known to one of skill in the art. In the illustrated embodiment, the self-locking features 2015a'' and 2015b'' have a finger-trap like configuration formed by having the first limb of the suture 2012'' pass through a portion of the second limb of the suture 2012'' and then exit the second limb resulting in fixation tails 2012f_1'', 2012f_2'' and tension tails 2012t_1'' and 2012t_2''. As shown, fixation tails 2012f_1'' and 2012f_2'' can be coupled to the tack 2010'' using one or more stitches 2013'', and tension tails 2012t_1'' and 2012t_2'' can extend from the proximal-most end 20120p'' of the tack 2010''. Both loops 2040a'' and 2040b'' can be coupled to a suture implant, anchor 2060a'' shown, and as described above, tension tails 2012t_1'' and 2012t_2'' can be operable to adjust the diameter of each loop 2040a'' and 2040b''. In the illustrated embodiment, the self-locking mechanisms 2015a'' and 2015b'' are shown as having a finger-trap like configuration, however, other types of self-locking mechanisms, including sliding knots, may be used in place of the illustrated self-locking mechanisms 2015a'' and 2015b''.
[0137] Methods for manufacturing tissue augmentation structures The tissue augmentation structures provided herein may be manufactured using a number of different techniques, some of which are provided below. Other techniques known to those of skill in the art or developed subsequently to this disclosure, particularly in light of this disclosure, may also be used to manufacture tissue augmentation structures of the various configurations disclosed.
[0138] Method for Producing Tissue Augmentation Constructs - Ultrasonic Molding In one exemplary embodiment of making tissue augmentation structures (blocks, scaffolds, etc.), the freeze-dried dermis is provided in one or more sheets or other bulk configurations and can be trimmed to a desired size to create a tissue augmentation structure configured for soft tissue repair applications. An exemplary method for trimming the sheet(s) or other bulk configurations includes the use of an ultrasonic generator and a hand piece. The hand piece can use a pre-made or custom blade to cut pieces of the sheet(s) or other bulk configurations to a desired size and shape. In some embodiments, a custom blade can be used to scrape fine pieces off the edge of the freeze-dried dermis and / or puncture the dermis. These actions can form one or more channels in the tissue augmentation structure(s), which can be used to pass sutures or other devices to hold the tissue augmentation structure at the surgical site. The use of ultrasonic technology, such as an ultrasonic generator and a hand piece, can be advantageous over traditional manual blade technology, as the ultrasonic technology can significantly reduce the force to cut and shape the freeze-dried dermis into a tissue augmentation structure. Additionally, the use of ultrasonic cutting techniques allows for less distortion of the freeze-dried dermis due to the cutting act, resulting in more precise cutting and puncturing and therefore more precisely sized tissue augmentation structures.
[0139] Ultrasound techniques, including cutting and shaping of freeze-dried dermis, can be used to create some or all of the features or shapes of the tissue augmentation structures disclosed herein.
[0140] Tissue Augmentation Structure - Method for Producing Blocks with Tape Configuration In one exemplary embodiment of the creation of the tissue augmentation tape or strip 10, the material used to create the strip 10 can be cut into the desired shape. For example, in an embodiment in which the strip is made from either autograft tissue, allograft tissue, or xenograft tissue, if the tissue is collected prior to surgery, the fresh tissue can be cut into the desired shape for the strip 10, for example, a generally rectangular shape having a length L, width W, and thickness T, as shown in FIG. 1A. Whether the strip is made from collected material or not, obtaining the material to create the strip can be accomplished using any technique known to those skilled in the art. In accordance with the present disclosure, the tape or strip 10 can have any shape, for example, the tissue can be cut into an oval, circle, triangle, etc. Furthermore, the tissue need not be cut with a traditional scalpel or scissors. In some examples, the tape or strip 10 can be sized by use of a punch, computer numerically controlled machine, laser cutter, or other known manufacturing techniques.
[0141] Once the tissue has been formed into the desired shape, a threader may be associated with the strip 10. For example, similar to the suture limb 12a shown in FIG. 1B, the intermediate filament portion 210 of the threader 206 may be threaded through the strip 10 using a running stitch. This stitch may be passed back and forth across the body of the tape strip 10 as many times as necessary. In an alternative embodiment, the intermediate filament portion 210 of the threader 206 may just pass from one side of the tape strip 10 to the other without passing outside the body. After the threader 206 is attached, the strip 10 may be dried for packaging. Alternatively, the threader 206 may be inserted after the tissue has been dried. Additionally, the strip 10 need not be dried.
[0142] Tissue Augmentation Structure - Method for Producing Blocks Having a Tube Configuration Exemplary embodiments for making tissue augmentation tube 110 are illustrated in Figures 22A-22C. The material used to make tube 110 may be collected or otherwise obtained using techniques known to those of skill in the art. This material may then be shaped using any of the techniques described above elsewhere herein with respect to strip 10 or known to those of skill in the art. As shown in Figure 22A, a piece of material 120 may be collected having a length L' and a width W'. As shown in Figure 2B, width W' is a distance D from the surface of the tissue augmentation tube 110. * 22A, the piece of material 120 may be generally rectangular having a first end 120a and a second end 120b with a width W' extending therebetween. Alternatively, the piece of material 120 may have any shape.
[0143] Once the piece of material 120 is cut, the first and second ends 120a, 120b may be brought together and then attached to one another to form a tube. As shown in Figures 22B and 22C, the first and second ends 120a, 120b may be attached by stitching the ends together using a suture or filament 122. Alternatively, the first and second ends 120a, 120b may be attached to one another by glue, collagen bond, staples, light curing, cross-linking, mechanical interlocking, dehydration, or other techniques for attaching soft tissue to soft tissue known to those skilled in the art. The threader 206 may be inserted into the tube 110 before the two ends 120a, 120b are attached, or after the threader 206 is inserted. The tube 110 may be dried for packaging. Alternatively, the tubes 110 may be maintained in a hydrated state without dehydrating the block 110 (as well as any of the structures discussed herein or others that may be derived therefrom). An alternative method for manufacturing tissue augmentation tubes is provided in Figures 23A-C. In this method, multiple tubes 110a-110c may be made one piece of material at a time or, as shown, two pieces of material (one piece of material placed over the other).
[0144] As shown, a first piece of material 130a and a second piece of material 130b are placed one on top of the other. As with the previous embodiment, the material 130a, 130b may be obtained, sized, and formed using any technique provided herein or known to one of skill in the art. As shown in FIG. 23B, the first and second pieces of material 130a, 130b may have a length L' and a width determined as a function of the number of tubes 110a-110c required. Specifically, each tube 110 has a diameter or width D as described above. Thus, the piece of material may have a width equal to the number of tubes 110 required multiplied by D. Alternatively, the manufacturing may be designed to allow a selected amount of space to be formed between each strip formed. In some embodiments, a single piece of material (not shown) having a generally rectangular shape may be used. In this case, the piece of material is folded in half and stacked one on top of the other to form the first and second pieces of material as shown.
[0145] Once the two pieces of material 130a, 130b are cut to the desired size, the pins 132a-132c may be placed between them. The pins 132a-132c may be placed approximately parallel to one another and perpendicular to the long side 131 of the material. The pins 132a-132c may be spaced such that there is sufficient space between each pin 132a-132c to allow for attachment and separation of the individual tubes 110a-110c.
[0146] As shown in Figures 23A-C, the first and second pieces of material 130a, 130b are attached using sutures 134 and stitching the two pieces together to form a tube around the pin 132a. Alternatively, the first and second pieces of material 130a, 130b may be attached to one another using glue, collagen bond, staples, light curing, or other known techniques. Once all of the tubes 110a-110c are stitched, the individual tubes 110a-110c may be cut along lines L1 and L2. As shown in Figure 23B, lines L1 and L2 are approximately parallel to the pins 132a-132c. Once the individual tubes 110a-110c are cut, the pins 132a-132c may be removed, leaving holes or lumens 114a, as shown in Figure 23C. The threader 206 may be associated with the lumen 114a in the manner provided herein for the lumen 114 of the tube 110 to pass the suture limb therethrough.
[0147] This method of manufacturing tube-like structures can also be used in a similar manner to manufacture cannula-like structures, such as the bars 3010, 3110 illustrated in Figures 2E and 2F. In such an example, the pins 132a-132c can be removed once the cannula has been formed using them, and the two layers of material 130a', 130b' can be slightly compressed or relaxed towards each other by themselves. As a result, the lumen 114a' can change from the tube-like shape shown in Figure 23C to the slit-shaped lumen 114a' shown in Figures 2E and 2F. As mentioned above, the overall shape of the structures 3010, 3110 can be a generally rectangular prism. In the construction of the structures 3010, 3110, for example, the use of the pins 132a'-132c' can be omitted entirely. Alternatively, pins 132a'-132c' may be replaced with comb blades, not shown, so that the shape of lumen 114c' begins as a slit rather than beginning with a tubular shape.
[0148] A further alternative method for manufacturing tissue augmentation tubes is provided in Figures 24A-24C. In this method, multiple tubes 110a'-110c' can be made from one piece of material at a time, or multiple pieces of material if desired. As shown, the piece of material 130' can have a length L'' and a width determined based on the number of tubes required. Specifically, each tube 110a'-110c' has a diameter or width D'. Thus, the piece of material can have a width equal to the number of augmentation blocks 110' required multiplied by D'. Alternatively, this width can include an additional space X between each tube 110', which can be taken into account when forming the size of the piece of material 130'. As with any of the embodiments provided herein, the thickness of the material can vary depending on a variety of factors, including, but not limited to, the size and shape of other components and tissues used with the tube, the patient's anatomy, and the type of surgery being performed. In some exemplary embodiments, the thickness T' illustrated in FIG. 24A can be in the range of approximately 0.5 millimeters to approximately 10 millimeters.
[0149] Once the piece of material 130' is cut to the desired size, the pins 132a'-132c' may be inserted through the piece of material 130' from the first edge 130a' to the second edge 130b'. The pins 132a'-132c' may be inserted such that they are approximately parallel to one another and approximately perpendicular to the first and second edges 130a', 130b' of the material 130'. The pins 132a'-132c' may be spaced such that there is sufficient space between each pin 132a'-132c' to allow for separation. The pins 132a'-132c' may be sized to have a diameter approximately equal to the diameter of the resulting lumen 114''.
[0150] Alternatively, as shown in FIG. 25, a trocar 2802 may be used to form a lumen 114'' in the piece of material. Trocars are generally known to those of skill in the art and therefore a detailed description of the trocar is not necessary. Indeed, in the illustrated embodiment, only the distal end of the trocar 2802 is shown, which includes a tip 2804 and a shaft 2806 with which the tip 2804 is associated, e.g., coupled. The distal-most end of the tip 2804 is pointed and sharp and thus configured to pierce tissue. The trocar shaft 2806 extends distally from a housing (not shown) to help guide the trocar through the material.
[0151] Trocar 2802 is unique as compared to other trocars because shaft 2806 has a gradually increasing diameter in the proximal direction P, i.e., toward the housing. More specifically, tip 2804 has a substantially constant diameter D, generally in the range of about 0.10 millimeters to about 1 millimeter. P1 and as shown, the most distal tip is D P1 The shaft 2806 has a first diameter D P1 and a second diameter D in the range of approximately 0.5 millimeters to approximately 5 millimeters. P2 Other dimensions are certainly possible, depending at least in part on the desired lumen size, the instruments that will be used with the trocar, and the preference of the surgeon.
[0152] The gradually increasing diameter of the shaft 2806 allows for more precise formation of a lumen in tissue. By starting with a trocar having a shaft with a smaller diameter proximal to the distal tip 2804, it is easier to position and advance the trocar 2802 into soft biological tissue. In use, the tip 2804 may be positioned, for example, on a first edge of a piece of material and advanced by applying pressure and / or twisting the trocar 2802 as it advances toward a second side of the tissue to form an initial lumen. As the trocar 2802 advances distally toward the second side, the size of the opening it forms increases by D P1 From D P2 This differs from a typical trocar, which generally has one size shaft associated with the distal tip.
[0153] Returning to Figures 24A-C, once all of the pins 132a'-132c' have been inserted, the individual tubes 110a'-110c' may be cut along lines C1-C6. As shown in Figure 24B, lines C1-C6 are generally parallel to the pins 132a'-132c'. Once the individual tubes 110a'-110c' have been cut, the pins 132a'-132c' may be removed, leaving the lumen 114a', as shown in Figure 24C. The threader 206 may be associated with the lumen 114a' in the manner provided herein.
[0154] The manufacturing methods illustrated herein need not be performed in the order described above. For example, with respect to the methods of FIGS. 23A-C and 24A-C, the pins 132a-c and 132a'-c' can be removed, followed by the tubes 110a-c and 110a'-c' being cut off. Furthermore, the tubes 110a-c and 110a'-c' can be dried at any suitable point during the manufacturing process. Furthermore, the process can be used to make any number of blocks having any number of shapes or configurations, including, but not limited to, tubular or rectangular, e.g., one tissue augmentation block 110a and 110a', two augmentation blocks, or four or more augmentation blocks. Still further, the manufacturing techniques provided with respect to the various manufacturing embodiments can be modified to manufacture other tissue augmentation structures in view of the present disclosure. As a non-limiting example, blocks having a tape or strip configuration may be formed in view of the present disclosure such that multiple strips are formed from one piece of material and / or multiple pieces of material stacked on top of each other if such additional thickness and / or additional material is required. This technique may likewise be employed to form reinforced washers, for example, by forming the disclosed blocks 110, 3010, or 3110 and then cutting them along their length to form the washers.
[0155] Method for Producing Tissue Augmentation Constructs - Coring In some embodiments of the various tissue augmentation structures disclosed, including blocks, strips, tubes, bars, washers, patches, and tacks, one or more lumens or cannulas may be formed in the body of the structure. Several techniques for forming such lumens are provided above, including the use of pins. Another exemplary technique for forming such lumens includes hollowing, as shown and described with respect to Figures 26A-I.
[0156] As shown in FIG. 26A, a pre-cut portion of structure 2110 having length L1 and width W1 may be prepared for hollowing. A tool, such as a coring tube 2132, may be used to hollow out structure 2110. Coring tube 2132 may have a handle 2134 at a proximal end and a hollow tube 2136 at a distal end. Hollow tube 2134 of coring tube 2132 may have a distal end 2138 that may be pointed or serrated to make a clean cut. Hollow tube 2134 may have a diameter d1 that is smaller than W1 of the structure. Diameter d1 may be selected based on the suture size desired for a given procedure.
[0157] As shown in FIG. 26B, the coring tube 2132 may be advanced in direction S while rotating in direction R. Rotation and linear movement of the tool 2132 may provide a cleaner cut. However, the tool may be pushed only in direction S without any rotation. As the distal end of the coring tube 2132 advances along the entire length of the structure 2110, it may be removed in the opposite direction S' to remove a portion of the material 2110a and leave a circular lumen 2114, as shown in FIG. 26C. Multiple lumens 2114a-c may be formed in a single structure 2110, as shown in FIG. 26D. Alternatively, the structure of FIG. 26D may be cut into strips running parallel to the lumens 2114a-c to form multiple structures, each containing only one lumen. In yet an alternative embodiment, as shown in Figures 26E and 26F, at least two holes 2114d, 2114e can be formed in the structure 2110 such that they intersect at some location 2120 in the structure.
[0158] In an alternative hollowing embodiment illustrated in Figures 26G-I, a curved lumen 2114' may be formed using a coring tube 2132'. As shown in Figure 26G, a generally U-shaped structure 2110' having first and second generally curved edges 2110a', 2110b' and two straight edges 2110c', 2110d' is prepared for hollowing. As with the embodiment of Figures 26A-C, a coring tube 2132' is used to hollow out the lumen 2114' through the structure, entering and exiting along edge 2110a'. In Figure 26H, the lumen 2114' is shown to be substantially straight. Once the lumen 2114' is formed, the structure may be stretched or otherwise repositioned so that edges 2110a'-d' are all substantially straight, forming a generally rectangular structure 2110', as shown in FIG. 26I.
[0159] Method for Producing a Tissue Augmentation Construct - Tunnel Station In yet another alternative manufacturing method, a structure forming tunnel station is provided. As shown in Figure 27A, the structure forming tunnel station 3200 may include a stage 3220 for holding a tissue augmentation structure, a lumen forming tool 3224 for forming a lumen in the structure, and a guide 3228 to help position the lumen forming tool 3224 relative to the structure held by the stage 3220.
[0160] In an exemplary embodiment, the structure stage 3220 can support and guide the piece of material 3230 on which the structure can be formed. The structure stage 3220 can be a self-centering compression stage to maintain the piece of material 3230 at a fixed height through the stage 3220. Self-centering of the structure stage 3220 can be achieved according to common manufacturing techniques. The structure stage 3220 can include two stages 3220a, 3220b that can move toward and away from each other Y1, Y2 to self-center and compress the material 3230. Alternatively, only one stage 3220a, 3220b can move, or the stages 3220a, 3220b can be fixed to each other. The first stage 3220a can have a distal surface 3219a that faces the proximal surface 3219b of the second stage 3220b. 27B and 27C, the distal and proximal faces 3219a, 3219b can include semicircular reliefs 3221a, 3221b, respectively, that can accommodate the material 3230 upon insertion of the lumen formation tool 3222. The construction stage 3220 can include a mechanism (not shown) for advancing the material 3230 in direction Z to automate the manufacturing process, for example, as described below with respect to FIG.
[0161] The structure forming tunnel station 3200 may include a lumen forming tool 3224, which may include a guide 3228 and a cutting tool 3222. In the illustrated embodiment, the guide 3228 may generally include a lumen 3227 and may be secured to the structure stage 3220 by connectors 3226a, 3226b to ensure that the relative orientation of the tool 3224 and stage 3220 remains fixed such that the orientation of the lumen in the structure formed by the fixture station 3200 is within an acceptable manufacturing tolerance between the structures. Alternatively, the guide 3228 may be secured to the stage 3220 by only one connector or by three or more connectors. Additionally, while the lumen forming tool 3224 is shown physically coupled to the structure stage 3220, alternatively the tool 3224 and stage 3220 may be separate pieces that are secured to one another, e.g., mounted to the same work table, to ensure proper lumen forming alignment.
[0162] The cutting tool 3222 may be disposed within the guide 3228 such that the tool 3222 is free to rotate R and move X within the guide 3228, including by being removably and replaceably associated with the guide 3228. In some embodiments, as shown in FIG. 27D, the tool 3222 may be a needle. Alternatively, as shown in FIG. 27E, the cutting tool may be a spear, such as a Premier Edge MVR knife available from Oasis Medical of Glendora, California. The spear may include a proximal stem portion 3222p having a substantially circular cross-sectional shape and a distal spear portion 3222d. The distal spear portion may have a plurality of straight, sharp edges 3223. The plurality of straight, sharp edges 3223 may have a smooth transition from the proximal stem portion 3222p of the tool.
[0163] In further alternative embodiments, the cutting tool 3222 may have a number of alternative designs, such as a trocar as shown in Figure 27F, a drill bit as shown in Figure 27G, a coring tube as shown in Figure 27H, or a straight blade as shown in Figure 271. Each of the alternative tools may be used to form a lumen in the structure 3210 according to the general manufacturing techniques provided throughout this disclosure.
[0164] In an exemplary method of use, multiple tubes 3210a-3210d may be made from one length of material at a time or from multiple pieces of material as needed. As shown, the piece of material 3230 may have a length L and a width W. The width W of the material may be the length of the resulting structure, while the length L may be determined based on the number of structures required. Specifically, each structure 3210a-3210d has a diameter or width D. Thus, the piece of material may have a length L equal to the number of structures 3210 required multiplied by D. Alternatively, the length L may include additional space between each structure 3210, which may be taken into account when forming the size of the piece of material 3230. As with any of the embodiments provided herein, the thickness of the material may vary depending on a variety of factors, including, but not limited to, the size and shape of other components and tissues used with the structure, the patient's anatomy, and the type of surgery being performed.
[0165] As the piece of material 3230 advances through the stage 3220, the lumen forming tool 3224 can be actuated such that the cutting tool 3222 can be inserted through the piece of material 3230 from the first edge 3230a to the second edge 3230b, as shown in FIGS. 27I-27K. Depending on the type of cutting tool 3222 used, the lumen forming tool 3224 can either move the tool 3222 in direction X, or rotate and move the tool 3222 in directions X and R, into the material 3230. Actuation of the cutting tool 3222 can be automatic by an actuator. Alternatively, the cutting tool 3222 can be manually actuated by a user. The cutting tool 3222 can then be retracted, leaving the lumens 3214a-3214c. The material 3230 can then be advanced a predetermined distance in direction Z, and the process can be repeated to create additional structures. 27K and 27L, the individual structures 3210a-3210d may then be separated from the piece of material 3230. For example, the individual structures 3210a-3210d may be separated by punches 3290a-3290d or other cutting mechanisms provided throughout this disclosure.
[0166] As shown in FIG. 27M, an alternative structure forming fixture station 3200' may provide parallel bore formation. As shown in FIG. 27M, the stage 3220' may accommodate a longer length L' of material 3230'. For example, as shown in FIG. 27M, the stage 3220' may accommodate the length required to create three structures. Alternatively, the stage 3220' may be expanded to accommodate any number of structures. The stage 3220' may have a semicircular relief and be self-centering, similar to the stages of the fixture station 3200. As with the embodiment of FIGS. 27A-L, the station 3220' may include multiple bore forming tools 3224a', 3224b', 3224c' aligned parallel to one another. Alternatively, the multiple tools 3224a', 3224b', 3224c' may be oriented at any angle to one another. The lumen forming tools 3224a', 3224b', 3224c' are aligned such that each cutting tool 3222a', 3222b', 3222c', respectively, moves in a parallel direction toward the stage. In the illustrated embodiment, three lumen forming tools 3224a', 3224b', 3224c' are shown, however, any number of lumen forming tools may be provided. After the lumen forming tools 3224a', 3224b', 3224c', respectively, are actuated and retracted to form lumens 3214a', 3214b', 3214c' in the material 3230', the material 3230' may advance in direction D'. The individual structures 3210a', 3210b', 3210c' may be separated according to the techniques provided herein. Alternatively, structures containing multiple lumens may be cut from the material to form patches or scaffolds, as discussed further below.
[0167] Methods for Producing Tissue Augmentation Constructs - General Methods The above described embodiments represent some specific techniques related to manufacturing blocks having specific configurations, e.g., strips, tubes, bars, and washers. More general techniques, e.g., hollowing, are also provided. Such techniques may be adopted for use with tissue augmentation structures of other configurations by those skilled in the art in light of the present disclosure. Furthermore, the present disclosure provides even more general techniques and methods that may be used to form the various tissue augmentation structures disclosed herein that may be derived from the present disclosure. The methods provided in this section may be used as standalone methods, in combination with each other, and / or with other manufacturing techniques provided in the present disclosure.
[0168] In some embodiments, the structure may be fully or partially fabricated by phase separation techniques, lyophilization, knitting, weaving, electrospinning, rapid prototyping (e.g., 3D printing), or combinations thereof. To promote tissue growth, perforations may be formed in the structure using thermal, electrical, and / or mechanical means, among others. For example, perforations may be formed by a laser or a sharp object, such as a needle, punch, or die. The size of the perforations may be any suitable size, but preferably the perforations are of a size that allows tissue growth. More preferably, the perforation size may be in the range of approximately about 50 micrometers to about 2000 micrometers, and even more preferably, in the range of approximately about 50 micrometers to about 1000 micrometers.
[0169] In some embodiments, living tissue (including but not limited to allograft or xenograft tissue) may optionally be included within the various tissue augmentation structures to form a bilayer structure. The combination of living tissue within the various tissue augmentation structures may provide improved biological and mechanical performance of the resulting structure.
[0170] For example, as shown in FIG. 28, structure 2710 (shown as a patch or scaffold, which are described in more detail below) may include a reconstituted collagen matrix or a biodegradable polymer 2702 or any of the other materials described herein for use in tissue augmentation structures (e.g., autograft, xenograft, ground collagen pieces, porcine dermis, etc.) and a biological component, e.g., extracellular matrix (ECM) 2704, attached to one side of matrix 2702 using techniques known to those of skill in the art. The reconstituted collagen matrix or biodegradable polymer may be a first layer or may be part of the first layer, and the biological component may be a second layer or may be part of the second layer, with the thickness and surface area of the first layer being greater than the thickness and surface area of the second layer, substantially greater as shown. In other embodiments, the biological component, e.g., ECM 2704, may be disposed on both sides of matrix 2702 and / or coated or impregnated onto matrix 2702. One skilled in the art will recognize numerous different attachment options that may be used to couple the ECM 2704 to the matrix 2702, including, but not limited to, gluing and stitching. The inclusion of the ECM 2704 or other biological components may help integrate the augmentation structure with the tissue in which it is used. In one exemplary embodiment, the matrix 2702 may have a thickness T1 approximately in the range of about 1 millimeter to about 4 millimeters, and the ECM layer may have a thickness approximately in the range of about 80 micrometers to about 3 millimeters.
[0171] In some embodiments, the biological component may be coated onto or included in the tissue-augmentation structure. When the biological component is coated onto the tissue-augmentation structure, the biological component is preferably associated with at least a portion of the structure. For example, the biocompatible structure may include an adhesive agent for anchoring the suspension of the biological component to the scaffold. The adhesive agent may be an anchoring agent, a crosslinking agent (i.e., chemical or physical), and combinations thereof. Suitable anchoring agents include, for example, hyaluronic acid, fibrin glue, fibrin clot, collagen gel, alginate gel, gelatin-resorcinol-formalin adhesive, mussel-based adhesive, dihydroxyphenylalanine (DOPA)-based adhesive, chitosan, transglutaminase, poly(amino acid)-based adhesive, cellulose-based adhesive, polysaccharide-based adhesive, synthetic acrylate-based adhesive, platelet rich plasma (PRP), platelet poor plasma (PPP), PRP clot, PPP clot, Matrigel, monostearoylglycerol co-succinate (MGSA), monostearoylglycerol co-succinate / polyethylene glycol (MGSA / PEG) copolymer, laminin, elastin, proteoglycans, and combinations thereof.
[0172] Crosslinking can be achieved using physical means and chemical agents. Examples of chemical agents used for crosslinking include dehydrothermal (DHT) treatment, divinyl sulfone (DVS), polyethylene glycol divinyl sulfone (VS-PEG-VS), hydroxyethyl methacrylate divinyl sulfone (HEMA-DIS-HEMA), formaldehyde, glutaraldehyde, aldehydes, isocyanates, alkyl and aryl halides, imide esters, N-substituted maleimides, acylating compounds, carbodiimides, hexamethylene diisocyanate, 1-ethyl-3-[3-dimethylaminopropyl]carbodiimide hydrochloride (EDC or EDAC), hydroxychlorides, N-hydroxysuccinimide, light (e.g., blue light and UV light), pH, temperature, and combinations thereof.
[0173] The biological component may be one or more effectors that promote healing and / or regeneration of affected tissue at the site of injury. The biological components of the construct may include xenogeneic or autologous growth factors, proteins, matrix proteins, peptides, antibodies, antibiotics, anti-inflammatory agents, therapeutic agents, chemotactic agents, antimicrobial agents, antibiotics, anti-inflammatory agents, compounds that minimize or prevent adhesion formation, compounds or agents that suppress the immune system, cell adhesion mediators, bioactive ligands, integrin binding sequences, enzymes, cytokines, glycosaminoglycans, polysaccharides, viruses, viral particles, nucleic acids, analgesics, cells, platelets, platelet rich plasma (PRP), ground extracellular particles, ground tissue fragments, hydroxyapatite, tricalcium phosphate, bioactive glass, biphasic calcium phosphate, calcium sulfate, other bone and / or tissue growth promoters, and combinations thereof.
[0174] As described herein, in some embodiments, the tissue augmentation structure may have one or more through holes or holes extending therethrough. The through holes may be slits or passages having different cross-sectional shapes, e.g., circular, oval, square, rectangular, etc. The through holes may be formed by any tool capable of removing material, including mechanical, thermal, or electrical tools. Alternatively, the through holes may be slits that may be formed by any tool that results in the separation of two surfaces.
[0175] In some embodiments, the structure may be made of two or more layers. The layers of the structure may be made of the same or different materials. The layers may be bonded or fused together using sutures, mechanical, electrical, and chemical fastening techniques. Examples of bonding or fusing may include, for example, tissue welding, staples, rivets, tissue tacks, darts, screws, pins, arrows, bridging, vacuum crimping, compression, compression in combination with dehydration, vacuum crimping in combination with dehydration, or bioadhesives, or combinations thereof. Dehydration in this context may include, for example, freeze-drying (i.e., lyophilization). Examples of bioadhesives include fibrin glue, fibrin clot, collagen gel, alginate gel, gelatin-resorcinol-formalin adhesive, mussel-based adhesive, dihydroxyphenylalanine (DOPA)-based adhesive, chitosan, transglutaminase, poly(amino acid)-based adhesive, cellulose-based adhesive, polysaccharide-based adhesive, synthetic acrylate-based adhesive, platelet rich plasma (PRP), platelet poor plasma (PPP), PPP clot, Matrigel, monostearoylglycerol co-succinate (MGSA), monostearoylglycerol co-succinate / polyethylene glycol (MGSA / PEG) copolymer, laminin, elastin, hyaluronic acid, proteoglycans, and combinations thereof.
[0176] In some embodiments, the structure may include a reinforcing material. The reinforcing material may be comprised of any absorbent or non-absorbent textile, including, for example, woven, knit, wrapped knit (i.e., lace-like), nonwoven, and braided structures. In one embodiment, the reinforcing material may have a mesh-like structure. The mechanical properties of the material may be altered by changing the density or texture of the material, the type of knit or weave of the material, the thickness of the material, or by embedding particles in the material.
[0177] The mechanical properties of the reinforcing material may further be altered by forming sites within the structure where the fibers are physically bonded to each other or to another agent, such as an adhesive or polymer. The fibers used to make the reinforcing component may be, for example, monofilaments, threads, strands, braids, or fiber bundles. The fibers may be made from any biocompatible material, such as, but not limited to, bioabsorbable materials, such as polylactic acid (PLA), polyglycolic acid (PGA), polycaprolactone (PCL), polydioxanone (PDO), trimethylene carbonate (TMC), copolymers or blends thereof. The fibers may also be made from any biocompatible material based on natural polymers, including silk and collagen-based materials. Alternatively, the fibers may be made from any biocompatible fiber that is non-absorbable, such as polyethylene, nylon, polyester, polyethylene terephthalate, poly(tetrafluoroethylene), polycarbonate, polypropylene, polyurethane, and poly(vinyl alcohol).
[0178] In another embodiment, the structure may include hydroxyapatite, tricalcium phosphate, bioglass, biphasic calcium phosphate, calcium sulfate, and other bone promoting materials throughout the structure or localized to the portion of the structure where bone regeneration is desired. Bioglass is a silicate containing calcium phosphate glass or calcium phosphate glass with various amounts of solid particles added to control the absorption time. Bioglass is an example of a material that can be processed into glass fibers and used as a reinforcing material. Bioglass can also be included in the structure in powder form. Suitable solid particles that can be added include iron, magnesium, sodium, potassium, and combinations thereof.
[0179] In some embodiments, both the biocompatible structure and the reinforcing material may be formed from thin, perforated elastomeric sheets having holes or perforations that allow tissue growth. The sheets may be made from blends or copolymers of polylactic acid (PLA), polyglycolic acid (PGA), polycaprolactone (PCL), and polydioxanone (PDO).
[0180] The structure may be formed partially or completely from a polymer foam component having pores with an open cell pore structure. The pore size may vary, but preferably the pores are of a size that allows for tissue in-growth. In some embodiments, the pore size is in the range of approximately 40 micrometers to approximately 1000 micrometers, and in other embodiments, the pore size is in the range of approximately 50 micrometers to approximately 500 micrometers. The polymer foam component may be made from natural and / or synthetic materials, such as reconstituted collagen. The polymer foam may be non-crosslinked or crosslinked. The polymer foam component may optionally contain a reinforcing component, such as a textile as described above. In some embodiments, the polymer foam component may contain a reinforcing component that may be integrated with the reinforcing component such that the pores of the foam component penetrate the mesh of the reinforcing component and connect with the reinforcing component.
[0181] In some embodiments, the polymeric foam component of the tissue implant may be formed as a foam by a variety of techniques known to those of skill in the art, for example, the polymeric starting material may be foamed by freeze drying, supercritical solvent foaming (supercritical solvent foaming is described at least in EP 464,163, the contents of which are incorporated herein by reference in their entirety), gas injection extrusion, gas injection molding or casting, including the inclusion of an extractable material (e.g., salt, sugar, or similar suitable material).
[0182] The polymer foam component of the engineered tissue repair implant device of the present disclosure may be made by a polymer-solvent phase separation technique, such as freeze-drying. The polymer solution may be separated into two phases by any one of four techniques: (a) thermally induced gelation / crystallization; (b) non-solvent induced separation of the solvent and polymer phases; (c) chemically induced phase separation, and (d) thermally induced spinodal decomposition. The polymer solution may be separated into either two distinct phases or two bi-continuous phases in a controlled manner. Subsequent removal of the solvent phase usually leaves a porous structure with a density less than the bulk polymer and pores in the micrometer range. Further information on the solvent phase is provided in Microcellular Foams Via Phase Separation, J. Vac. Sci. Technol., AT Young, Vol. 4(3), May / June 1986, the contents of which are incorporated herein by reference in their entirety.
[0183] The steps involved in the preparation of these foams include, for example, selecting a suitable solvent for the polymer to be freeze-dried and preparing a homogenous solution. The polymer solution may then be subjected to freezing and vacuum drying cycles. In the freezing step, the phases may separate the polymer solution, and in the vacuum drying step, the solvent may be removed by sublimation and / or drying, leaving behind a porous polymer structure or an interconnected open-cell porous foam. Suitable solvents that may be used in the preparation of the foam components include, for example, formic acid, ethyl formate, acetic acid, hexafluoroisopropanol (HFIP), cyclic ethers (e.g., tetrahydrofuran (THF), dimethylene fluoride (DMF), and polydioxanone (PDO)), acetone, acetates of C2-C5 alcohols (e.g., ethyl acetate and t-butyl acetate), glymes (e.g., monoglyme, ethyl glyme, diglyme, ethyl diglyme, triglyme, butyl diglyme, and tetraglyme), methyl ethyl ketone, dipropylene glycol methyl ether, lactate, ethyl dimethylene fluoride (DMF), ethyl dimethylene fluoride (DMF), and polydioxanone (PDO)). Examples of suitable solvents include 1,4-dioxane, 1,3-dioxolane, 1,3-dioxolan-2-one (e.g., γ-valerolactone, δ-valerolactone, β-butyrolactone, γ-butyrolactone), 1,4-dioxane, 1,3-dioxolane, 1,3-dioxolan-2-one (ethylene carbonate), dimethyl carbonate, benzene, toluene, benzyl alcohol, p-xylene, naphthalene, tetrahydrofuran, N-methylpyrrolidone, dimethylformamide, chloroform, 1,2-dichloromethane, morpholine, dimethylsulfoxide, hexafluoroacetone sesquihydrate (HFAS), anisole, and mixtures thereof. Among these solvents, one exemplary solvent is 1,4-dioxane. A homogeneous solution of the polymer in the solvent is prepared using standard techniques.
[0184] The applicable polymer concentration or amount of solvent that can be utilized may vary for each system. In one embodiment, the amount of polymer in the solvent may vary from about 0.5% to about 90% by weight. In another embodiment, preferably, the amount of polymer in the solvent may vary from about 0.5% to about 30% by weight. The amount of polymer in the solution may vary depending on factors such as the solubility of the polymer in a given solvent and the final properties required for the foam.
[0185] In embodiments of structures that include polymer foam, solids may be added to the polymer-solvent system to modify the composition of the resulting polymer foam surface. When the added particles settle out of the solvent to the bottom surface, a region will be formed that has the composition of the added solid rather than the foamed polymer material. Alternatively, the added solid may be more concentrated in desired regions of the resulting tissue-augmentation structure (i.e., near the top, sides, or bottom), resulting in a compositional change in all such regions. For example, solid concentration at selected locations may be achieved by adding a metal solid to a solution placed in a mold made of a magnetic material (or vice versa).
[0186] Various types of solids can be added to the polymer-solvent system. In one embodiment, the solids are of a type that will not react with the polymer or the solvent. The added solids can have an average diameter of less than about 2 millimeters. In other embodiments, the added solids can have an average diameter of about 50 micrometers to about 1000 micrometers. The solids can be present in an amount such that they will constitute about 1 volume percent to about 50 volume percent of the total volume of the solids and polymer-solvent mixture (this total volume percent equals 100 volume percent).
[0187] Exemplary solids include, for example, demineralized bone particles, calcium phosphate particles, bioglass powders, calcium sulfate, or calcium carbonate powders for bone repair, leachable solids for pore formation, and bioabsorbable natural polymers, bioabsorbable synthetic polymers, non-bioabsorbable materials, ground extracellular particles, ground tissue fragments, or particles of any biocompatible material that is not soluble in the solvent system.
[0188] Exemplary leachable solids include non-toxic leachable materials such as, for example, salts (e.g., sodium chloride, potassium chloride, calcium chloride, sodium tartrate, sodium citrate, etc.), biocompatible mono- and disaccharides (e.g., glucose, fructose, dextrose, maltose, lactose, and sucrose), polysaccharides (e.g., starch, alginates, chitosan), water-soluble proteins (e.g., gelatin and agarose). The leachable material may be removed by immersing the foam containing the leachable material in a solvent capable of dissolving the particles for a time sufficient to leach substantially all of the particles. The solvent may be selected so as not to dissolve or adversely alter the foam. A preferred embodiment may include water, e.g., distilled-deionized water, as the extraction solvent. Such a process is further described in U.S. Pat. No. 5,514,378, the contents of which are incorporated herein by reference in their entirety. Preferably, the foam is dried after completing the leaching process at low temperatures and / or vacuum to minimize hydrolysis of the foam unless accelerated absorption of the foam is desired.
[0189] Non-bioabsorbable materials can include, for example, bioinert ceramic particles (e.g., alumina, zirconia, and calcium sulfate particles), polymers such as polyethylene, polyvinyl acetate, polymethyl methacrylate, polypropylene, poly(ethylene terephthalate), silicone, polyethylene oxide, polyethylene glycol, polyurethane, polyvinyl alcohol, natural polymers (e.g., cellulose particles, chitin, and keratin), and fluorinated polymers and copolymers (e.g., fluoride, polytetrafluoroethylene, and hexafluoropropylene). In one embodiment, solids that will render the tissue implant radiopaque (e.g., barium sulfate) can be added. Those solids that can be added also include those that will promote tissue regeneration or healing and those that act as cushioning materials, reinforcing materials, or porosity modifiers.
[0190] As discussed above, the polymer foam component may contain a reinforcing component. The structure may be made by injecting, pouring, or otherwise disposing a suitable polymer solution into a mold setup containing the mold and reinforcing elements of the present disclosure. The mold setup may be cooled in a suitable bath or refrigerated shelf and then freeze-dried to provide the reinforced structure.
[0191] In embodiments utilizing polymer foams, one or more biological components provided throughout this disclosure may be added either before or after the freeze-drying process. In the process of forming the polymer foam component, it may be beneficial to control the freezing rate of the polymer-solvent system. The type of pore morphology formed during the freezing process is a function of factors such as solution thermodynamics, freezing rate, cooling temperature, solution concentration, and homogeneous or heterogeneous nucleation. The orientation of the polymer fibers may be adjusted by controlling the orientation of the pores. The orientation of the pores in the polymer foam component may be customized, for example, by controlling the temperature gradient introduced during the freezing cycle. Controlling the orientation of the fibers may result in improved mechanical properties in the direction in which the fibers are oriented.
[0192] Typical processing steps required for structures using polymer foams may include the selection of the appropriate material to make the polymer foam. The processing steps may further include the selection of the material of the reinforcing component, if used. If a mesh reinforcing material is used, the appropriate mesh density should be selected. Additionally, the reinforcing material should be properly aligned within the mold, the polymer solution should be added to the inclined mold at the proper rate, preferably at an appropriate angle to avoid the formation of air bubbles, and the polymer solution needs to be freeze-dried.
[0193] In embodiments utilizing mesh reinforcement materials in polymer foams, for example, the reinforcing mesh should be selected to be of a particular density. That is, the openings in the mesh material should not be so small as to prevent proper bonding between the foam and the reinforcing mesh, so that the foam material and the open cells and their cell walls can penetrate the mesh openings. Without proper bonding, the integrity of the layered structure may be compromised, leaving the structure fragile and difficult to handle. The mesh density may determine the mechanical strength of the structure. The mesh density may be varied according to the desired use for tissue repair. In addition, the type of weave used for the mesh may determine the directionality of the mechanical strength of the structure and the mechanical properties of the reinforcing material, such as the elasticity, stiffness, breaking strength, suture retention strength, and tensile strength of the structure. As a non-limiting example, the mesh reinforcement material in the foam-based biocompatible structures of the present disclosure can be designed to be stiff in one direction and elastic in another, or alternatively, the mesh reinforcement material can be made isotropic.
[0194] During freeze-drying of the reinforced foam in those embodiments utilizing mesh reinforcement materials in the polymer foam, several parameters and techniques may be useful to produce an implant with desired integrity and mechanical properties. For example, if a reinforcement material is used, it may be beneficial to keep the reinforcement material substantially flat when placed in the mold. To ensure an appropriate degree of flatness, the reinforcement material (e.g., mesh) may be pressed flat using a heated press before placing it in the mold. Furthermore, if the reinforcement structure is not isotropic, it may be desirable to indicate this anisotropy by marking to indicate the directional nature of the structure. This marking may be accomplished by embedding one or more indicators, such as dyed markings or dyed threads, into the woven reinforcement material. The direction or orientation of the indicator may, for example, indicate to the surgeon the dimensions of the implant with superior physical properties.
[0195] In embodiments utilizing the polymer foam described above, the manner in which the polymer solution is added to the mold prior to freeze-drying can help contribute to the creation of a tissue implant with adequate mechanical integrity. Assuming that a mesh reinforcement material will be used and that it will be placed between two thin (e.g., approximately 0.75 millimeter) shims, the mesh can be placed in a substantially flat orientation at the desired depth in the mold. The polymer solution can be injected in a manner that allows air bubbles to escape between the layers of the foam structure. The mold can be tilted at a desired angle, and injection is accomplished at a controlled rate to best prevent air bubble formation. A number of variables will control the tilt angle and injection rate. For example, the mold should be tilted at an angle greater than about 1 degree to avoid air bubble formation. In addition, the injection rate should be slow enough to allow any air bubbles to escape the mold without being trapped in the mold.
[0196] In those embodiments that utilize mesh reinforcing materials in polymer foams, the density of the mesh openings can be an important factor in forming a structure with the desired mechanical strength. For example, a low density or cellular knit mesh material can be used. One example of such a material is a 90:10 glycolide and lactide copolymer sold under the trade name VICRYL. VICRYL is available from Ethicon, Inc., Somerville, New Jersey. One exemplary low density cellular knit mesh is woven VICRYL VKM-M, also available from Ethicon, Inc., Somerville, New Jersey. Other materials can include, but are not limited to, polydioxanone and a 95:5 lactide and glycolide copolymer blend.
[0197] In embodiments utilizing polymer foam, the through holes can be formed by placing rods in the polymer foam solution / slurry prior to curing. After the polymer foam is formed, the rods can be removed. For example, if the polymer foam is made by freeze drying, the rods are removed after a freezing and vacuum drying cycle. The rods can have any desired shape.
[0198] The polymer foam component may optionally contain one or more layers formed from the materials discussed above. In one embodiment, the foam component may be integrated with the material by forming pores in the material, and the polymer foam component penetrates and connects with the pores formed in the material. In another embodiment, pores are formed in two layers of material, and the two layers are positioned to best align the pores. The combination of the two layers may be placed in a polymer solution or slurry, and the polymer foam may be formed by one of the methods provided herein or known to one of skill in the art.
[0199] In some embodiments, the structure may be formed from an expanding medium that may advantageously provide pressure to the repair site. One non-limiting example of such a structure 2910 is shown in FIG. 29A, where the structure is a patch or scaffold (described in more detail below). For example, the structure 2910 may be formed from a woven or braided mesh having a core 2904 enclosed or sandwiched between two layers 2902a, 2902b. The two layers 2902a, 2902b may be referred to as a jacket. The core 2904 may be made from a variety of expandable materials, such as salt-loaded silicone, sodium polyacrylate, polyacrylamide copolymers, polyurethane, and other absorbent polymers and hydrogels, while the jackets 2902a, 2902b may be more rigid so that the core may compress against the jacket when expanded during use. Non-limiting exemplary materials that may be used to form the jackets 2902a, 2909b include fabrics or filaments, such as polyethylene, polypropylene, polyester, poly(ethylene terephthalate), nylon, polyurethane, and silk. Further non-limiting exemplary materials that may be used to form the jackets 2902a, 2902b include bioabsorbable materials, such as polylactic acid (PLA), polyglycolic acid (PGA), polycaprolactone (PCL), polydioxanone (PDO), trimethylene carbonate (TMC), copolymers or blends thereof. Some materials that may be used with the structure include, but are not limited to, those disclosed and provided in U.S. Patent No. 8,870,915, entitled "Joining Element," the contents of which are incorporated herein by reference in their entirety. As shown in FIG. 29A, the structure 2910 has a length L P and thickness T P and may include at least one suture limb 2911 for securing the structure to one or more repair sites. In the illustrated example, the structure 2910 has four suture limbs 2911, 2912, 2913, 2914 associated therewith. These limbs may be from the same or different sutures.
[0200] In use, as shown in FIG. 29B, construct 2910 can be placed over repair sites 2938a, 2938b and suture limbs 2911, 2912, 2913, 2914 can be secured within respective anchors 2961, 2962, 2963, 2964. As with other disclosures, the repairs associated with repair sites 2938a, 2938b can be any type of repair provided herein or known to one of skill in the art. Construct 2910 can be further secured to the medial location of repairs 2938a, 2938b with sutures, staples, or other devices and components used to secure tissue to bone. As shown, sutures 2940a-c provide the fixation. The structure 2910 may, for example, be exposed to an aqueous solution after installation such that the silicone and salt-filled core absorbs the fluid, causing the structure to expand in at least one dimension and contract in at least one other dimension, depending on the configuration of the structure 2910. In the illustrated example, the expansion increases by a factor of 10, which is the thickness T P On the other hand, the length L P After the structure 2910 is attached, the length L P The shorter length provides a greater compressive force against the soft tissue 2930 and allows the tissue to contact the bone 2950 more uniformly, at least in part, due to the limited space for fixation of the structure 2910, the configuration of the structure 2910, and the surface geometry of the attachment site. One of ordinary skill in the art will recognize that the structure configurations having an expandable core sandwiched between layers or jackets can be used with other structure configurations provided herein, including those that do not require a patch or scaffold to provide the applied compressive force at the repair site. Further discussion of tissue augmentation patches and scaffolds is provided below.
[0201] Unless otherwise specified, any of the materials and any of the techniques disclosed for forming materials may be used with any of the structures provided herein. This includes any combination of materials. Similarly, the disclosed manufacturing techniques may be used or employed generally to form the various structures provided herein. The use of materials and manufacturing techniques for the various tissue augmentation structures is within the scope of the present disclosure.
[0202] Tissue Augmentation Structure - Tissue Augmentation Patch The tissue augmentation structure may also take the form of a patch or scaffold that may be associated with one or more limbs of the suture to increase the footprint of one or more limbs to provide additional surface area over which forces may be distributed, among other benefits as set forth throughout this disclosure, such as promoting healing of otherwise injured tissue and / or providing bulk to otherwise injured or degenerated tissue and / or tendons. The patch may be placed over the suture or may be attached or connected to the surgical suture rather than simply riding on top of it. Additionally, the patch may be delivered to the surgical site and threaded over the suture using a suture threader as described herein, thereby eliminating the need for extensive suturing of each edge of the patch. A number of different techniques may be used to associate the illustrated patch with the suture, including threading the suture through the patch and / or placing the suture between layers of the scaffold. The patch may then be placed adjacent to the surgical site as described. Methods for manufacturing the scaffold or patch and methods for attaching the various scaffolds and patches are also provided below. The systems and methods disclosed herein allow for a quick, easy and affordable technique for preventing injury to tissue from tensioned sutures. As with the other structures described above, surgeons can apply patches in an on-demand manner to create the desired suture footprint for repair. Those skilled in the art will recognize that the disclosure provided herein regarding the materials used to form tissue augmentation blocks, such as, by way of non-limiting example, tissue augmentation blocks 10, 110, 3010, 3110, 310, 410, among other structures, can be applied to the patches discussed below.
[0203] An exemplary embodiment of a tissue augmentation structure 2210 having a patch or scaffold configuration is provided in Figures 30A and 30B. As shown, the tissue augmentation patch 2210 has a rectangular body and may be disposed on or otherwise associated with suture limbs 2212a, 2212b. In the illustrated embodiment, the patch 2210 includes holes or lumens 2214a, 2214b formed in and extending through the body from a proximal-most end 2210p to a distal-most end 2210d. The holes 2214a, 2214b may be used, for example, to receive the suture limbs 2212a, 2212b such that the patch 2210 and limbs 2212a, 2212b may be associated with one another. As shown in Figure 30B, the patch 2210 may be pre-threaded with suture threaders 2206a, 2206b. Threaders 2206a, 2206b are of a similar nature to threader 206' and may be configured in a manner similar to threader 206 or in a manner known to those skilled in the art and / or derivable from this disclosure. As shown, patch 2210 has a width W P Length L substantially equal to P and has a thickness T P Furthermore, the thickness T P may be greater than the diameter of the filament or suture with which the tissue augmentation patch 2210 is associated, for example, the suture rim 2212a.
[0204] Those skilled in the art will appreciate that the length L of the tissue augmentation patch 2210 P , width W P , and thickness T P It will be appreciated that the dimensions of the holes 2214a, 2214b, as well as the diameters of the holes 2214a, 2214b, may depend on a variety of factors, including but not limited to the size of the filament associated with the tissue augmentation patch 2210, the anatomy of the patient, and the type of surgery being performed. Some example, non-limiting dimensions for the tissue augmentation patch 2210 may be useful in understanding the present disclosure.
[0205] In some embodiments, the length L PThe length L may cover a substantial portion to almost the entire length of tissue extending between the stitches formed in the tissue and the bone anchor used to help secure the tissue. P and width W P can range from approximately 10 millimeters to approximately 50 millimeters, and the thickness T P can range from approximately 0.5 millimeters to approximately 5 millimeters. The size of the diameter of the holes 2214a, 2214b can also depend on a variety of factors, including but not limited to the size of the rim that passes through the holes 2214a, 2214b. In some embodiments, the diameter can range from approximately 0.5 millimeters to approximately 3 millimeters.
[0206] Numerous techniques known to those skilled in the art may be used to associate the patch 2210 with the suture limbs 2212a, 2212b. The suture limbs 2212a, 2212b may be threaded or passed from the proximal-most end 2210p to the distal-most end 2210d of the patch 2210 without passing through the body of the patch 2210, i.e., without passing through the side walls that define the holes 2214a, 2214b. As a result, the patch 2210 may pass freely, unimpeded or unrestricted, along the length of the limbs 2212a, 2212b. In other embodiments, the suture limbs 2212a, 2212b may pass through the body one or more times, for example, similar to the embodiment of the strip or tape 10 illustrated in FIG. 1B, to further secure the position of the patch 2210 relative to the limbs 2212a, 2212b. In yet other embodiments, the rims 2212a, 2212b may pass through the patch 2210 from the most proximal end 2210p to the most distal end 2210d, for example by passing through the body if holes 2214a, 2214b are not provided, but by entering and exiting the body only once. Of course, the rims 2212a, 2212b need not extend all the way to the most proximal end 2210p or the most distal end 2210d, but instead may enter and exit the patch 2210 at some other location across its surface area. Those skilled in the art will recognize various other ways in which the patch 2210 may be associated with the rims 2212a, 2212b without departing from the spirit of the present disclosure.
[0207] The tissue augmentation patch 2210 may be threaded onto the suture limbs 2212a, 2212b manually, either at the surgical site or outside the body. Alternatively, as shown in FIGURE 30B, threaders 2206a, 2206b may be operated to associate the suture limbs 2212a, 2212b with the patch 2210. In this case, the operation is similar to either the threader 206 or threader 206' described above, including proximal handle portions 2208a, 2208b, intermediate elongated portions 2207a, 2207b, and distal suture receiving ends 2209a, 2209b. Thus, the tissue augmentation patch 2210 can be associated with the intermediate elongated portions 2207a, 2207b, as shown by passing through the lumens 2214a, 2214b, and the limbs 2212a, 2212b can be coupled to the distal suture receiving ends 2209a, 2209b. The proximal handle portions 2208a, 2208b can be grasped and pulled away from the tissue augmentation patch 2210 to advance the limbs 2212a, 2212b towards and into the patch 2210. After the patch 2210 is successfully associated with the limbs 2212a, 2212b, the threaders 2206a, 2206b can be disassociated from the limbs 2212a, 2212b and the tissue augmentation patch 2210, and can either be discarded or reused.
[0208] Similar to the tissue augmentation strips described above, by associating the tissue augmentation patch 2210 with the suture rims 2212a, 2212b, the footprint of the suture rims 2212a, 2212b is increased, allowing the force applied to the tissue by the suture rims 2212a, 2212b to be distributed over a larger amount of surface area, i.e., the surface area of the patch 2210. The increased distributed force of the tissue augmentation patch 2210 may result in reduced pressure peaks on the soft tissue. Where the soft tissue has become degenerated due to injury or aging, the increased tissue surface area coverage and reduced pressure may result in less likelihood of tissue detachment. Additionally, the larger surface area of the tissue augmentation patch 2210 may provide a larger scaffold for new tissue to develop during the repair, further strengthening the repair site. The greater tissue coverage provided by the patch 2210 may improve healing of tissue that has been injured in some way and / or provide bulk to tissue and / or tendons that have been injured or degenerated in some way.
[0209] Methods for Producing Tissue Augmentation Structures - Tissue Augmentation Patches The tissue augmentation patch 2210 may be manufactured using a number of different techniques, some of which have been previously discussed above with respect to the tissue augmentation blocks 10, 110. In one exemplary embodiment for making the tissue augmentation patch illustrated by FIGS. 30C-30E, the material used to make the patch 2210 may be collected or otherwise obtained using techniques known to those of skill in the art. This material may then be shaped using any of the techniques described above, such as those described with respect to the strip 10, or techniques known to those of skill in the art in light of this disclosure. Length L P , width 2W P , and thickness 1 / 2T P A piece of material having a width W P is the resulting width W of the patch 2210 P It can be twice as thick as 1 / 2T Pcan be half the width of the resulting patch 2210. As shown in FIG. 30D, the piece of material 2220 can have a first end 2220a and a second end 2220b with a width 2W extending therebetween. P Alternatively, the piece of material 2220 may have any shape.
[0210] When the piece of material 2220 is cut, the two pins 2222a, 2222b are on the same side of the material, extending from the first and second ends 2220a, 2220b, respectively, by a width of 2W. PThe two ends 2220a, 2220b may be folded over the respective pins 2222a, 2222b, adjacent to each other, and then attached to each other to form the patch 2210. As shown in FIG. 30C and FIG. 30D, four rows of stitches 2224a-d may be stitched onto the folded patch such that they are substantially parallel to each other. Furthermore, the first and fourth stitches 2224a, 2224d may be positioned substantially parallel and adjacent to the pins 2222a, 2222b, respectively. Still further, the stitches 2224a, 2224d may form two lumens 2214a, 2214b that are held open by the pins 2222a, 2222b. After the stitching is completed, the pins 2222a, 2222b may be removed, leaving the patch 2210, as shown in FIG. 30E. Alternatively, no pins are required to manufacture the patch 2210. The second and third stitches 2224b, 2224c can be located substantially parallel and adjacent to the two ends 2220a, 2220b. Further alternatively, instead of stitches, the material 2220 itself can be secured by glue, collagen bond, staples, light curing, or other techniques for attaching soft tissue to soft tissue known to those of skill in the art and provided throughout this disclosure. In embodiments that include pre-positioned threaders on the patch 2210, the threaders 2206a, 2206b can be inserted into the lumens 2214a, 2214b, after which the two ends 2220a, 2220b are attached. Alternatively, the threaders 2206a, 2206b are inserted into the lumens 2214a, 2214b after the two ends 2220a, 2220b are attached. As with the other structures provided herein, the patch 2220 may be dried for packaging at any suitable point during the manufacturing process.
[0211] An alternative method for manufacturing the patch 2210 is to P , width W P , and thickness T P The pieces of material 2220 may include collecting pieces of material that may be collected having a width W PThe first pin 2222a may be inserted or penetrated into the material 2220 adjacent and parallel to the first end 2220a to form a first lumen 2214a. The second pin 2222b may be inserted or penetrated into the material 2220 adjacent and parallel to the second end 2220b to form a second lumen 2214b. In a further alternative, a coring tube may be used in place of the pins 2222a, 2222b, as described above with respect to Figures 26A-I. The patch 2210 may be made from any of the materials provided above with respect to the blocks 10, 110, 3010, 3110, 310, and 410, as well as any other structures described above. Additionally, the patch 2210 may have any shape. Examples of the shape include a rectangle, a trapezoid, an ellipse, a circle, a square, a pentagon, a hexagon, and an octagon.
[0212] A further alternative method of manufacturing the patch 3320 may include the use of a parallel production tunnel station 3300, similar to the tunnel stations 3200, 3200' of Figures 27A-27M. As shown in Figure 31A, the stage 3320 may accommodate a longer length L of material 3330. For example, as shown in Figure 31A, the stage 3320 may accommodate two patch structures 3310a, 3310b. Alternatively, the stage 3320 may be expanded to accommodate any number of structures. The stage 3320 may have multiple semicircular reliefs that may be aligned with the lumen forming tools 3324a, 3324b, 3324c, 3324d, similar to the stages of the tunnel station 3200', and the stage 3320 may be self-centering.
[0213] Similar to tunnel stations 3200, 3200' of Figures 27A-27M, tunnel station 3300 may include multiple lumen forming tools 3324a, 3324b, 3324c, 3324d. In the illustrated embodiment, lumen forming tools 3324a, 3324b form first station 3323a, and lumen forming tools 3324c, 3324d form second station 3323b. As shown, lumen forming tools 3324a, 3324b may be angularly offset from one another, for example, by approximately up to about 30 degrees from one another. In one embodiment, lumen forming tools 3324a, 3324b may be angularly offset from one another by approximately 16 degrees from one another. Lumen forming tools 3324c, 3324d of second station 3323b may be similarly offset relative to one another, or alternatively, may be angularly offset at different angles. The second station 3323b may be positioned on the opposite side of the stage 3320 from the first station 3323a to provide easier parallel lumen formation. In alternative embodiments, the lumen forming tools 3324a, 3324b, 3324c, 3324d may be aligned parallel to one another. The lumen forming tools 3324a, 3324b, 3324c, 3324d may be aligned such that each cutting tool 3322a, 3322b, 3322c, 3322d moves toward the stage to form the lumens 3314a, 3314b, 3314c, 3314d in the material 3330. In the illustrated embodiment, two lumen forming stations 3323a, 3323b are shown, however, any number of lumen forming stations may be provided.
[0214] After the lumen forming tools 3324a, 3324b, 3324c, 3324d have been actuated and retracted to form the lumens 3314a, 3314b, 3314c, 3314d in the material 3330, the material 3330 may be advanced in a direction D, as shown in FIG. 31A. The individual structures 3310a, 3310b, 3310c may then be separated by punches 3190a-3190c or other cutting mechanisms provided throughout this disclosure or known to those of skill in the art. The resulting structures 3310a, 3310b, 3310c, 3310d are illustrated in FIG. 31B and FIG. 31C. In this case, the resulting patches 3310a, 3310b, 3310c, 3310d have a generally trapezoidal shape. One of ordinary skill in the art will recognize in light of this disclosure that any number of patch shapes may be formed. For example, lumen forming tools 3324a, 3324b, 3324c, 3324d may be parallel to one another to form a patch having parallel lumens and a rectangular shape.
[0215] How to Use-Tissue Augmentation Patch One exemplary method of attaching the tissue augmentation patch 2210 is illustrated in FIG. 30F. The illustrated method provides a piece of soft tissue 2230, e.g., a rotator cuff, secured to a bone 2250. Either a single row or a double row repair may be used. Once the surgeon has access to the surgical site and the tissue, bone, and tissue augmentation patch are prepared according to common surgical techniques, including those provided herein, the surgeon may perform the tissue repair (not visible because it is under the patch 2210) according to common surgical techniques. As shown in FIG. 30F, a suture 2212 extending from an anchor (not shown) used in the repair is attached medially from the repair and into the tissue 2230, such that two suture limbs 2212a, 2212b extend outwardly from the tissue 2230.
[0216] The tissue augmentation patch 2210 may be threaded over the suture limbs 2212a, 2212b using techniques provided throughout this disclosure, and then advanced along each of the suture limbs 2212a, 2212b until adjacent the inner stitch 2242. Once the tissue augmentation patch 2210 is attached over the suture limbs 2212a, 2212b, the free ends of each of the suture limbs 2212a, 2212b may be secured within the body. For example, the free ends of each of the suture limbs 2212a, 2212b may be coupled to a respective anchor 2260a, 2260b in an outer row fixation. The suture limbs 2212a, 2212b may then be tightened to secure the patch 2210 to the repair, after which the anchors 2260a, 2260b are fully secured to the bone 2250.
[0217] The tissue augmentation patch 2210 may provide a larger footprint for the suture rims 2212a, 2212b, providing a larger surface area for distributing the loading forces of the suture rims 2212a, 2212b onto the soft tissue 2230. While the patient is healing from surgery, the patch may remodel into tendon-like tissue and integrate with the underlying native tissue. The additional tendon-like tissue coverage over the soft tissue may increase the strength of the soft tissue-to-bone attachment and prevent further injury.
[0218] Another exemplary method of attaching the tissue augmentation patch 2210' is provided in Figures 30G-30I where a piece of soft tissue 2230', e.g., the rotator cuff, is secured to a bone 2250' using a dual row repair. Once the surgeon has access to the surgical site and the tissue, bone, and tissue augmentation patch have been prepared according to common surgical techniques, including those provided herein, the surgeon may attach first and second medial anchors 2260a', 2260b' to the bone 2250'. The first and second medial anchors 2260a', 2260b' have sutures 2212', 2216' associated therewith. As shown in FIG. 30G, sutures 2212' and 2216' can have suture limbs 2212a', 2212b', and 2216a', 2216b' extending from each anchor 2260a' and 2260b', which limbs are threaded through tissue 2230', for example, using one or more inner stitches 2242a', 2242b'.
[0219] The patch 2210' can have similar characteristics as the patch 2210 and can be threaded onto the suture limbs 2212a', 2216a' using techniques provided throughout this disclosure. The patch 2210' can then be advanced in direction D1 along each of the suture limbs 2212a', 2216a' until adjacent the inner stitches 2242a', 2242b', as shown in FIG. 30H. After the patch 2210' is attached onto the suture limbs 2212a', 2216a', the free ends of each of the suture limbs 2212b', 2216b' can be positioned on the patch 2210' in an X or cross configuration shown in FIG. 30I. The suture limbs 2212a', 2216b' can then be attached within the outer anchor 2262a' and the suture limbs 2212b', 2216a' can be attached within the outer anchor 2262b' with an outer row fixation. The suture limbs 2212a', 2212b', 2216a', 2216b' can then be tightened to fixate the soft tissue 2230' to the bone 2250', after which the outer anchors 2262a', 2262b' are fully fixed to the bone 2250'. The same benefits as described above with respect to the method of using the patch 2210 are equally applicable to this embodiment using the patch 2210'. Additionally, the crossing nature of the suture configuration provides additional stability to hold the tissue 2230' in a desired position relative to the bone 2250'.
[0220] A further exemplary embodiment of attaching the tissue augmentation patch 2210'' is illustrated in FIGS. 30J-30L and may be used with either the single or double row repairs described above with respect to FIGS. 30F-30I. The illustrated patch 2210'' is threaded over the suture limbs 2212a'', 2216a'' in accordance with the techniques provided throughout this disclosure. The illustrated method provides for the formation of retractable loops 2212l'', 2216l'' and associated knots 2270a'', 2270b'' disposed on the distal end 2210d'' of the patch 2210''. The retractable loops 2212l'', 2216l'' and associated knots 2270a'', 2270b'' may be formed on each suture limb 2212a'', 2216a'' after the suture limbs have been threaded through the patch 2210''. In one exemplary embodiment, the knots may be, for example, sliding knots, figure of eights, or finger traps, among other knot types. The knots 2270a'', 2270b'' may be larger than the associated lumen through which the suture limbs 2212a'', 2212b'' are threaded, such that the knots 2270a'', 2270b'' are not pulled out. The knots 2270a'', 2270b'' may be formed after the patch 2210'' is advanced in the direction D1 until it is adjacent the soft tissue 2230''.
[0221] After the loops 2212l'', 2216l'' are formed, the suture limb 2216b'' can be guided through the loops 2212l'', and the suture limb 2212b'' can be guided through the loops 2216l'', as shown in FIG. 30K. Once the suture limbs 2212b'', 2216b'' are threaded through the suture loops 2212l'', 2216l'', the suture limbs are beneficially maintained in a desired configuration. The suture limbs 2212a'', 2216b'' can then be attached within the outer anchors 2262a'', and the suture limbs 2212b'', 2216a'' can be attached within the outer anchors 2262b'' with an outer row fixation. At this point, the retractable loops 2212l'', 2216l'' can be contracted by applying a force to the suture limbs 2212a'', 2216a'', which can secure the suture limbs 2212b'', 2216b'' in an X or cross configuration as shown in FIGS. 30K and 30L. The suture limbs 2212a'', 2212b'', 2216a'', 2216b'' can then be tightened to secure the soft tissue 2230'' to the bone 2250'', after which the outer anchors 2262a'', 2262b'' are fully secured to the bone 2250''. One benefit of the knots 2270a'', 2270b'' and loops 2212l'', 2216l'' is that the patch 2210'' can be prevented from sliding outward towards the anchors 2262a'', 2262b'' and can be secured relative to the bones 2250'' and 2230''. By reducing the loops 2212l'', 2216l'' around the suture limbs 2212a'', 2212b'', 2216a'', 2216b'', unintentional sliding of the patch 2210'' relative to the suture limbs 2212a'', 2212b'', 2216a'', 2216b'' can be prevented. The loops and knots can be beneficially provided in any of the structures provided herein to prevent outward sliding and hold the structure (including but not limited to tissue augmentation blocks and tissue augmentation patches) after attachment.
[0222] Tissue Augmentation Structures - Further Tissue Augmentation Patches, Methods of Using Same, and Methods of Making Same Another exemplary embodiment of a tissue augmentation structure 2310 having a patch or scaffold configuration is illustrated in FIGURE 32A. As shown, the tissue augmentation patch 2310 has a rectangular shaped body and is generally similar in nature and configuration to the tissue augmentation patch 2210. The patch 2310 differs in that it includes additional lumens 2314a-2314d extending from the proximal-most end 2310p to the distal-most end 2310d to have threaders 2306a-2306d therethrough and thus suture limbs 2312a, 2312b, 2316a, 2316b disposed therein after actuation of the threaders 2306a-2306d. Optionally, threaders 2306a-d may not be used and suture limbs 2312a, 2312b, 2316a, 2316b may be associated with patch 2310 using any technique provided herein or known to one of skill in the art. As shown in FIGURE 32A, lumens 2314a, 2314d can be substantially parallel to both sides of patch 2310 extending between proximal-most surface 2310p and distal-most surface 2310d, and lumens 2314b, 2314c can form a substantially X-shaped or crossed configuration. In the illustrated embodiment, or in other embodiments illustrated herein where a patch has two threaders associated therewith, when the threaders 2306a and 2306b are associated with the patch 2310, the intermediate portion 2307a of the first threader 2306a can be positioned closer to the first side 2310a of the patch 2310 than the second, opposite side 2310b of the patch, and the intermediate portion 2307b of the second threader 2306b can be positioned closer to the second side 2310b than the first side 2310a.Additionally, when the threaders 2306c and 2306d are associated with the patch 2310, the intermediate portion 2307c of the third threader is disposed at an angle relative to the patch 2310 such that the distal receiving end 2309c of the third threader 2306c is proximal to the distal receiving end 2309a of the first threader 2306a, while the proximal handle 2308c of the third threader 2306c is proximal to the proximal handle 2308a of the second threader 2306b. 08b, and an intermediate portion 2307d of the fourth threader may be positioned at an angle relative to the patch 2310 such that a distal receiving end 2309d of the fourth threader 2306d is proximal to the distal receiving end 2309b of the second threader 2306b, while a proximal handle 2308d of the fourth threader 2306d is proximal to the proximal handle 2308a of the first threader 2306a.
[0223] Those skilled in the art will recognize that in any embodiment in which multiple threaders are used with a structure, the locations of the proximal and distal ends of the threaders may differ from the illustrated embodiment depending, at least in part, on the type of procedure being performed, the components used to perform the procedure, and the user's preferences. Thus, in any illustrated embodiment, the locations of the proximal and distal ends of the threaders may be swapped in other embodiments. Furthermore, in any of the illustrated embodiments, the position of any threader relative to the tissue augmentation structure prior to using the threader to associate a suture with the tissue augmentation structure is considered to be a pre-attachment configuration, and after the threader has been used to associate a suture with the tissue augmentation structure and subsequently removed, such configuration is considered to be a post-attachment configuration.
[0224] As shown, patch 2310 has a width W P ' and a length L substantially equal to P ' and thickness T P '. Furthermore, the thickness T P' may be larger than the diameter of the filament or suture with which the tissue augmentation patch 2310 is associated, e.g., suture rim 2312a. In other embodiments, the suture rims 2312a, 2312b, 2316a, 2316b may extend through the lumens 2314a-d without the need to be positioned within the lumens 2314a-d using a threader. The rims 2312a, 2312b, 2316a, 2316b may extend in the same hybrid parallel and cross configuration as shown and described with respect to the location of the threaders 2306a-d.
[0225] Those skilled in the art will appreciate that the length L of the tissue augmentation patch 2310 P ', width W P ', and thickness T P It will be appreciated that the dimensions of the lumens 2314a-d, as well as the diameters of the holes 2314a-d, may depend on a variety of factors, including, but not limited to, the size of the filament associated with the tissue augmentation patch 2310, the patient's anatomy, and the type of surgery being performed. Alternatively, the patch 2310 may have any other shape (e.g., rectangular, trapezoidal, oval, circular, square, pentagonal, hexagonal, octagonal, etc.) and the lumens 2314a-d may follow any path (e.g., they may follow edges). It will be understood that the exemplary, non-limiting dimensions provided above for the patch 2210 may also be applicable to the size of the patch 2310, and that other dimensions are possible. Similarly, numerous techniques known to those of skill in the art can be used to associate patch 2310 with suture limbs 2312a, 2312b, 2316a, 2316b, and the techniques described above with respect to patch 2210 can be adopted for use with patch 2310. Thus, in light of the present disclosure, one of skill in the art will understand how to operate threaders 2306a-d to associate suture limbs 2312a, 2312b, 2316a, 2316b with patch 2310.
[0226] One exemplary method of attaching the patch 2310 is provided in Figures 32B-32E. The illustrated method provides a piece of soft tissue 2330, e.g., a rotator cuff, secured to a bone 2350. Either a single row or double row repair may be used. Once the surgeon has access to the surgical site and the tissue, bone, and tissue augmentation patch are prepared according to common surgical techniques, including those provided herein, the surgeon may perform a single row repair 2340a, 2340b of the tissue 2330 according to common surgical techniques. Alternatively, one repair may be performed on the tissue 2330, or three or more repairs may be completed. 32C, a first suture 2312 can be inserted into the tissue 2330 medially from the repairs 2340a, 2340b with two suture limbs 2312a, 2312b extending out of the tissue 2230, and similarly, a second suture 2316 can be inserted into the tissue 2330 medially from the repairs 2340a, 2340b with two suture limbs 2316a, 2316b extending out of the tissue 2230. In the illustrated embodiment, the sutures 2312, 2316 are inserted into the tissue 2330 using mattress stitches 2342a, 2342b, respectively, although other stitches may be used.
[0227] 32D, the suture limbs 2312a, 2312b, 2316a, 2316b may be threaded into the lumens 2314a-d, respectively, using techniques provided throughout this disclosure, for example, by manipulating the threaders 2306a-d, and the patch 2310 may be advanced along each suture limb 2312a, 2312b, 2316a, 2316b until the proximal end 2310p is adjacent the inner stitches 2342a, 2342b. After the patch 2310 is attached to the suture limbs 2312a, 2312b, 2316a, 2316b, the free ends of each suture limb 2312a, 2316b may be secured within the body. 32E, the free end of each suture limb 2312a, 2316b, and 2312b, 2316a can be coupled to an outer anchor 2362a and 2362b, respectively, in an outer row fixation. The suture limbs 2312a, 2312b, 2316a, 2316b can then be tightened to secure the patch 2310 to the repair 2340, after which the outer anchors 2360a, 2360b are fully secured to the bone 2350.
[0228] Another exemplary method of attaching a tissue augmentation patch 2310' is provided in Figures 32F-H where a piece of soft tissue 2330', e.g., the rotator cuff, is secured to a bone 2350' using a dual row repair. Once the surgeon has access to the surgical site and the tissue, bone, and patch have been prepared according to common surgical techniques, including those provided herein, the surgeon may attach first and second medial anchors 2360a', 2360b' to the bone 2350'. The first and second medial anchors 2360a', 2360b' have sutures 2312', 2316' associated with them. As shown in FIG. 32F, the sutures 2312' and 2316' can have suture limbs 2312a', 2312b' and 2316a', 2316b' extending from each anchor 2360a' and 2360b', which limbs are threaded through the tissue 2330' using, for example, one or more inner stitches 2342a', 2342b'.
[0229] Patch 2310' can have similar characteristics as patch 2310 and can be threaded over suture limbs 2312a', 2312b', 2316a', 2316b' using techniques provided throughout this disclosure. As shown in Figures 32G and 32H, patch 2310' can then be advanced along suture limbs 2312a', 2312b', 2316a', 2316b' until proximal end 2310p' is adjacent inner stitches 2342a', 2342b'. After the patch 2310' is installed over the suture limbs 2312a', 2312b', 2316a', 2316b', the free ends of each of the suture limbs 2312a', 2316b', and 2312b', 2316a' may then be installed in the respective outer anchors 2362a' and 2362b' in an outer row fixation. The suture limbs 2312a', 2312b', 2316a', 2316b' may then be tightened to fixate the patch 2310' to the repair 2340', after which the outer anchors 2360a', 2360b' are fully fixed to the bone 2350'. The same benefits discussed above with respect to the method of use of the patch 2210' are equally applicable to the embodiments using the patches 2310 and 2310'. Such benefits include those that arise due to the crossed nature of the suture configuration. Additional benefits of these two embodiments will be apparent to those of skill in the art in view of this disclosure.
[0230] The patch 2310 may be manufactured using a number of different techniques, some of which have been previously discussed above with respect to at least the tissue augmentation blocks 10, 110, and other structures. The patch 2310, and therefore also the patch 2310', may be made from any of the materials provided above with respect to the tissue augmentation blocks 10, 110, 3010, 3110, 310, and 410 and / or other structures described herein. In one exemplary embodiment for making the patch illustrated by FIGS. 32I and 32J, the materials used to make the patch 2310 may be collected or otherwise obtained using the same techniques as described above with respect to the patch 2210. As shown in FIG. 32I, the piece of material 2320 may have a first end 2320a and a second end 2320b, and may have a width 2W extending therebetween. P Alternatively, the piece of material 2320 may have any shape.
[0231] When the piece of material 2320 is cut, the two ends 2320a, 2320b are cut to a width of 2W PThe first and second ends 2320a, 2320b may be folded away from each other about ¼ of the length of the patch 2310, proximate to each other, and then attached to each other to form the patch 2310. As shown in FIG. 32J, the patch 2310 is stitched together to form the folded patch. The stitches 2324a-d are performed such that two parallel lumens 2314a, 2314b are formed in combination with the X-shaped lumens 2314c, 2314d. The first stitch 2324a may be substantially V-shaped with both ends located at the distal-most end 2310d of the patch 2130 and the apex of the V-shape pointing toward the proximal-most end 2310p of the patch 2130. The second stitch 2324b may be substantially V-shaped with both ends located at the proximal-most end 2310p of the patch 2130 and the apex of the V-shape facing the distal-most end 2310d of the patch 2130. The third and fourth stitches 2324c, 2324d may be substantially triangular in shape and may be substantially a mirror image of the other to define the lumens 2314a, 2314d. Alternatively, pins may be placed along where the lumens 2314a-d are located and then the patch 2310 may be stitched together to produce the patch 2310. The pins may be removed once the patch is produced. Further alternatively, instead of stitches, the material 2320 itself may be secured by glue, collagen bond, staples, light curing, or other techniques for attaching soft tissue to soft tissue known to those of skill in the art and provided throughout this disclosure.
[0232] In embodiments including pre-placed threaders on the patch 2310, the threaders 2306a-d can be inserted into the lumens 2314a-d after which the two ends 2320a, 2320b are attached. Or, the two ends 2320a, 2320b are attached and then the threaders 2306a-d are inserted into the lumens 2314a-d. The patch 2320 can be dried for packaging at any suitable point during the manufacturing process. Further alternatives for forming patch 2310 in accordance with the present disclosure include, but are not limited to, collecting a piece of material, piercing or punching the piece of material using a pin to form lumens 2314a-2314d, as described at least with respect to Figures 30C-30E, and using a coring device or tube to form lumens 2314a-2314d, as described at least with respect to Figures 26A-26I.
[0233] Many more configurations of patches and sutures are within the scope of this disclosure. Configurations can be obtained by adjusting various parameters or variables provided and discussed throughout this application. Some parameters or variables that can be altered to provide various configurations include: (1) the number of layers used to form the patch (e.g., one layer, two layers); (2) the orientation of the first set of suture limbs relative to each other and to the patch (e.g., limbs traverse the patch in a non-crossing manner, limbs traverse the patch in a crossing manner, etc.); (3) the location of the second set of suture limbs relative to the patch (e.g., on top of the patch, through the patch, etc.); (4) the orientation of the second set of suture limbs relative to each other and to the patch (e.g., limbs traverse the patch in a non-crossing manner, limbs traverse the patch in a crossing manner, etc.); (5) inclusion of one or more "stitches" with the first set of suture limbs to secure the patch to at least one of the suture limbs (referred to herein as "loops" and "jogs"); (6) whether the second set of suture limbs is disposed in a lumen formed in the patch; (7) whether additional sutures are provided (e.g., inner central suture, outer central suture); and (8) the location of the first set of suture limbs relative to the second set of suture limbs (e.g., inner of the second set of suture limbs, outer of the second set of suture limbs).
[0234] A small sample of some patch configurations illustrating options for the parameters or variables listed above are shown in FIGS. 33A-E. Some configurations may be better than others to aid in patch delivery and / or to aid in attaching the patch to soft tissue. Those skilled in the art will appreciate that the various parameters can be combined and matched to arrive at a plethora of configurations, many of which are not explicitly illustrated herein but can be derived based on an understanding provided for each of the variables and structures disclosed herein more generally. To aid in understanding some of the options associated with the parameters listed above, each parameter is discussed in more detail below with a limited number of example configurations illustrated. However, the present disclosure is intended to encompass each separate combination of parameters along with the many different patch configurations provided in the present disclosure. Additionally, because the parameters are interchangeable across various configurations (e.g., patches, sutures, and anchors) using the same materials, the same reference numbers are used across each of the examples illustrated in FIGS. 33A-E.
[0235] One parameter that may be varied to achieve various patch configurations is the number of layers forming each patch. For example, each patch may include a single layer of material. In this case, a lumen is formed in the single layer for placement of a suture limb therethrough, as illustrated in FIGS. 26D-F, 30A, 30B, and 31A-C. The single layer may include a tissue-facing or tissue-engaging surface, also referred to herein as the bottom side 3410d of the patch 3410, and a second surface opposite the tissue-facing surface (e.g., the surface visible in FIGS. 33A-E), also referred to herein as the top side 3410p of the patch 3410. Alternatively, each patch may include two or more layers of material stitched together to form a patch with a lumen formed between the two or more layers for placement of a suture limb therethrough, as illustrated in FIGS. 32A-J. When a second layer is used, each layer includes a tissue-facing surface and a second surface opposite the tissue-facing surface. In such an embodiment, the tissue-facing surface of the patch is formed by the tissue-facing surface of the bottom or more distal patch, and the second surface of the patch opposite the tissue-facing surface is formed by the second surface of the top or more proximal patch. Even in a patch that includes multiple layers, the lumen may be formed in one layer. In an embodiment in which the patch includes two layers, stitches may form the lumen, as described with reference to Figures 32A-32J. For purposes of brevity, a first set of suture limbs 3412, 3414 and a second set of suture limbs 3416, 3418 will be referenced in the discussion below, although one set may be used. As discussed above, in an embodiment in which two layers of material are used, each layer may be formed from a different material to provide various advantages. Advantages include, but are not limited to, that the overall thickness of the patch construction may not be limited by biological sources, the level of cellular activity can be controlled (e.g., a high tissue integration layer on the tissue-facing side and an adhesion barrier layer on the opposite side), and other material properties can be varied between layers (e.g., durability, biological / synthetic, thick / thin, high / low-porosity, etc.).
[0236] As shown in FIG. 33A, two inverted mattress stitches 3440a, 3440b may be formed in the soft tissue medial to any repair (repair not shown). More specifically, a first suture 3411a may be used to form the first inverted mattress stitch 3440a and a second suture 3411b may be used to form the second inverted mattress stitch 3440b. The first mattress stitch 3440a may have a suture rim 3412 and a suture rim 3416 extending therefrom and the second mattress stitch 3440b may have a suture rim 3414 and a suture rim 3418 extending therefrom. For purposes of explanation only, the suture rims 3412 and 3414 are defined as a first set of suture rims and the suture rims 3416 and 3418 are defined as a second set of suture rims. For purposes of brevity, each of the embodiments shown in Figures 33A-33E illustrates two mattress stitches, and so the discussion will not be repeated for each figure.
[0237] Further, as shown in each embodiment, the suture rims 3412, 3414 of the first set of suture rims generally pass through the patch 3410. This may include configurations in which the suture rims 3412, 3414 extend through the patch 3410 for the entire length of the patch, i.e., from the inner edge 3410M to the opposing outer edge 3410L, or configurations in which the suture rims 3412, 3414 extend through the patch 3410 for a portion of its length. Generally, the suture rims 3412, 3414 extend along a length that extends substantially between the inner edge 3410M and the opposing outer edge 3410L. For example, as shown in FIG. 33D, the suture rims 3412, 3414 do not extend the entire length of the patch 3410, but rather a significant portion of its length. A substantial portion of the length can be at least about 50 percent of the length, or alternatively, at least about 75 percent of the length, or even alternatively, at least about 90 percent of the length.
[0238] When the suture rims 3412, 3414 and 3416, 3418 are passed through the patch, they do so by directing the ends of the suture rims through, over and / or under a portion of the patch 3410. The ends described as passing through the patch in the illustrated embodiment can be considered to be the outer ends, since they are the ends that pass toward the outer edge 3410L and toward the illustrated anchors 3460a, 3460b. When the outer ends are described as connecting to the anchors, one skilled in the art will recognize that it is not necessarily the outer ends of the suture rims themselves that are attached to the anchors. This is because, in associating a suture with an anchor, the ends may extend some distance beyond the anchor, for example, as a result of tying the suture to the anchor. Thus, a description of the outer ends of the suture rims being attached to or otherwise connected to an anchor does not require that the ends of the sutures themselves be in contact with or directly connected to the anchors. Rather, some portion of the limbs, as one skilled in the art would understand in view of this disclosure, are just shown to be equivalent to the ends of the system when the patch-suture configuration is the outer ends described. Moreover, as shown, the anchors 3460a, 3460b are disposed on either side of a central longitudinal axis 3410c extending between the inner side 3410M and the outer side 3410L of the patch 3410. In general, the outer ends of the various suture limbs may be described as proximate to one another when associated with anchors. One skilled in the art will recognize that the outer ends of the suture limbs on the same side may also be described as proximate to one another in view of this disclosure even when the outer ends are associated with different anchors on the same side of the scaffold and / or associated with one or more other fixation objects (including, but not limited to, bone, tissue, and medical implants) on the same side of the scaffold.
[0239] A second parameter that may be varied to achieve various patch configurations relates to the orientation of the first set of suture limbs relative to each other and relative to the patch. For example, as shown in FIG. 33A, the first set of suture limbs 3412, 3414 may each be positioned across the patch 3410 from the inner edge 3410M to the outer edge 3410L in a manner such that the limbs do not cross each other. In the illustrated embodiment, the limbs 3412, 3414 extend substantially parallel to each outer edge 3410S, 3410T of the patch 3410 and are positioned on separate halves of the central longitudinal axis 3410c. This configuration may provide additional fixation of the limbs 3410S, 3410T when the limbs 3412, 3414 are extended beyond the edges. One skilled in the art will recognize that the limbs 3412, 3414 may be oriented in many other ways relative to each other and the patch 3410 without them crossing. For example, the first set of suture limbs 3412, 3414 may be arranged to be substantially parallel to one another as the limbs extend substantially straight across the patch 3410 from the inner edge 3410M to the outer edge 3410L. Examples of limbs configured in this manner are illustrated in at least Figures 30A-L (e.g., limbs 2212a and 2212b, limbs 2212a' and 2216a', and limbs 2212a'' and 2216a'').
[0240] In a further alternative, the first set of suture limbs 3412, 3414 may be arranged across the patch 3410 from the inner edge 3410M to the outer edge 3410L in such a manner that the limbs cross over one another. For example, the limbs 3412, 3414 may be arranged across the patch 3410 to form an X-configuration or shape similar to limbs 2212b' and 2216b' in FIG. 30I, limbs 2312b, 2316b in FIG. 32A-32E, limbs 2312b', 2316b' in FIG. 32F-32H, and limbs 3416 and 3418 in FIG. 33B (which are described as a second set of limbs but are generally referenced for purposes of illustrating the crossing configuration). This configuration may provide more distributed compression over a larger area of the structure. Those skilled in the art will recognize that the rims 3412, 3414 can be oriented in many other ways relative to each other and the patch 3410, even while intersecting each other. Additionally, insofar as the rims 3412, 3414 are described as being disposed across the patch, they can extend across the top surface of the patch, through the patch (e.g., disposed between two layers, through a single layer), or a combination of both across the top surface of the patch and through the patch. Additionally, the rims 3412, 3414 need not be oriented in a similar manner. For example, the rim 3412 can extend substantially parallel to the outer edge 3410S, or extend substantially straight across the patch 3410, with the rim 3412 remaining to one side of the central longitudinal axis 3410c, while the rim 3414 extends more diagonally to intersect the central longitudinal axis 3410c.
[0241] A third parameter that may be varied to achieve various patch configurations relates to the location of the second set of suture limbs relative to the patch. For example, the second set of suture limbs 3416, 3418 may be positioned such that they extend through the patch from the inner edge 3410M to the outer edge 3410L, similar to the orientation of limbs 2312b and 2316b and limbs 2312b' and 2316b' in Figures 32A-32J. Advantageously, if at least one suture limb is positioned through the patch, the patch may be more secured after installation. Alternatively, the second set of suture limbs 3416, 3418 may be positioned on the top surface of the patch 3410, similar to the orientation of limbs 2212b and 2216b, limbs 2212b' and 2216b', and limbs 2212b'' and 2216b'' in Figures 30A-30L. In some examples, some portion of the second rim may extend through the patch, while some other portion extends on the top surface of the patch, and the configuration of this parameter for any rim need not be the same as any other rim.
[0242] A fourth parameter that may be varied to achieve various patch configurations relates to the orientation of the second set of suture limbs relative to each other and relative to the patch. For example, the second set of suture limbs 3416, 3418 may each be arranged across the patch 3410 from the inner edge 3410M to the outer edge 3410L in a manner such that they do not cross each other or in a manner such that they do cross. The possibilities for such configurations are similar to those discussed above with respect to the second parameter, which was for the orientation of the first set of suture limbs relative to each other and the patch. Furthermore, in some instances, the second suture limbs 3416, 3418 may not extend on or through the patch 3410, but rather may extend around and / or adjacent to the patch 3410. The first suture limbs 3412, 3414 may also be configured in such a manner that at least a portion of them extend around and / or adjacent to the patch 3410, rather than over or through the patch.
[0243] As a non-limiting example, FIG. 33A illustrates an embodiment in which the second set of suture rims 3416, 3418 do not intersect and extend around and / or adjacent to the patch 3410 such that the rims 3416, 3418 do not extend over or through the patch 3410. As a further non-limiting example, FIG. 33C and FIG. 33E each illustrate an embodiment in which the second set of rims 3416, 3418 do not intersect and extend over the top surface of the patch 3410. As shown in FIG. 33D, various orientations can be combined over the length extending between the inner edge 3410M and the outer edge 3410L. For example, as shown, the rims 3416, 3418 do not intersect, but the orientation of the rims relative to the patch 3410 changes as the rims extend between the inner edge 3410M and the outer edge 3410L. More specifically, as shown, a first portion 3416p1, 3418p1 of each rim 3416, 3418 extends around and / or adjacent to the patch 3410, a second portion 3416p2, 3418p2 of each rim 3416, 3418 extends over the top surface of the patch 3410, and a third portion 3416p3, 3418p3 of each rim 3416, 3418 extends through the patch 3410. The orientation of the first set of suture limbs 3412, 3414 may likewise have different configurations over their lengths.
[0244] FIG. 33B, on the other hand, provides an embodiment in which the second set of suture limbs 3416, 3418 intersect. As shown, the limbs 3416, 3418 are arranged across the patch 3410 (through the patch, as shown) to form an "X" configuration or shape, similar to limbs 2212b and 2216b' in FIG. 30I, limbs 2312b, 2316b in FIGS. 32A-32E, and limbs 2312b', 2316b' in FIGS. 32F-32H. The "X" configuration may provide more distributed compression over a larger area of the structure. One skilled in the art will recognize that the limbs 3416, 3418, while still intersecting each other, may be oriented in many other ways relative to each other and the patch 3410. Further, in the illustrated embodiment of Figure 33B, the rims 3416, 3418 extend through the patch 3410, however, they may extend across the top surface of the patch and / or around or adjacent to the patch, or any combination thereof. Similarly, a rim that extends through a patch may extend through a single layer and / or be disposed between two layers.
[0245] A fifth parameter that may be varied to achieve various patch configurations relates to the inclusion of one or more "stitches" with the first set of suture limbs. As described in this disclosure, these "stitches" may be referred to as "loops" as shown and described with respect to FIG. 33C and "jogs" as shown and described with respect to FIG. 33D. As described in more detail below, stitching for both loops and jogs involves passing an end of a suture limb through at least a portion of the patch (e.g., through the most proximal surface of the patch) and then through the outer edge of the patch. A loop may include a suture limb that passes through the entire length of the patch extending between the inner and outer edges, while a jog may include a suture limb that passes through a portion of the length, which need not be the entire length (but may be a significant portion of the length). Loops and jogs are used to help secure the patch to at least one suture limb.
[0246] As shown in FIG. 33C, the loop stitch or loop 3444a may be formed by passing the suture rim 3412 from the bottom side 3410d of the patch 3410 facing the soft tissue 3430 to the top side 3410p of the patch 3410 at a location 3408a proximate the inner edge 3410M. The location 3408a may be a preformed lumen or may be a lumen formed during advancement of the suture rim 3412 through the patch 3410, for example because the material of the patch 3410 is knitted such that the rim 3412 may pass through it. The patch 3410 may include at least one outer lumen 3407a, 3407b extending from the inner edge 3410M to the outer edge 3410L. Alternatively, the lumens 3407a, 3407b may not be preformed or present, but may instead simply be locations within the patch 3410 where a filament may pass, for example, between two layers or through a single layer with material to aid in the passage of the material. The suture 3412 may then be threaded inwardly to enter the lumen 3407a at the inner edge 3410M and extend through the lumen to the outer edge 3410L. When tension is applied to the loop 3444a and the loop contacts the patch 3410, the suture rim 3412 may be secured relative to the patch 3410 so that the patch 3410 does not slide along the suture 3412 after implantation. The loop 3444a may also provide additional stability during patch attachment. This process may be repeated to form a second loop stitch or loop 3444b for the suture rim 3414. The loops 3444a, 3444b can be formed in vivo, or alternatively, can be formed before the patch is introduced to the surgical site using a patch delivery system described below. The free ends (also referred to herein as outer ends) of each suture limb 3412, 3416, and 3414, 3418 can then be anchored within the body using techniques provided throughout this disclosure. For example, as shown in FIG. 33C, the free ends of each suture limb 3412, 3416, and 3414, 3418 can be coupled to outer anchors 3460a and 3460b, respectively, in an outer row fixation.The suture limbs 3412 , 3414 , 3416 , 3418 can then be tightened to secure the patch 3410 to the repair, after which the outer anchors 3460 a , 3460 b are fully secured to the bone 3450 .
[0247] Alternatively, instead of a loop, the suture rims 3412 of the first set of suture rims 3412, 3414 may be used to form a jog. As shown in FIG. 33D, the jog stitch or jog 3446a may be formed by passing the suture rim 3412 from the bottom side 3410d of the patch 3410 to the top side 3410p of the patch 3410 at a location 3408a proximate the inner edge 3410M, then advancing the suture rim 3412 toward the outer edge 3410S, and then passing the suture rim 3412 back into the patch 3410 from the top side 3410p toward the bottom side 3410d. The suture rim 3412 may then be advanced toward the outer edge 3410L. In the illustrated embodiment, the suture rim 3412 passes through an outer lumen 3407a, which extends from the inner edge 3410M to the outer edge 3410L. Alternatively, the lumen 3407a and / or the other lumen 3407b shown may not be preformed or present, but may instead simply be a location within the patch 3410 where the filament may pass, for example, between two layers or through a single layer with material that aids in the passage of the material. As with the embodiment in FIG. 33C, the location 3408a may be a preformed lumen or may be a lumen formed during advancement of the suture rim 3412 through the patch 3410, for example because the material of the patch 3410 is braided such that the rim 3412 may pass through it. As shown, the portion of the rim 3412 that extends through the patch 3410 extends a significant portion of the length of the rim, extending between the inner edge 3410M and the outer edge 3410L, but not the entire length.
[0248] In forming the jog 3446a, the suture 3412 may be advanced any desired distance toward the outer edge 3410S, based at least in part on the size of the patch 3410 and the desired configuration of the patch and suture combination. By way of non-limiting example, in some embodiments, the jog 3446a may extend substantially perpendicular to the central longitudinal axis 3410c and may extend approximately from about 1.0 millimeter to about 5.0 millimeters away from the location 3408a. When tension is applied to the jog 3446a and the jog 3446a contacts the patch 3410, this may secure the suture limb 3412 relative to the patch 3410 so that the patch 3410 does not slide along the suture limb 3412 after implantation. The jog 3446a may also provide additional stability during patch attachment. A second jog stitch 3446b may be formed by the second limb 3414. The jog stitches 3446a, 3446b can be formed in vivo, or alternatively, can be formed before the patch 3410 is introduced to the surgical site using a patch delivery system described below. Alternatively, the two sutures of the first set of suture limbs 3412, 3414 can be associated with the patch 3410 with a different stitch or without an additional stitch. Additionally, in some instances, a combination of loops and jogs can be used.
[0249] A sixth parameter that may be varied to achieve various patch configurations relates to whether the second set of suture limbs are disposed in a lumen formed in the patch, or alternatively through a portion of the patch through which the first set of suture limbs pass. One example of such a configuration is illustrated in FIG. 33D. As shown, the second set of suture limbs 3416, 3418 may be introduced into each lumen 3407a, 3407b of the patch 3410 along with one of the suture limbs 3412, 3414 of the first set of suture limbs. This is done at lateral locations 3409a, 3409b relative to the inner edge 3410M of the patch 3410. This configuration of the second set may provide additional fixation of the patch in the anterior-posterior direction. Those skilled in the art will recognize that the location at which the second or first set of suture limbs are disposed within the patch 3410 may vary without departing from the spirit of the present disclosure.
[0250] A seventh parameter that may be varied to achieve various patch configurations is the inclusion of additional sutures, such as a central inner suture or a central outer suture, to provide additional fixation of the patch at a location separate from the lumen. For example, as shown in FIG. 33E, one or more central inner inverted mattress stitches 3470 may be formed in the soft tissue 3430 medial to the patch 3410. In the illustrated embodiment, the stitches 3470 are generally aligned with the first and second mattress stitches 3440a, 3440b, although other configurations, locations, and numbers of stitches are possible without departing from the spirit of the present disclosure. The central inner inverted mattress stitch 3470 may be generally aligned with the center of the patch 3410 in some instances, for example, in the illustrated embodiment. The central inner stitch 3470 may have suture rims 3472a, 3472b extending therefrom. The suture limbs 3472a, 3472b may be disposed on the proximal surface 3410p of the suture patch 3410 and secured by suture anchors 3460a, 3460b, respectively, in accordance with the techniques provided herein.
[0251] Alternatively or in addition to the central inner inverted mattress stitch 3470, the central outer mattress stitch 3474 may be pre-attached onto the patch at a location on the outer half of the patch. Alternatively, the central outer mattress stitch 3474 may be formed in vivo into the patch 3410. The central outer mattress stitch 3474 may be generally aligned with the center of the patch 3410. As with the inner inverted mattress stitch, many different configurations, locations, and numbers of stitches are possible, and in the illustrated embodiment, the inverted mattress stitch 3474 results in suture rims 3476a, 3476b extending from the patch 3410. In the illustrated embodiment, the suture rims 3476a, 3476b are disposed on the proximal surface 3410p of the suture patch 3410 and are further secured to the suture anchors 3460a, 3460b. Both the central inner stitch and the outer central stitch may provide additional compression of the patch against the soft tissue to aid in healing. The patch 3410 illustrated in Figure 33E illustrates both a central inner mattress stitch and a central outer mattress stitch in the same embodiment, while in other embodiments only one or none may be provided. Additionally, other locations for the additional stitches are possible without departing from the spirit of this disclosure.
[0252] An eighth parameter that may be varied to achieve various patch configurations is the position of the first set of suture limbs relative to the second set of suture limbs. More specifically, this parameter relates to whether the limbs of the first set of suture limbs are disposed on the inside or outside of the second set of suture limbs. In this case, outside refers to being further from the central longitudinal axis 3410c. In the embodiment illustrated in Fig. 33A and Fig. 33D, the first set of suture limbs are disposed on the inside of the second set of suture limbs, while in the embodiment illustrated in Fig. 33B, 33C, and Fig. 33E, the first set of suture limbs are disposed on the outside of the second set of suture limbs. With particular reference to Fig. 33D, the first set of suture limbs are disposed on the inside of the second set of suture limbs until they converge at a position 3409a, which is the point at which they are substantially aligned. Thus, the orientation of the suture limbs of the first set relative to the suture limbs of the second set may vary between the inner edge 3410M and the outer edge 3410L, including having some portions inside the other and some portions outside the other. Furthermore, one skilled in the art will recognize that each limb of a set of limbs need not be arranged in the same manner. This means that some limbs of the first set of limbs can be arranged inside one or more limbs of the second set of limbs, and similarly, some limbs of the first set of limbs can be arranged outside one or more limbs of the second set of limbs, in the same patch configuration.
[0253] In particular, almost any of the parameters or variables described above may be combined and coordinated into one or more patch configurations without departing from the spirit of this disclosure. Thus, there are many other configurations that may result from this disclosure. The term "most any" is used because one of ordinary skill in the art would recognize that depending on the values of some of these parameters, some of the other parameters may not be adjustable, and one of ordinary skill in the art would recognize such in light of this disclosure and the knowledge of the art. FIGS. 33A-E represent a small sample of possible configurations intended to illustrate various configurations based on the eight parameters identified in this disclosure. Each of the illustrated configurations may be used with a variety of procedures. FIG. 33C represents one particularly useful configuration in that it provides the stability provided by the loops 3444a, 3444b, and provides a configuration in which the first set of limbs are disposed approximately straight through the patch 3410 to provide additional fixation of the edges 3410S, 3410T. Additionally, this configuration is particularly useful because the second set of limbs are positioned generally straight on the patch 3410 (as opposed to crossing in an "X" configuration or shape) to aid in medialization of the patch and ease of pulling the limbs, the four limbs reduce the possibility of undesirable "cheese-wiring," and this configuration does not include additional stitches, etc., and may be easier and / or quicker to perform than some options that include additional stitches.
[0254] Yet another exemplary embodiment of a tissue augmentation structure 2410 having a patch or scaffold configuration is illustrated in Figures 34A and 34B. As shown, the patch 2410 has a generally rectangular body with rounded corners. Alternatively, the patch 2410 may have any shape, for example, a circular shape. The patch 2410 may be disposed on or otherwise associated with the sutures 2412, 2416. As shown, the patch 2410 has a width W P '' and a length L substantially equal to P '', and has thickness T P '' is also included.
[0255] Those skilled in the art will appreciate that the length L of the augmentation patch 2410 P '', width W P '', thickness T P It will be appreciated that the dimensions of "" may depend on a variety of factors, including, but not limited to, the size of the filament with which the augmentation patch 2410 is associated, the patient's anatomy, and the type of surgery being performed. It will be understood that the exemplary, non-limiting dimensions provided above for the patch 2210 may be applicable to the size of the patch 2410, and other dimensions are possible. Similarly, numerous techniques known to those of skill in the art may be used to associate the augmentation patch 2410 with the sutures 2412, 2416. However, FIGS. 34A and 34B illustrate one exemplary method for using the suture threaders 2406a, 2406b to associate the patch 2410 with the sutures 2412, 2416.
[0256] 34A and 34B, the suture limbs 2412, 2416 are threaded onto the patch 2410 at inner locations 2411a, 2411b, respectively, of the patch to secure the sutures 2412, 2416 in a pre-attachment configuration relative to the patch 2410. In the illustrated embodiment, the inner locations 2411a, 2411b are located approximately midway between the sides 2410a, 2410b of the patch 2410, although other locations are possible. The sutures 2412 and 2416 may be stitched or otherwise threaded onto the patch 2410 such that the two suture limbs 2412a, 2412b and 2416a, 2416b, respectively, extend from a proximal surface of the patch 2410. The suture limbs 2412a and 2416a can each have a first portion including a hollow self-locking mechanism 2470a and 2470b having a lumen 2472a and 2472b extending therethrough. In the illustrated embodiment, the self-locking mechanisms 2470a, 2470b are finger-trap like configurations, however, other self-locking mechanisms provided herein or known to one of ordinary skill in the art can be used in view of the present disclosure.
[0257] Each of the self-locking features 2470a, 2470b may have a length that is less than the distance extending between the side 2410a of the patch 2410 and each of the stitches 2411a, 2411b. A suture threader 2406a, 2406b may be inserted through each of the self-locking features 2470a, 2470b such that the proximal handle portion 2408a, 2408b is located proximate the respective intermediate position 2411a, 2411b and the distal suture receiving end 2409a, 2409b is located proximate the side 2410a than the side 2410b. The suture limbs 2412a, 2416a may have a respective leading tail 2413a, 2413b extending from the self-locking features 2470a, 2470b. As shown, the leading tail 2413a, 2413b of each suture 2412, 2416 may be threaded from the proximal surface 2410p to the distal surface 2410d of the patch 2410 closer to the side 2410a than the side 2410b. Additionally, as shown, the suture limbs 2412b, 2416b are threaded from the proximal surface 2410p to the distal surface 2410d of the patch 2410 closer to the side 2410b than the side 2410a to form the trailing tail. Those skilled in the art will recognize various other ways in which the patch 2410 may be associated with the sutures 2412, 2416 without departing from the spirit of the present disclosure.
[0258] 34C-34J provide one exemplary method of attaching a tissue augmentation patch 2410 to aid in securing a piece of soft tissue 2430, e.g., a rotator cuff, to a bone 2450 using a single row repair 2432. As with many other methods provided herein, the patch 2410 and associated techniques may also be used for other types of repairs, e.g., double row repairs. Once the surgeon has access to the surgical site and the tissue, bone, and tissue augmentation patch have been prepared according to common surgical techniques, including those provided herein, the tissue 2430 may be secured to the bone 2450 using sutures 2403 attached to anchors 2404 inserted into the bone 2450, as shown in FIG. 34C. Although one suture 2403 and one anchor 2404 are shown, multiple may be used to effectively secure the tissue 2430 to the bone 2450. Additionally, in the illustrated embodiment, only components associated with one of the threaders and sutures are visible for the perspective shown, but one of ordinary skill in the art will appreciate that other threaders and sutures may be operated in a similar manner, and for ease of explanation, both components may be referenced even if only one is visible.
[0259] Once the tissue 2430 is secured to the bone 2450, the leading tails 2413a, 2413b can be stitched into the tissue and to the inside of the repair, as shown in FIG. 34D. In the illustrated embodiment, the leading tails 2413a, 2413b are threaded in and out of the tissue 2430, for example, using a mattress stitch 2442a. As shown in FIG. 34E, the leading tail 2413a can be coupled to the suture receiving end 2409a of the suture threader 2406a, which can then be manipulated to advance the leading tail 2413a through the lumen 2472a of the self-locking mechanism 2470a, as provided in this disclosure. A similar action may be performed on the leading tail 2413b such that it is disposed within the lumen 2472b of the self-locking mechanism 2470b, although as noted above, this is not visible in the illustrated perspective. After the distal ends of the tails 2413a, 2413b have passed through their respective self-locking mechanisms 2470a, 2470b such that the distal ends are visible and can be grasped by the user, as shown in FIG. 34F, the threaders 2406a, 2406b may be disengaged from the tails 2413a, 2413b and discarded and / or prepared for future use. In the illustrated embodiment, the self-locking mechanisms 2470a, 2470b may be operable to advance each leading tail 2413a, 2413b i...
Claims
1. 1. A foldable soft tissue repair system, comprising:
1. A tissue-augmenting scaffold comprising: a first layer of material; a tissue-facing surface; a second surface opposite the tissue-facing surface; the first layer of material includes two or more penetration features each defining a fold axis that spans at least a portion of the length of the first layer of material; the two or more penetration mechanisms enable the tissue-augmented scaffold to fold about the fold axis to reduce an insertion profile of the tissue-augmented scaffold relative to the fold axis; A foldable soft tissue repair system, wherein the two or more penetration features include at least one first penetration feature defined on the tissue-facing surface and at least one second penetration feature defined on the second surface.
2. the tissue-facing surface defines the first intrusion mechanism along a first folding axis, the first intrusion mechanism configured to bias folding of the first layer of material in a first direction; 2. The foldable soft tissue repair system of claim 1, wherein the second surface defines the second intrusion mechanism along a second folding axis, the second intrusion mechanism configured to bias folding of the first layer of material in a second direction opposite to the first direction.
3. 2. The foldable soft tissue repair system of claim 1, wherein each of the two or more penetration mechanisms is a break in the first layer of material from an inner edge of the first layer of material to an outer edge of the first layer of material along a respective folding axis.
4. 2. The foldable soft tissue repair system of claim 1, wherein each of the two or more penetration mechanisms is a channel cut in the first layer of material from an inner edge of the first layer of material to an outer edge of the first layer of material along each of the folding axes.
5. 2. The foldable soft tissue repair system of claim 1, wherein the first layer of material includes first, second, and third segments, the first intrusion mechanism being defined at a boundary between adjacent first and second segments, and the second intrusion mechanism being defined at a boundary between adjacent second and third segments.
6. 2. The foldable soft tissue repair system of claim 1, wherein the tissue augmentation scaffold comprises at least one of a fabric, a plastic, a synthetic polymer, a natural polymer, collagen, a collagen scaffold, a reconstituted collagen, a biological autograft connective tissue, a biological allograft connective tissue, a biological xenograft connective tissue, a human dermal matrix, a porcine dermal matrix, a bovine dermal matrix, a periosteum tissue, a pericardial tissue, and a fascia.
7. The foldable soft tissue repair system of claim 6 , wherein the tissue augmentation scaffold comprises collagen.
8. The foldable soft tissue repair system of claim 3 , wherein the depth of the cut is less than a thickness of the first layer of material.
9. The foldable soft tissue repair system of claim 3 , wherein the incision has a triangular shape in a cross section perpendicular to the folding axis.
10. 10. The foldable soft tissue repair system of claim 9, wherein the gap defined by the first penetration feature tapers from the tissue facing surface toward the second surface and the gap defined by the second penetration feature tapers from the second surface toward the tissue facing surface.
11. The foldable soft tissue repair system of claim 4 , wherein the depth of the notch channel is less than a thickness of the first layer of material.
12. The collapsible soft tissue repair system of claim 4 , wherein the notched channel has a trapezoidal shape in a cross section perpendicular to the folding axis.
13. 13. The foldable soft tissue repair system of claim 12, wherein the cutout channel defined by the first penetration feature tapers from the tissue-facing surface toward the second surface and the cutout channel defined by the second penetration feature tapers from the second surface toward the tissue-facing surface.
Citation Information
Patent Citations
Method and device for delivering and affixing tissue scaffold
JP2010227578A
flexible deformable suture anchor
JP2016507346A
Tissue augmentation tacks for use with soft tissue fixation repair systems and methods
JP2019000637A
Porous three dimensional nest scaffolding
US20070168021A1
Deterministic Manufacturing Process For Creating 3D Living Tissues Based on 2D Directed Assembly And Origami Techniques
US20160032239A1
